EP1565540B1 - Liquid crystalline compounds - Google Patents

Liquid crystalline compounds Download PDF

Info

Publication number
EP1565540B1
EP1565540B1 EP03811758A EP03811758A EP1565540B1 EP 1565540 B1 EP1565540 B1 EP 1565540B1 EP 03811758 A EP03811758 A EP 03811758A EP 03811758 A EP03811758 A EP 03811758A EP 1565540 B1 EP1565540 B1 EP 1565540B1
Authority
EP
European Patent Office
Prior art keywords
ocf
ochfcf
ncs
ochf
chfcf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP03811758A
Other languages
German (de)
French (fr)
Other versions
EP1565540A1 (en
Inventor
Peer Kirsch
Alexander Hahn
Eike Poetsch
Volker Meyer
Michael Heckmeier
Melanie Klasen-Memmer
Georg LÜSSEM
Christian Hock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of EP1565540A1 publication Critical patent/EP1565540A1/en
Application granted granted Critical
Publication of EP1565540B1 publication Critical patent/EP1565540B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/42Mixtures of liquid crystal compounds covered by two or more of the preceding groups C09K19/06 - C09K19/40
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K2019/0444Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group
    • C09K2019/0466Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group the linking chain being a -CF2O- chain
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K2019/3422Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a six-membered ring
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2323/00Functional layers of liquid crystal optical display excluding electroactive liquid crystal layer characterised by chemical composition

Landscapes

  • Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Nonlinear Science (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Liquid Crystal Substances (AREA)
  • Pyrane Compounds (AREA)
  • Liquid Crystal (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

New liquid crystal compounds (I) containing cyclic structures, at least one of which is a tetrahydropyran-2,5-diyl group, and various linking groups, at least one of which is an oxydifluoromethylene group. Liquid crystal compounds of formula (I) are new: R1, R2 = H, halogen or optionally halogenated 1-15C alkyl or alkoxy (optionally with one or more CH2 groups replaced by -C triple bond C-, -CH=CH-, O, COO or OCO, with the proviso that one of these groups can also be CN, OCN, SCN, NCS or SF5; A1-A4 = trans-1,4-cyclohexylene (Cyc), 1,4-phenylene (Phe), 2- or 3-fluoro-1,4-phenylene, 3,5- or 2,3-difluoro-1,4-phenylene, 1,3-dioxan-5,2-diyl, tetrahydropyran-5,2-diyl or -2,5-diyl, dihydropyran-5,2-diyl, 1,4-cyclohex-4-enylene (optionally with F at position 5), or 1,4-bicyclo(2.2.2)octylene; Z1-Z3 = COO, OCO, CF2O, OCF2, CH2O, OCH2, -CH2CH2-, -(CH2)4-, -C2F4-, -CH2CF2-, -CF2CH2-, -CF=CF-, -CH=CH-, -C triple bond C- or a single bond; a, b, c = 0, 1, 2 or 3; and (a+b+c) = not more than 3. Independent claims are also included for: (1) liquid crystal compounds of formula (IA); (2) liquid crystal media containing at least two mesogenic compounds, which contain at least one compound (I); and (3) electro-optical liquid crystal displays containing such liquid crystal media. (a+b) = 1 or 2; and L1, L2 = H or F.

Description

Die vorliegende Erfindung betrifft flüssigkristalline Verbindungen sowie ein flüssigkristallines Medium, dessen Verwendung für elektrooptische Zwecke und dieses Medium enthaltende Anzeigen.The present invention relates to liquid-crystalline compounds and to a liquid-crystalline medium, the use thereof for electro-optical purposes and displays containing this medium.

Flüssige Kristalle werden vor allem als Dielektrika in Anzeigevorrichtungen verwendet, da die optischen Eigenschaften solcher Substanzen durch eine angelegte Spannung beeinflusst werden können. Elektrooptische Vorrichtungen auf der Basis von Flüssigkristallen sind dem Fachmann bestens bekannt und können auf verschiedenen Effekten beruhen. Derartige Vorrichtungen sind beispielsweise Zellen mit dynamischer Streuung, DAP-Zellen (Deformation aufgerichteter Phasen), Gast/Wirt-Zellen, TN-Zellen mit verdrillt nematischer ("twisted nematic") Struktur, STN-Zellen ("supertwisted nematic"), SBE-Zellen ("superbirefringence effect") und OMI-Zellen ("optical mode interference"). Die gebräuchlichsten Anzeigevorrichtungen beruhen auf dem Schadt-Helfrich-Effekt und besitzen eine verdrillt nematische Struktur.Liquid crystals are mainly used as dielectrics in display devices, since the optical properties of such substances can be influenced by an applied voltage. Electro-optical devices based on liquid crystals are well known to the person skilled in the art and can be based on various effects. Such devices include, for example, dynamic scattering cells, DAP (out-of-phase deformation) cells, guest / host cells, twisted nematic (TN) cells, supertwisted nematic (STN) cells, SBE cells. Cells ("superbirefringence effect") and OMI cells ("optical mode interference"). The most common display devices are based on the Schadt-Helfrich effect and have a twisted nematic structure.

Die Flüssigkristallmaterialien müssen eine gute chemische und thermische Stabilität und eine gute Stabilität gegenüber elektrischen Feldern und elektromagnetischer Strahlung besitzen. Ferner sollten die Flüssigkristallmaterialien niedere Viskosität aufweisen und in den Zellen kurze Ansprechzeiten, tiefe Schwellenspannungen und einen hohen Kontrast ergeben.The liquid crystal materials must have good chemical and thermal stability and good stability against electric fields and electromagnetic radiation. Further, the liquid crystal materials should have low viscosity and provide short response times, low threshold voltages, and high contrast in the cells.

Weiterhin sollten sie bei üblichen Betriebstemperaturen, d.h. in einem möglichst breiten Bereich unterhalb und oberhalb Raumtemperatur eine geeignete Mesophase besitzen, beispielsweise für die oben genannten Zellen eine nematische oder cholesterische Mesophase. Da Flüssigkristalle in der Regel als Mischungen mehrerer Komponenten zur Anwendung gelangen, ist es wichtig, dass die Komponenten untereinander gut mischbar sind. Weitere Eigenschaften, wie die elektrische Leitfähigkeit, die dielektrische Anisotropie und die optische Anisotropie, müssen je nach Zellentyp und Anwendungsgebiet unterschiedlichen Anforderungen genügen. Beispielsweise sollten Materialien für Zellen mit verdrillt nematischer Struktur eine positive dielektrische Anisotropie und eine geringe elektrische Leitfähigkeit aufweisen.Furthermore, they should have a suitable mesophase at normal operating temperatures, ie in the widest possible range below and above room temperature, for example, for the above-mentioned cells a nematic or cholesteric mesophase. Since liquid crystals are generally used as mixtures of several components, it is important that the components are readily miscible with each other. Further properties, such as the electrical conductivity, the dielectric anisotropy and the optical anisotropy, must, depending on Cell type and application area meet different requirements. For example, materials for cells of twisted nematic structure should have positive dielectric anisotropy and low electrical conductivity.

Beispielsweise sind für Matrix-Flüssigkristallanzeigen mit integrierten nicht-linearen Elementen zur Schaltung einzelner Bildpunkte (MFK-Anzeigen) Medien mit großer positiver dielektrischer Anisotropie, breiten nematischen Phasen, relativ niedriger Doppelbrechung, sehr hohem spezifischen Widerstand, guter UV- und Temperaturstabilität und geringem Dampfdruck erwünscht.For example, for matrix liquid crystal displays with integrated non-linear elements for single pixel switching (MFK displays), media with high positive dielectric anisotropy, broad nematic phases, relatively low birefringence, very high resistivity, good UV and temperature stability, and low vapor pressure are desired ,

Derartige Matrix-Flüssigkristallanzeigen sind bekannt. Als nichtlineare Elemente zur individuellen Schaltung der einzelnen Bildpunkte können beispielsweise aktive Elemente (d.h. Transistoren) verwendet werden. Man spricht dann von einer "aktiven Matrix", wobei man zwei Typen unterscheiden kann:

  1. 1. MOS (Metal Oxide Semiconductor) oder andere Dioden auf Silizium-Wafer als Substrat.
  2. 2. Dünnfilm-Transistoren (TFT) auf einer Glasplatte als Substrat.
Such matrix liquid crystal displays are known. As non-linear elements for individual switching of the individual pixels, for example, active elements (ie transistors) can be used. One speaks then of an "active matrix", whereby one can distinguish two types:
  1. 1. MOS (Metal Oxide Semiconductor) or other diodes on silicon wafer as a substrate.
  2. 2. Thin-film transistors (TFT) on a glass plate as a substrate.

Die Verwendung von einkristallinem Silizium als Substratmaterial beschränkt die Displaygröße, da auch die modulartige Zusammensetzung verschiedener Teildisplays an den Stößen zu Problemen führt.The use of monocrystalline silicon as a substrate material limits the display size, since the modular composition of various partial displays on the joints leads to problems.

Bei dem aussichtsreicheren Typ 2, welcher bevorzugt ist, wird als elektrooptischer Effekt üblicherweise der TN-Effekt verwendet. Man unterscheidet zwei Technologien: TFT's aus Verbindungshalbleitem wie z.B. CdSe oder TFT's auf der Basis von polykristallinem oder amorphem Silizium. An letzterer Technologie wird weltweit mit großer Intensität gearbeitet.In the more promising type 2, which is preferred, the TN effect is usually used as the electro-optical effect. A distinction is made between two technologies: TFTs made of compound semiconductors such as CdSe or TFTs based on polycrystalline or amorphous silicon. The latter technology is being worked on worldwide with great intensity.

Die TFT-Matrix ist auf der Innenseite der einen Glasplatte der Anzeige aufgebracht, während die andere Glasplatte auf der Innenseite die transparente Gegenelektrode trägt. Im Vergleich zu der Größe der Bildpunkt-Elektrode ist der TFT sehr klein und stört das Bild praktisch nicht. Diese Technologie kann auch für voll farbtaugliche Bilddarstellungen erweitert werden, wobei ein Mosaik von roten, grünen und blauen Filtern derart angeordnet ist, dass je ein Filterelement einem schaltbaren Bildelement gegenüber liegt.The TFT matrix is applied on the inside of one glass plate of the display, while the other glass plate on the inside carries the transparent counter electrode. Compared to the size of the pixel electrode, the TFT is very small and practically does not disturb the image. This technology can also be extended to fully color-capable image representations, wherein a mosaic of red, green and blue filters is arranged such that each one filter element is opposite to a switchable image element.

Die TFT-Anzeigen arbeiten üblicherweise als TN-Zellen mit gekreuzten Polarisatoren in Transmission und sind von hinten beleuchtet.The TFT displays usually operate as TN cells with crossed polarizers in transmission and are backlit.

Der Begriff MFK-Anzeigen umfasst hier jedes Matrix-Display mit integrierten nichtlinearen Elementen, d.h. neben der aktiven Matrix auch Anzeigen mit passiven Elementen wie Varistoren oder Dioden (MIM = Metall-Isolator-Metall).The term MFK displays here includes any matrix display with integrated nonlinear elements, i. in addition to the active matrix also displays with passive elements such as varistors or diodes (MIM = metal-insulator-metal).

Derartige MFK-Anzeigen eignen sich insbesondere für TV-Anwendungen (z.B. Taschenfemseher) oder für hochinformative Displays für Rechner anwendungen (Laptop) und im Automobil- oder Flugzeugbau. Neben Problemen hinsichtlich der Winkelabhängigkeit des Kontrastes und der Schaltzeiten resultieren bei MFK-Anzeigen Schwierigkeiten bedingt durch nicht ausreichend hohen spezifischen Widerstand der Flüssigkristallmischungen [ TOGASHI, S., SEKIGUCHI, K., TANABE, H., YAMAMOTO, E., SORIMACHI, K., TAJIMA, E., WATANABE, H., SHIMIZU, H., Proc. Eurodisplay 84, Sept. 1984 : A 210-288 Matrix LCD Controlled by Double Stage Diode Rings, p. 141 ff, Paris; STROMER, M., Proc. Eurodisplay 84, Sept. 1984 : Design of Thin Film Transistors for Matrix Adressing of Television Liquid Crystal Displays, p. 145 ff, Par is]. Mit abnehmendem Widerstand verschlechtert sich der Kontrast einer MFK-Anzeige und es kann das Problem der "after image elimination" auftreten. Da der spezifische Widerstand der Flüssigkristallmischung durch Wechselwirkung mit den inneren Oberflächen der Anzeige im allgemeinen über die Lebenszeit einer MFK-Anzeige abnimmt, ist ein hoher (Anfangs)-Widerstand sehr wichtig, um akzeptable Standzeiten zu erhalten. Insbesondere bei low-volt-Mischungen war es bisher nicht möglich, sehr hohe spezifische Widerstände zu realisieren. Weiterhin ist es wichtig, dass der spezifische Widerstand eine möglichst geringe Zunahme bei steigender Temperatur sowie nach Temperatur- und/oder UV-Belastung zeigt. Besonders nachteilig sind auch die Tieftemperatureigenschaften der Mischungen aus dem Stand der Technik. Gefordert wird, dass auch bei tiefen Temperaturen keine Kristallisation und/oder smektische Phasen auftreten und die Temperaturabhängigkeit der Viskosität möglichst gering ist. Die MFK-Anzeigen aus dem Stand der Technik genügen somit nicht den heutigen Anforderungen.Such MFK displays are particularly suitable for TV applications (eg Taschenfemseher) or for high-information displays for computer applications (laptop) and in the automotive or aircraft. In addition to problems with regard to the angle dependence of the contrast and the switching times, difficulties arise with MFK displays due to the insufficiently high specific resistance of the liquid-crystal mixtures [ TOGASHI, S., SEKIGUCHI, K., TANABE, H., YAMAMOTO, E., SORIMACHI, K., TAJIMA, E., WATANABE, H., SHIMIZU, H., Proc. Eurodisplay 84, Sept. 1984 : A 210-288 Matrix LCD Controlled by Double Stage Diode Rings, p. 141 ff, Paris; STROMER, M., Proc. Eurodisplay 84, Sept. 1984 : Design of Thin Film Transistors for Matrix Liquid Crystal Displays, p. 145 ff, par is]. With decreasing resistance, the contrast of a MFK display deteriorates and the problem of "after image elimination" may occur. Since the specific resistance of the liquid crystal mixture decreases by interaction with the inner surfaces of the display, generally over the lifetime of an MFK display, a high (initial) resistance is very high important to maintain acceptable service life. In particular, in low-volt mixtures, it has not been possible to realize very high resistivities. Furthermore, it is important that the resistivity shows the smallest possible increase with increasing temperature and after temperature and / or UV exposure. Also particularly disadvantageous are the low-temperature properties of the mixtures of the prior art. It is required that no crystallization and / or smectic phases occur even at low temperatures, and that the temperature dependence of the viscosity is as low as possible. The MFK displays from the prior art thus do not meet today's requirements.

Es besteht somit immer noch ein großer Bedarf nach MFK-Anzeigen mit sehr hohem spezifischen Widerstand bei gleichzeitig großem Arbeitstemperaturbereich, kurzen Schaltzeiten auch bei tiefen Temperaturen und niedriger Schwellenspannung, die diese Nachteile nicht oder nur in geringerem Maße zeigen.Thus, there is still a great need for MFK displays with very high resistivity at the same time large working temperature range, short switching times even at low temperatures and low threshold voltage, which do not show these disadvantages or only to a lesser extent.

Bei TN-(Schadt-Helfrich)-Zellen sind Medien erwünscht, die folgende Vorteile in den Zellen ermöglichen:

  • erweiterter nematischer Phasenbereich (insbesondere zu tiefen Temperaturen)
  • Schaltbarkeit bei extrem tiefen Temperaturen (out-door-use, Automobil, Avionik)
  • erhöhte Beständigkeit gegenüber UV-Strahlung (längere Lebensdauer)
In TN (Schadt-Helfrich) cells, media are desired which allow the following advantages in the cells:
  • extended nematic phase range (especially at low temperatures)
  • Switchability at extremely low temperatures (out-door-use, automotive, avionics)
  • increased resistance to UV radiation (longer life)

Mit den aus dem Stand der Technik zur Verfügung stehenden Medien ist es nicht möglich, diese Vorteile unter gleichzeitigem Erhalt der übrigen Parameter zu realisieren.With the media available from the prior art, it is not possible to realize these advantages while maintaining the other parameters.

Bei höher verdrillten Zellen (STN) sind Medien erwünscht, die eine höhere Multiplexierbarkeit und/oder kleinere Schwellenspannungen und/oder breitere nematische Phasenbereiche (insbesondere bei tiefen Temperaturen) ermöglichen. Hierzu ist eine weitere Ausdehnung des zur Verfügung stehenden Parameterraumes (Klärpunkt, Übergang smektisch-nematisch bzw. Schmelzpunkt, Viskosität, dielektrische Größen, elastische Größen) dringend erwünscht.For higher-twisted cells (STN), media are desired which allow for higher multiplexability and / or lower threshold voltages and / or broader nematic phase ranges (especially at low temperatures). For this purpose, a further expansion of the available parameter space (clearing point, transition smectic-nematic or melting point, viscosity, dielectric values, elastic sizes) is urgently desired.

In der Druckschrift DE 10008712 A1 werden flüssigkristalline Medien mit wenigstens einer Verbindung, die einen Oxa-Cyclohexanring und eine -CF2O-Gruppe mit umfasst, offenbart. Die Druckschrift EP 1182186 A2 offenbart ein Verfahren zur Herstellung von Verbindungen mit einer CF2O-Gruppe zwischen einem Cyclohexanring und einem Benzolring auf der Seite des O-Atoms. Als weitere Substituenten sind weitere Ringe möglich, darunter auch ein Oxa-Cyclohexan-1,4-diyl. In der Druckschrift DE 10050071 A1 wird eine Flüssigkristallzusammensetzung mit Verbindungen, die einen 2.5-substituierten Tetrahydropyranring enthalten, offenbart.In the publication DE 10008712 A1 For example, liquid crystalline media having at least one compound comprising an oxa-cyclohexane ring and a -CF 2 O group are disclosed. The publication EP 1182186 A2 discloses a process for preparing compounds having a CF 2 O group between a cyclohexane ring and a benzene ring on the side of the O atom. Further substituents other rings are possible, including an oxa-cyclohexane-1,4-diyl. In the publication DE 10050071 A1 discloses a liquid crystal composition having compounds containing a 2,5-substituted tetrahydropyran ring.

Der Erfindung liegt die Aufgabe zugrunde, Medien insbesondere für derartige MFK-, IPS-, TN- oder STN-Anzeigen bereitzustellen, die die oben angegebenen Nachteile nicht oder nur in geringerem Maße, und vorzugsweise gleichzeitig sehr hohe spezifische Widerstände und niedrige Schwellenspannungen aufweisen. Für diese Aufgabe werden flüssigkristalline Verbindungen benötigt, die einen hohen Klärpunkt und eine niedrige Rotationsviskosität besitzen.The invention has for its object to provide media especially for such MFK, IPS, TN or STN displays that do not have the disadvantages mentioned above, or only to a lesser extent, and preferably at the same time very high resistivities and low threshold voltages. For this task, liquid-crystalline compounds are required which have a high clearing point and a low rotational viscosity.

Es wurde nun gefunden, dass diese Aufgabe gelöst werden kann, wenn man die erfindungsgemäßen flüssigkristallinen Verbindungen verwendet.It has now been found that this object can be achieved by using the liquid-crystalline compounds according to the invention.

Gegenstand der Erfindung sind somit flüssigkristalline Verbindungen der Formel I,

Figure imgb0001
worin

R1 und R2
jeweils unabhängig voneinander H, Halogen, einen halogenierten oder unsubstituierten Alkyl- oder Alkoxyrest mit 1 bis 15 C-Atomen, wobei in diesen Resten auch eine oder mehrere CH2-Gruppen jeweils unabhängig voneinander durch -C≡C-, -CH=CH-, -0-, -CO-O- oder -O-CO- so ersetzt sein können, dass O-Atome nicht direkt miteinander verknüpft sind, wobei einer der Reste R1 und R2 auch CN, OCN, SCN, NCS oder SF5 bedeuten kann,
A1, A2, A3 und A4
jeweils unabhängig voneinander
Figure imgb0002
Figure imgb0003
Figure imgb0004
Z1, Z2 und Z3
jeweils unabhängig voneinander -CO-O-, -O-CO-, -CF2O-, -OCF2-, -CH2O-, -OCH2-, -CH2CH2-, -(CH2)4-, -C2F4-. -CH2CF2-, -CF2CH2-, -CF=CF-, -CH=CH-, -C≡C- oder eine Einfachbindung, und
a, b und c
jeweils unabhängig voneinander 0,1,2 oder 3, wobei a + b + c ≤ 3 ist,
bedeuten.The invention thus relates to liquid-crystalline compounds of the formula I,
Figure imgb0001
wherein
R 1 and R 2
each independently of one another H, halogen, a halogenated or unsubstituted alkyl or alkoxy radical having 1 to 15 C atoms, where in these radicals also one or more CH 2 groups are each independently denoted by -C≡C-, -CH = CH- , -O-, -CO-O- or -O-CO- can be replaced so that O atoms are not directly linked to each other, where one of the radicals R 1 and R 2 also CN, OCN, SCN, NCS or SF 5 can mean
A 1 , A 2 , A 3 and A 4
each independently
Figure imgb0002
Figure imgb0003
Figure imgb0004
Z 1 , Z 2 and Z 3
are each independently -CO-O-, -O-CO-, -CF 2 O-, -OCF 2-, -CH 2 O -, -OCH 2 -, -CH 2 CH 2 -, - (CH 2) 4 -, -C 2 F 4 -. -CH 2 CF 2 -, -CF 2 CH 2 -, -CF = CF-, -CH = CH-, -C≡C- or a single bond, and
a, b and c
independently of each other 0,1,2 or 3, where a + b + c ≤ 3,
mean.

Gegenstand der Erfindung ist weiterhin die Verwendung der Verbindungen der Formel I in flüssigkristallinen Medien.The invention further relates to the use of the compounds of the formula I in liquid-crystalline media.

Die Verbindungen der Formel I besitzen einen breiten Anwendungsbereich. In Abhängigkeit von der Auswahl der Substituenten können diese Verbindungen als Basismaterialien dienen, aus denen flüssigkristalline Medien zum überwiegenden Teil zusammengesetzt sind; es können aber auch Verbindungen der Formel I flüssigkristallinen Basismaterialien aus anderen Verbindungsklassen zugesetzt werden, um beispielsweise die dielektrische und/oder optische Anisotropie eines solchen Dielektrikums zu beeinflussen und/oder um dessen Schwellenspannung und/oder dessen Viskosität zu optimieren.The compounds of the formula I have a wide range of applications. Depending on the choice of substituents, these compounds may serve as base materials from which liquid crystalline media are predominantly composed; However, it is also possible to add compounds of the formula I to liquid-crystalline base materials from other classes of compounds in order, for example, to influence the dielectric and / or optical anisotropy of such a dielectric and / or to optimize its threshold voltage and / or its viscosity.

Die Verbindungen der Formel I sind in reinem Zustand farblos und bilden flüssigkristalline Mesophasen in einem für die elektrooptische Verwendung günstig gelegenen Temperaturbereich. Insbesondere zeichnen sich die erfindungsgemäßen Verbindungen durch ihren breiten nematischen Phasenbereich aus. In flüssigkristallinen Mischungen unterdrücken die erfindungsgemäßen Substanzen die smektischen Phasen und führen zu einer deutlichen Verbesserung der Tieftemperatur-Lagerstabilität. Chemisch, thermisch und gegen Licht sind sie stabil.The compounds of the formula I are colorless in the pure state and form liquid-crystalline mesophases in a temperature range which is favorably located for the electro-optical use. In particular, the compounds according to the invention are distinguished by their broad nematic phase range. In liquid-crystalline mixtures, the substances according to the invention suppress the smectic phases and lead to a marked improvement in the low-temperature storage stability. Chemically, thermally and against light, they are stable.

Gegenstand der Erfindung sind insbesondere die Verbindungen der Formel I, worin R1 Alkyl oder Alkenyl und R2 Halogen oder OCF3 bedeutet. Halogen bedeutet vorzugsweise F, ferner CI.The invention relates in particular to the compounds of the formula I in which R 1 is alkyl or alkenyl and R 2 is halogen or OCF 3 . Halogen is preferably F, furthermore CI.

Insbesondere bevorzugt sind Verbindungen der Formel I, worin a = 0, ferner a = 1, ist. Z1, Z2 und/oder Z3 ist vorzugsweise eine Einfachbindung, ferner -CF2O- -OCF2-, -C2F4-, -CH2O-, -OCH2- oder -COO-. A1, A2, A3 und A4 bedeuten vorzugsweise

Figure imgb0005
Figure imgb0006
A4 bedeutet insbesondere
Figure imgb0007
Particular preference is given to compounds of the formula I in which a = 0, furthermore a = 1. Z 1 , Z 2 and / or Z 3 is preferably a single bond, furthermore -CF 2 O- OCF 2 -, -C 2 F 4 -, -CH 2 O-, -OCH 2 - or -COO-. A 1 , A 2 , A 3 and A 4 are preferably
Figure imgb0005
Figure imgb0006
A 4 means in particular
Figure imgb0007

Besonders bevorzugt sind Verbindungen der Formeln IA

Figure imgb0008
worin a und b jeweils 0, 1 oder 2 und a + b = 1 oder 2 bedeuten. Vorzugsweise bedeutet a =1 und b = 0 oder a = 0 und b = 1. Vorzugsweise ist L1 = F und L2 = H oder Fluor, insbesondere bedeuten L1 = L2 = Fluor.Particular preference is given to compounds of the formulas IA
Figure imgb0008
wherein a and b are each 0, 1 or 2 and a + b = 1 or 2. Preferably, a = 1 and b = 0 or a = 0 and b = 1. Preferably, L 1 = F and L 2 = H or fluorine, in particular L 1 = L 2 = fluorine.

R1 bedeutet vorzugsweise Alkyl, Alkoxy, Alkenyl, Alkenyloxy. Vorzugsweise bedeutet R2 F, Cl, OCF3, OCHF2, OCHFCF3, OCF2CHFCF3, CN, SF5, NCS, SCN, insbesondere F oder OCF3, R1 bedeutet vorzugsweise geradkettiges Alkyl oder Alkenyl. L1 und L2 bedeuten jeweils unabhängig voneinander H oder F. Besonders bevorzugt sind Verbindungen worin X = L1 = L2 = Fluor, ferner X = OCF3 und L1 = L2 = F bedeuten.R 1 is preferably alkyl, alkoxy, alkenyl, alkenyloxy. Preferably, R 2 is F, Cl, OCF 3 , OCHF 2 , OCHFCF 3 , OCF 2 CHFCF 3 , CN, SF 5 , NCS, SCN, in particular F or OCF 3 , R 1 is preferably straight-chain alkyl or alkenyl. L 1 and L 2 are each, independently of one another, H or F. Particular preference is given to compounds in which X = L 1 = L 2 = fluorine, furthermore X = OCF 3 and L 1 = L 2 = F.

Besonders bevorzugte Verbindungen der Formel I sind die Verbindungen der Formeln l1 bis l31,

Figure imgb0009
Figure imgb0010
Figure imgb0011
Figure imgb0012
Figure imgb0013
Figure imgb0014
Figure imgb0015
Figure imgb0016
Figure imgb0017
Figure imgb0018
Figure imgb0019
Figure imgb0020
Figure imgb0021
Figure imgb0022
Figure imgb0023
Figure imgb0024
Figure imgb0025
Figure imgb0026
Figure imgb0027
Figure imgb0028
Figure imgb0029
Figure imgb0030
Figure imgb0031
Figure imgb0032
Figure imgb0033
Figure imgb0034
Figure imgb0035
Figure imgb0036
Figure imgb0037
Figure imgb0038
Figure imgb0039
worin R1 die oben angegebenen Bedeutungen hat X besitzt die Bedeutungen von R2.Particularly preferred compounds of the formula I are the compounds of the formulas I1 to I31,
Figure imgb0009
Figure imgb0010
Figure imgb0011
Figure imgb0012
Figure imgb0013
Figure imgb0014
Figure imgb0015
Figure imgb0016
Figure imgb0017
Figure imgb0018
Figure imgb0019
Figure imgb0020
Figure imgb0021
Figure imgb0022
Figure imgb0023
Figure imgb0024
Figure imgb0025
Figure imgb0026
Figure imgb0027
Figure imgb0028
Figure imgb0029
Figure imgb0030
Figure imgb0031
Figure imgb0032
Figure imgb0033
Figure imgb0034
Figure imgb0035
Figure imgb0036
Figure imgb0037
Figure imgb0038
Figure imgb0039
wherein R 1 has the meanings given above X has the meanings of R 2 .

Die Verbindungen der Formel I lassen sich sehr leicht in die Enantiomere auftrennen, in dem man das Racemat z. B. über eine chirale HPLC-Säule gibt. Gegenstand der Erfindung sind daher die Verbindungen der Formel I, die sowohl als Racemat als auch als Enantiomer vorliegen.The compounds of formula I can be very easily separated into the enantiomers, in which the racemate z. B. via a chiral HPLC column. The invention therefore relates to the compounds of the formula I which are present both as racemate and as enantiomer.

Die Verbindungen der Formel I werden nach an sich bekannten Methoden dargestellt, wie sie in der Literatur (z.B. in den Standardwerken wie Houben-Weyl, Methoden der Organischen Chemie, Georg-Thieme-Verlag, Stuttgart) beschrieben sind und zwar unter Reaktionsbedingungen, die für die genannten Umsetzungen bekannt und geeignet sind. Dabei kann man auch von an sich bekannten, hier nicht näher erwähnten Varianten Gebrauch machen.The compounds of the formula I are prepared by methods known per se, as described in the literature (for example in the standard works such as Houben-Weyl, Methods of Organic Chemistry, Georg-Thieme-Verlag, Stuttgart), specifically under reaction conditions suitable for the said reactions are known and suitable. One can also make use of known per se, not mentioned here variants.

Die Verbindungen der Formel I können z.B. wie folgt hergestellt werden:

Figure imgb0040
Figure imgb0041
Figure imgb0042
Figure imgb0043
Figure imgb0044
The compounds of the formula I can be prepared, for example, as follows:
Figure imgb0040
Figure imgb0041
Figure imgb0042
Figure imgb0043
Figure imgb0044

Gegenstand der Erfindung sind auch elektrooptische Anzeigen (insbesondere STN- oder MFK-Anzeigen mit zwei planparallelen Trägerplatten, die mit einer Umrandung eine Zelle bilden, integrierten nicht-linearen Elementen zur Schaltung einzelner Bildpunkte auf den Trägerplatten und einer in der Zelle befindlichen nematischen Flüssigkristallmischung mit positiver dielektrischer Anisotropie und hohem spezifischem Widerstand), die derartige Medien enthalten sowie die Verwendung dieser Medien für elektrooptische Zwecke.The invention also provides electro-optical displays (in particular STN or MFK displays with two plane-parallel support plates, which form a cell with a border, integrated non-linear elements for switching individual pixels on the support plates and a nematic liquid crystal mixture in the cell with positive dielectric anisotropy and high resistivity) containing such media as well as the use of these media for electro-optical purposes.

Die erfindungsgemäßen Flüssigkristallmischungen ermöglichen eine bedeutende Erweiterung des zur Verfügung stehenden Parameterraumes.The liquid-crystal mixtures according to the invention enable a significant expansion of the available parameter space.

Die erzielbaren Kombinationen aus Klärpunkt, Viskosität bei tiefer Temperatur, thermischer und UV-Stabilität und dielektrischer Anisotropie übertreffen bei weitem bisherige Materialien aus dem Stand der Technik.The achievable combinations of clearing point, low temperature viscosity, thermal and UV stability, and dielectric anisotropy far surpass existing prior art materials.

Die Forderung nach hohem Klärpunkt, nematischer Phase bei tiefer Temperatur sowie einem hohen Δε konnte bislang nur unzureichend erfüllt werden. Flüssigkristallmischungen, wie z. B. MS 99295 (Merck KGaA, Darmstadt, Deutschland) weisen zwar vergleichbare Klärpunkte und Tieftemperaturstabilitäten auf, sie haben jedoch relativ hohe An-Werte als auch höhere Schwellenspannungen von ca. ≥ 1,7 V.The requirement for a high clearing point, nematic phase at low temperature and a high Δε has so far been insufficiently fulfilled. Liquid crystal mixtures, such as. Although MS 99295 (Merck KGaA, Darmstadt, Germany) have comparable clearing points and low-temperature stabilities, they have relatively high on-values as well as higher threshold voltages of about ≥ 1.7 V.

Andere Mischungssysteme besitzen vergleichbare Viskositäten und Werte von Δε, weisen jedoch nur Klärpunkte in der Gegend von 60 °C auf.Other mixing systems have comparable viscosities and values of Δε, but have only clearing points in the region of 60 ° C.

Die erfindungsgemäßen Flüssigkristallmischungen ermöglichen es bei Beibehaltung der nematischen Phase bis -20 °C und bevorzugt bis -30 °C, besonders bevorzugt bis -40°C, Klärpunkte oberhalb 80°, vorzugsweise oberhalb 90°, besonders bevorzugt oberhalb 100 °C, gleichzeitig dielektrische Anisotropiewerte △ε ≥ 4, vorzugsweise ≥ 6 und einen hohen Wert für den spezifischen Widerstand zu erreichen, wodurch hervorragende STN- und MKF-Anzeigen erzielt werden können. Insbesondere sind die Mischungen durch kleine Operationsspannungen gekennzeichnet. Die TN-Schwellen liegen unterhalb 1,5 V, vorzugsweise unterhalb 1,3 V.The liquid-crystal mixtures according to the invention make it possible to maintain the nematic phase at -20 ° C. and preferably at -30 ° C., particularly preferably at -40 ° C., clearing points above 80 °, preferably above 90 °, particularly preferably above 100 ° C., simultaneously dielectric Anisotropy values △ ε ≥ 4, preferably ≥ 6 and to achieve a high value for the resistivity, whereby excellent STN and MKF displays can be achieved. In particular, the mixtures are characterized by low operating voltages. The TN thresholds are below 1.5 V, preferably below 1.3 V.

Es versteht sich, dass durch geeignete Wahl der Komponenten der erfindungsgemäßen Mischungen auch höhere Klärpunkte (z.B. oberhalb 110°) bei höheren Schwellenspannung oder niedrigere Klärpunkte bei niedrigeren Schwellenspannungen unter Erhalt der anderen vorteilhaften Eigenschaften realisiert werden können. Ebenso können bei entsprechend wenig erhöhten Viskositäten Mischungen mit größerem Δε und somit geringeren Schwellen erhalten werden. Die erfindungsgemäßen MFK-Anzeigen arbeiten vorzugsweise im ersten Transmissionsminimum nach Gooch und Tarry [ C.H. Gooch und H.A. Tarry, Electron. Lett. 10, 2-4, 1974 ; C.H. Gooch und H.A. Tarry, Appl. Phys., Vol. 8, 1575-1584, 1975 ], wobei hier neben besonders günstigen elektrooptischen Eigenschaften wie z.B. hohe Steilheit der Kennlinie und geringe Winkelabhängigkeit des Kontrastes ( DE-PS 30 22 818 ) bei gleicher Schwellenspannung wie in einer analogen Anzeige im zweiten Minimum eine kleinerere dielektrische Anisotropie ausreichend ist. Hierdurch lassen sich unter Verwendung der erfindungsgemäßen Mischungen im ersten Minimum deutlich höhere spezifische Widerstände verwirklichen als bei Mischungen mit Cyanverbindungen. Der Fachmann kann durch geeignete Wahl der einzelnen Komponenten und deren Gewichtsanteilen mit einfachen Routinemethoden die für eine vorgegebene Schichtdicke der MFK-Anzeige erforderliche Doppelbrechung einstellen.It is understood that by suitable choice of the components of the mixtures according to the invention also higher clearing points (eg above 110 °) can be realized at higher threshold voltage or lower clearing points at lower threshold voltages while maintaining the other advantageous properties. Likewise, mixtures can be obtained with a larger Δε and thus lower thresholds at correspondingly little increased viscosities. The MFK displays according to the invention preferably operate in the first transmission minimum according to Gooch and Tarry [ CH Gooch and HA Tarry, Electron. Lett. 10, 2-4, 1974 ; CH Gooch and HA Tarry, Appl. Phys., Vol. 8, 1575-1584, 1975 ], where in addition to particularly favorable electro-optical properties such as high slope of the characteristic and low angle dependence of the contrast ( DE-PS 30 22 818 ) at the same threshold voltage as in an analog display in the second minimum a smaller dielectric anisotropy is sufficient. As a result, significantly higher specific resistances can be achieved using the mixtures according to the invention in the first minimum than in the case of mixtures with cyano compounds. By suitable choice of the individual components and their proportions by weight, the person skilled in the art can set the birefringence required for a given layer thickness of the MFK display with simple routine methods.

Die Fließviskosität ν20 bei 20 °C ist vorzugsweise < 60 mm2 · s-1, besonders bevorzugt < 50 mm2 · s-1. Der nematische Phasenbereich ist vorzugsweise mindestens 90°, insbesondere mindestens 100°. Vorzugsweise erstreckt sich dieser Bereich mindestens von -30° bis +80°. Die Rotationsviskosität γ1 bei 20 °C ist vorzugsweise < 200 mPa·s, besonders bevorzugt < 180 mPa·s, insbesondere < 160 mPa·s.The flow viscosity ν 20 at 20 ° C is preferably <60 mm 2 · s -1 , more preferably <50 mm 2 · s -1 . The nematic phase range is preferably at least 90 °, in particular at least 100 °. Preferably, this range extends at least from -30 ° to + 80 °. The rotational viscosity γ 1 at 20 ° C. is preferably <200 mPa · s, particularly preferably <180 mPa · s, in particular <160 mPa · s.

Messungen des "Capacity Holding-ratio" (HR) [S. Matsumoto et al., Liquid Crystals 5,1320 (1989); K. Niwa et al., Proc. SID Conference, San Francisco, June 1984, p. 304 (1984); G. Weber et al., Liquid Crystals 5, 1381 (1989)] haben ergeben, dass erfindungsgemäße Mischungen enthaltend Verbindungen der Formel I eine deutlich kleinere Abnahme des HR mit steigender Temperatur aufweisen als analoge Mischungen enthaltend anstelle den Verbindungen der Formel I Cyanophenylcyclohexane der Formel

Figure imgb0045
oder Ester der Formel
Figure imgb0046
Measurements of the Capacity Holding Ratio (HR) [p. Matsumoto et al., Liquid Crystals 5 , 1320 (1989); K. Niwa et al., Proc. SID Conference, San Francisco, June 1984, p. 304 (1984); G. Weber et al., Liquid Crystals 5, 1381 (1989)] have shown that mixtures according to the invention comprising compounds of the formula I have a significantly smaller decrease in HR with increasing temperature than analogous mixtures instead of the compounds of formula I cyanophenylcyclohexanes of the formula
Figure imgb0045
or esters of the formula
Figure imgb0046

Auch die UV-Stabilität der erfindungsgemäßen Mischungen ist erheblich besser, d. h. sie zeigen eine deutlich kleinere Abnahme des HR unter UV-Belastung.The UV stability of the mixtures according to the invention is significantly better, d. H. they show a much smaller decrease in HR under UV exposure.

Vorzugsweise basieren die erfindungsgemäßen Medien auf mehreren (vorzugsweise zwei, drei oder mehr) Verbindungen der Formel I, d.h. der Anteil dieser Verbindungen ist 5-95 %, vorzugsweise 10-60 % und besonders bevorzugt im Bereich von 15-40 %.Preferably, the media of the invention are based on several (preferably two, three or more) compounds of formula I, i. the proportion of these compounds is 5-95%, preferably 10-60%, and more preferably in the range of 15-40%.

Die einzelnen Verbindungen der Formeln I bis IX und deren Unterformeln, die in den erfindungsgemäßen Medien verwendet werden können, sind entweder bekannt, oder sie können analog zu den bekannten Verbindungen hergestellt werden.The individual compounds of the formulas I to IX and their sub-formulas which can be used in the media according to the invention are either known or they can be prepared analogously to the known compounds.

Bevorzugte Ausführungsformen sind im folgenden angegeben:

  • Das Medium enthält vorzugsweise ein, zwei oder drei homologe Verbindungen der Formel I, wobei jedes Homologe zu maximal 10 % in der Mischung enthalten ist.
  • Medium enthält zusätzlich eine oder mehrere Verbindungen ausgewählt aus der Gruppe bestehend aus den allgemeinen Formeln II bis IX:
    Figure imgb0047
    Figure imgb0048
    Figure imgb0049
    Figure imgb0050
    Figure imgb0051
    Figure imgb0052
    Figure imgb0053
    Figure imgb0054
worin die einzelnen Reste die folgenden Bedeutungen haben:
R0
n-Alkyl, Oxaalkyl, Fluoralkyl, Alkenyloxy oder Alkenyl mit jeweils bis zu 9 C-Atomen
X0
F, Cl, halogeniertes Alkyl, halogeniertes Alkenyl, halogeniertes Alkenyloxy oder halogeniertes Alkoxy mit bis zu 7 C-Atomen,
-CH=CH-, -C2H4-, -(CH2)4-, -C2F4-, -CH2O-, -OCH2-, -CF=CF-, -CF2O-, -OCF2- oder -COO-,
Y1,Y2, Y3 und Y4
jeweils unabhängig voneinander H oder F, und
r
0 oder 1.
Preferred embodiments are given below:
  • The medium preferably contains one, two or three homologous compounds of the formula I, wherein each homologue is contained in the mixture to a maximum of 10%.
  • Medium additionally contains one or more compounds selected from the group consisting of the general formulas II to IX:
    Figure imgb0047
    Figure imgb0048
    Figure imgb0049
    Figure imgb0050
    Figure imgb0051
    Figure imgb0052
    Figure imgb0053
    Figure imgb0054
in which the individual radicals have the following meanings:
R 0
n-alkyl, oxaalkyl, fluoroalkyl, alkenyloxy or alkenyl, each having up to 9 carbon atoms
X 0
F, Cl, halogenated alkyl, halogenated alkenyl, halogenated alkenyloxy or halogenated alkoxy having up to 7 C atoms,
Z °
-CH = CH-, -C 2 H 4 -, - (CH 2 ) 4 -, -C 2 F 4 -, -CH 2 O-, -OCH 2 -, -CF = CF-, -CF 2 O- , -OCF 2 - or -COO-,
Y1, Y2, Y 3 and Y 4
each independently of one another H or F, and
r
0 or 1.

Die Verbindung der Formel IV ist vorzugsweise

Figure imgb0055
Figure imgb0056
Figure imgb0057
Figure imgb0058
Figure imgb0059
oder
Figure imgb0060

  • Das Medium enthält vorzugsweise eine oder mehrere Verbindungen der Formeln
    Figure imgb0061
    Figure imgb0062
    Figure imgb0063
    Figure imgb0064
    Figure imgb0065
    Figure imgb0066
    Figure imgb0067
    Figure imgb0068
    Figure imgb0069
    Figure imgb0070
    Figure imgb0071
    und/oder
    Figure imgb0072
    worin R0 und Y2 die oben angegebene Bedeutung haben.
  • Das Medium enthält vorzugsweise ein, zwei oder drei, ferner vier, Homologe der Verbindungen ausgewählt aus der Gruppe H1 bis H19 (n = 1-7):
    Figure imgb0073
    Figure imgb0074
    Figure imgb0075
    Figure imgb0076
    Figure imgb0077
    Figure imgb0078
    Figure imgb0079
    Figure imgb0080
    Figure imgb0081
    Figure imgb0082
    Figure imgb0083
    Figure imgb0084
    Figure imgb0085
    Figure imgb0086
    Figure imgb0087
    Figure imgb0088
    Figure imgb0089
    Figure imgb0090
    Figure imgb0091
  • Das Medium enthält zusätzlich eine oder mehrere Verbindungen ausgewählt aus der Gruppe bestehend aus den allgemeinen Formeln X bis XV:
    Figure imgb0092
    Figure imgb0093
    Figure imgb0094
    Figure imgb0095
    Figure imgb0096
    Figure imgb0097
    worin R0, X0, Y1, Y2, Y3 und Y4 jeweils unabhängig voneinander eine der in Anspruch 8 angegebene Bedeutung haben. Vorzugsweise bedeutet X0 F, Cl, CF3, OCF3, OCHF2. R0 bedeutet vorzugsweise Alkyl, Oxaalkyl, Fluoralkyl, Alkenyl oder Alkenyloxy.
  • Der Anteil an Verbindungen der Formeln I bis IX zusammen beträgt im Gesamtgemisch mindestens 50 Gew.-%.
  • Der Anteil an Verbindungen der Formel I beträgt im Gesamtgemisch 5 bis 50 Gew.-%.
  • Der Anteil an Verbindungen der Formel II beträgt im Gesamtgemisch 3-40 Gew.-%.
  • Der Anteil an Verbindungen der Formeln II bis IX im Gesamtgemisch beträgt 30 bis 70 Gew.-%.
    Figure imgb0098
    ist vorzugsweise
    Figure imgb0099
    Figure imgb0100
    Figure imgb0101
    Figure imgb0102
    Figure imgb0103
  • Das Medium enthält Verbindungen der Formeln II, III, IV, V, VI, VII, VIII und/oder IX.
  • R0 ist geradkettiges Alkyl oder Alkenyl mit 2 bis 7 C-Atomen.
  • Das Medium besteht im wesentlichen aus Verbindungen der Formeln I bis XV.
  • Das Medium enthält 5-40 Gew.-% an Verbindungen der Formeln H17 und/oder H18.
  • Das Medium enthält weitere Verbindungen, vorzugsweise ausgewählt aus der folgenden Gruppe bestehend aus den allgemeinen Formeln XVI bis XX:
    Figure imgb0104
    Figure imgb0105
    Figure imgb0106
    Figure imgb0107
    Figure imgb0108
worin R0 und X0 die oben angegebene Bedeutung haben und die 1,4-Phenylenringe durch CN, Chlor oder Fluor substituiert sein können. Vorzugsweise sind die 1,4-Phenylenringe ein- oder mehrfach durch Fluoratome substituiert.
  • Das Medium enthält weitere Verbindungen, vorzugsweise ausgewählt aus der folgenden Gruppe bestehend aus den Formeln RI bis RIX,
    Figure imgb0109
    Figure imgb0110
    Figure imgb0111
    Figure imgb0112
    Figure imgb0113
    Figure imgb0114
    Figure imgb0115
    Figure imgb0116
    Figure imgb0117
    worin
    R0
    n-Alkyl, Oxaalkyl, Fluoralkyl, Alkenyloxy oder Alkenyl mit jeweils bis zu 9 C-Atomen,
    d
    0, 1 oder 2,
    Y1
    H oder F,
    Alkyl oder Alkyl*
    jeweils unabhängig voneinander ein geradkettiger oder verzweigter Alkylrest mit 1-9 C-Atomen,
    Alkenyl oder Alkenyl*
    jeweils unabhängig voneinander einen geradkettigen oder verzweigten Alkenylrest mit bis zu 9 C-Atomen
    bedeuten.
  • Das Medium enthält vorzugsweise eine oder mehrere Verbindungen der Formeln
    Figure imgb0118
    Figure imgb0119
    Figure imgb0120
    Figure imgb0121
    Figure imgb0122
    Figure imgb0123
    Figure imgb0124
    Figure imgb0125
    worin n und m jeweils eine ganze Zahl von 1-9 bedeuten.
  • Das Gewichtsverhältnis I: (II + III + IV + V + VI + VII + VIII + IX) ist vorzugsweise 1 : 10 bis 10 : 1.
  • Das Medium besteht im wesentlichen aus Verbindungen ausgewählt aus der Gruppe bestehend aus den allgemeinen Formeln I bis XV.
The compound of formula IV is preferred
Figure imgb0055
Figure imgb0056
Figure imgb0057
Figure imgb0058
Figure imgb0059
or
Figure imgb0060
  • The medium preferably contains one or more compounds of the formulas
    Figure imgb0061
    Figure imgb0062
    Figure imgb0063
    Figure imgb0064
    Figure imgb0065
    Figure imgb0066
    Figure imgb0067
    Figure imgb0068
    Figure imgb0069
    Figure imgb0070
    Figure imgb0071
    and or
    Figure imgb0072
    wherein R 0 and Y 2 have the meaning given above.
  • The medium preferably contains one, two or three, further four, homologues of the compounds selected from the group H1 to H19 (n = 1-7):
    Figure imgb0073
    Figure imgb0074
    Figure imgb0075
    Figure imgb0076
    Figure imgb0077
    Figure imgb0078
    Figure imgb0079
    Figure imgb0080
    Figure imgb0081
    Figure imgb0082
    Figure imgb0083
    Figure imgb0084
    Figure imgb0085
    Figure imgb0086
    Figure imgb0087
    Figure imgb0088
    Figure imgb0089
    Figure imgb0090
    Figure imgb0091
  • The medium additionally contains one or more compounds selected from the group consisting of the general formulas X to XV:
    Figure imgb0092
    Figure imgb0093
    Figure imgb0094
    Figure imgb0095
    Figure imgb0096
    Figure imgb0097
    wherein R 0 , X 0 , Y 1 , Y 2 , Y 3 and Y 4 each independently have one of the meanings given in claim 8. Preferably, X 0 is F, Cl, CF 3 , OCF 3 , OCHF 2 . R 0 is preferably alkyl, oxaalkyl, fluoroalkyl, alkenyl or alkenyloxy.
  • The proportion of compounds of the formulas I to IX together in the total mixture is at least 50% by weight.
  • The proportion of compounds of formula I is in the total mixture 5 to 50 wt .-%.
  • The proportion of compounds of formula II is in the total mixture 3-40 wt .-%.
  • The proportion of compounds of the formulas II to IX in the total mixture is 30 to 70 wt .-%.
    Figure imgb0098
    is preferable
    Figure imgb0099
    Figure imgb0100
    Figure imgb0101
    Figure imgb0102
    Figure imgb0103
  • The medium contains compounds of the formulas II, III, IV, V, VI, VII, VIII and / or IX.
  • R 0 is straight-chain alkyl or alkenyl having 2 to 7 C atoms.
  • The medium consists essentially of compounds of formulas I to XV.
  • The medium contains 5-40% by weight of compounds of the formulas H17 and / or H18.
  • The medium contains further compounds, preferably selected from the following group consisting of the general formulas XVI to XX:
    Figure imgb0104
    Figure imgb0105
    Figure imgb0106
    Figure imgb0107
    Figure imgb0108
wherein R 0 and X 0 have the abovementioned meaning and the 1,4-phenylene rings may be substituted by CN, chlorine or fluorine. Preferably, the 1,4-phenylene rings are mono- or polysubstituted by fluorine atoms.
  • The medium contains further compounds, preferably selected from the following group consisting of the formulas RI to RIX,
    Figure imgb0109
    Figure imgb0110
    Figure imgb0111
    Figure imgb0112
    Figure imgb0113
    Figure imgb0114
    Figure imgb0115
    Figure imgb0116
    Figure imgb0117
    wherein
    R 0
    n-alkyl, oxaalkyl, fluoroalkyl, alkenyloxy or alkenyl having in each case up to 9 C atoms,
    d
    0, 1 or 2,
    Y 1
    H or F,
    Alkyl or alkyl *
    each independently of one another a straight-chain or branched alkyl radical having 1-9 C atoms,
    Alkenyl or alkenyl *
    each independently of one another a straight-chain or branched alkenyl radical having up to 9 C atoms
    mean.
  • The medium preferably contains one or more compounds of the formulas
    Figure imgb0118
    Figure imgb0119
    Figure imgb0120
    Figure imgb0121
    Figure imgb0122
    Figure imgb0123
    Figure imgb0124
    Figure imgb0125
    wherein n and m each represents an integer of 1-9.
  • The weight ratio I: (II + III + IV + V + VI + VII + VIII + IX) is preferably 1:10 to 10: 1.
  • The medium consists essentially of compounds selected from the group consisting of the general formulas I to XV.

Es wurde gefunden, dass bereits ein relativ geringer Anteil an Verbindungen der Formel I im Gemisch mit üblichen Flüssigkristallmaterialien, insbesondere jedoch mit einer oder mehreren Verbindungen der Formel II, III, IV, V, VI, VII, VIII oder IX zu einer beträchtlichen Erniedrigung der Schwellenspannung und zu niedrigen Werten für die Doppelbrechung führt, wobei gleichzeitig breite nematische Phasen mit tiefen Übergangstemperaturen smektisch-nematisch beobachtet werden, wodurch die Lagerstabilität verbessert wird. Die Verbindungen der Formeln I bis IX sind farblos, stabil und untereinander und mit anderen Flüssigkristallmaterialien gut mischbar.It has been found that even a relatively small proportion of compounds of the formula I in admixture with conventional liquid crystal materials, but in particular with one or more compounds of the formula II, III, IV, V, VI, VII, VIII or IX to a considerable reduction of Threshold voltage and too low values for the birefringence results, while simultaneously observing broad nematic phases with low transition temperatures smectic-nematic, whereby the storage stability is improved. The compounds of formulas I to IX are colorless, stable and readily miscible with each other and with other liquid crystal materials.

Der Ausdruck "Alkyl" oder "Alkyl*" umfasst geradkettige und verzweigte Alkylgruppen mit 1-9 Kohlenstoffatomen, insbesondere die geradkettigen Gruppen Methyl, Ethyl, Propyl, Butyl, Pentyl, Hexyl und Heptyl. Gruppen mit 2-5 Kohlenstoffatomen sind im allgemeinen bevorzugt.The term "alkyl" or "alkyl *" embraces straight-chain and branched alkyl groups having 1-9 carbon atoms, in particular the straight-chain groups methyl, ethyl, propyl, butyl, pentyl, hexyl and heptyl. Groups of 2-5 carbon atoms are generally preferred.

Der Ausdruck "Alkenyl" oder "Alkenyl*" umfasst geradkettige und verzweigte Alkenylgruppen mit bis zu 9 Kohlenstoffatomen, insbesondere die geradkettigen Gruppen. Besonders bevorzugte Alkenylgruppen sind C2- C7- 1E-Alkenyl, C4-C7-3E-Alkenyl, C5-C7-4-Alkenyl, C6-C7-5-Alkenyl und C7-6-Alkenyl, insbesondere C2C7-1 E-Alkenyl, C4-C7-3E-Alkenyl und C5-C7-4-Alkenyl. Beispiele bevorzugter Alkenylgruppen sind Vinyl, 1 E-Propenyl, 1 E-Butenyl, 1 E-Pentenyl, 1 E-Hexenyl, 1 E-Heptenyl, 3-Butenyl, 3E-Pentenyl, 3E-Hexenyl, 3E-Heptenyl, 4-Pentenyl, 4Z-Hexenyl, 4E-Hexenyl, 4Z-Heptenyl, 5-Hexenyl, 6-Heptenyl und dergleichen. Gruppen mit bis zu 5 Kohlenstoffatomen sind im allgemeinen bevorzugt.The term "alkenyl" or "alkenyl *" includes straight-chain and branched alkenyl groups having up to 9 carbon atoms, especially the straight-chain groups. Particularly preferred alkenyl groups are C 2 - C 7 - 1E-alkenyl, C 4 -C 7 -3E-alkenyl, C 5 -C 7 -4-alkenyl, C 6 -C 7 -5-alkenyl and C 7 -6-alkenyl , in particular C 2 C 7 -1 E-alkenyl, C 4 -C 7 3E-alkenyl and C 5 -C 7 -4-alkenyl. Examples of preferred alkenyl groups are vinyl, 1E-propenyl, 1E-butenyl, 1E-pentenyl, 1E-hexenyl, 1E-heptenyl, 3-butenyl, 3E-pentenyl, 3E-hexenyl, 3E-heptenyl, 4-pentenyl , 4Z-hexenyl, 4E-hexenyl, 4Z-heptenyl, 5-hexenyl, 6-heptenyl and the like. Groups of up to 5 carbon atoms are generally preferred.

Der Ausdruck "Fluoralkyl" umfasst vorzugsweise geradkettige Gruppen mit endständigen Fluor, d.h. Fluormethyl, 2-Fluorethyl, 3-Fluorpropyl, 4-Fluorbutyl, 5-Fluorpentyl, 6-Fluorhexyl und 7-Fluorheptyl. Andere Positionen des Fluors sind jedoch nicht ausgeschlossen.The term "fluoroalkyl" preferably includes straight-chain fluoro-end-capped groups, ie, fluoromethyl, 2-fluoroethyl, 3-fluoropropyl, 4-fluorobutyl, 5-fluoropentyl, 6-fluorohexyl, and 7-fluoroheptyl. Other positions of the fluorine are not excluded.

Der Ausdruck "Oxaalkyl" umfasst vorzugsweise geradkettige Reste der Formel CnH2n+1-O-(CH2)m, worin n und m jeweils unabhängig voneinander 1 bis 6 bedeuten. Vorzugsweise ist n = 1 und m 1 bis 6.The term "oxaalkyl" preferably includes straight-chain radicals of the formula C n H 2n + 1 -O- (CH 2 ) m , wherein n and m are each independently 1 to 6. Preferably, n = 1 and m is 1 to 6.

Durch geeignete Wahl der Bedeutungen von R0 und X0 können die Ansprechzeiten, die Schwellenspannung, die Steilheit der Transmissionskennlinien etc. in gewünschter Weise modifiziert werden. Beispielsweise führen 1E-Alkenylreste, 3E-Alkenylreste, 2E-Alkenyloxyreste und dergleichen in der Regel zu kürzeren Ansprechzeiten, verbesserten nematischen Tendenzen und einem höheren Verhältnis der elastischen Konstanten k33 (bend) und k11 (splay) im Vergleich zu Alkyl- bzw. Alkoxyresten. 4-Alkenylreste, 3-Alkenylreste und dergleichen ergeben im allgemeinen tiefere Schwellenspannungen und kleinere Werte von k33/k11 im Vergleich zu Alkyl- und Alkoxyresten.By suitably selecting the meanings of R 0 and X 0 , the response times, the threshold voltage, the transconductance of the transmission characteristics etc. can be modified in the desired manner. For example, 1E-alkenyl radicals, 3E-alkenyl radicals, 2E-alkenyloxy radicals and the like generally lead to shorter response times, improved nematic tendencies and a higher ratio of the elastic constants k 33 (bend) and k 11 (splay) compared to alkyl or alkoxy. 4-Alkenyl radicals, 3-alkenyl radicals and the like generally give lower threshold voltages and smaller values of k 33 / k 11 compared to alkyl and alkoxy radicals.

Eine Gruppe -CH2CH2- in Z1 und/oder Z2 führt im allgemeinen zu höheren Werten von k33/k11 im Vergleich zu einer einfachen Kovalenzbindung. Höhere Werte von k33/k11 ermöglichen z.B. flachere Transmissionskennlinien in TN-Zellen mit 90° Verdrillung (zur Erzielung von Grautönen) und steilere Transmissionskennlinien in STN-, SBE- und OMI-Zellen (höhere Multiplexierbarkeit) und umgekehrt.A group -CH 2 CH 2 - in Z 1 and / or Z 2 generally results in higher values of k 33 / k 11 compared to a single covalent bond. Higher values of k 33 / k 11 allow, for example, flatter transmission characteristics in TN cells with 90 ° twist (to achieve shades of gray) and steeper transmission characteristics in STN, SBE and OMI cells (higher multiplexability) and vice versa.

Das optimale Mengenverhältnis der Verbindungen der Formeln I und II + III + IV + V + VI + VII + VII + VIII + IX hängt weitgehend von den gewünschten Eigenschaften, von der Wahl der Komponenten der Formeln I, II, III, IV, V, VI, VII, VIII und/oder IX und von der Wahl weiterer gegebenenfalls vorhandener Komponenten ab. Geeignete Mengenverhältnisse innerhalb des oben angegebenen Bereichs können von Fall zu Fall leicht ermittelt werden.The optimum ratio of the compounds of the formulas I and II + III + IV + V + VI + VII + VII + VIII + IX depends largely on the desired properties, on the choice of the components of the formulas I, II, III, IV, V, VI, VII, VIII and / or IX and from the choice of other optionally present components. Suitable proportions within the range given above can be easily determined on a case-by-case basis.

Die Gesamtmenge an Verbindungen der Formeln I bis XV in den erfindungsgemäßen Gemischen ist nicht kritisch. Die Gemische können daher eine oder mehrere weitere Komponenten enthalten zwecks Optimierung verschiedener Eigenschaften. Der beobachtete Effekt auf die Ansprechzeiten und die Schwellenspannung ist jedoch in der Regel umso größer je höher die Gesamtkonzentration an Verbindungen der Formeln I bis XV ist.The total amount of compounds of the formulas I to XV in the mixtures according to the invention is not critical. The mixtures may therefore contain one or more other components to optimize various properties. However, the observed effect on the response times and the threshold voltage is generally greater the higher the total concentration of compounds of the formulas I to XV.

In einer besonders bevorzugten Ausführungsform enthalten die erfindungsgemäßen Medien Verbindungen der Formel II bis IX (vorzugsweise II und/oder III), worin X0 OCF3, OCHF2, F, OCH=CF2, OCF=CF2, OCF2CHFCF3, oder OCF2-CF2H bedeutet. Eine günstige synergistische Wirkung mit den Verbindungen der Formel I führt zu besonders vorteilhaften Eigenschaften.In a particularly preferred embodiment, the media according to the invention comprise compounds of the formulas II to IX (preferably II and / or III) wherein X is 0 OCF 3, OCHF 2, F, OCH = CF 2, OCF = CF 2, OCF 2 CHFCF 3, or OCF 2 -CF 2 H means. A favorable synergistic effect with the compounds of the formula I leads to particularly advantageous properties.

Der Aufbau der erfindungsgemäßen MFK-Anzeige aus Polarisatoren, Elektrodengrundplatten und Elektroden mit Oberflächenbehandlung entspricht der für derartige Anzeigen üblichen Bauweise. Dabei ist der Begriff der üblichen Bauweise hier weit gefasst und umfasst auch alle Abwandlungen und Modifikationen der MFK-Anzeige, insbesondere auch Matrix-Anzeigeelemente auf Basis poly-Si TFT oder MIM.The structure of the MFK display of polarizers, electrode base plates and electrodes with surface treatment according to the invention corresponds to the usual construction for such displays. Here, the term of the usual construction is broad and includes all modifications and modifications of the MFK display, in particular matrix display elements based on poly-Si TFT or MIM.

Ein wesentlicher Unterschied der erfindungsgemäßen Anzeigen zu den bisher üblichen auf der Basis der verdrillten nematischen Zelle besteht jedoch in der Wahl der Flüssigkristallparameter der Flüssigkristallschicht.However, a significant difference of the displays of the invention on the basis of the usual twisted nematic cell is the choice of the liquid crystal parameters of the liquid crystal layer.

Die Herstellung der erfindungsgemäß verwendbaren Flüssigkristallmischungen erfolgt in an sich üblicher Weise. In der Regel wird die gewünschte Menge der in geringerer Menge verwendeten Komponenten in der den Hauptbestandteil ausmachenden Komponenten gelöst, zweckmäßig bei erhöhter Temperatur. Es ist auch möglich, Lösungen der Komponenten in einem organischen Lösungsmittel, z.B. in Aceton, Chloroform oder Methanol, zu mischen und das Lösungsmittel nach Durchmischung wieder zu entfernen, beispielsweise durch Destillation.The preparation of the liquid crystal mixtures which can be used according to the invention is carried out in a conventional manner. In general, the desired amount of the components used in lesser amount is dissolved in the constituent of the main component, expediently at elevated temperature. It is also possible to use solutions of the components in an organic solvent, e.g. in acetone, chloroform or methanol, and to remove the solvent again after thorough mixing, for example by distillation.

Die Dielektrika können auch weitere, dem Fachmann bekannte und in der Literatur beschriebene Zusätze, wie z. B. Stabilisatoren, Antioxidation, enthalten. Beispielsweise können 0-15 % pleochroitische Farbstoffe oder chirale Dotierstoffe zugesetzt werden.The dielectrics may also other, known in the art and described in the literature additives such. As stabilizers, antioxidation included. For example, 0-15% pleochroic dyes or chiral dopants may be added.

C bedeutet eine kristalline, S eine smektische, SC eine smektische C, SB eine smektische B, N eine nematische und I die isotrope Phase.C means a crystalline, S a smectic, S C a smectic C, S B a smectic B, N a nematic and I the isotropic phase.

V10 bezeichnet die Spannung für 10 % Transmission (Blickrichtung senkrecht zur Plattenoberfläche). ton bezeichnet die Einschaltzeit und toff die Ausschaltzeit bei einer Betriebsspannung entsprechend dem 2fachen Wert von V10. Δn bezeichnet die optische Anisotropie und no den Brechungsindex. Δε bezeichnet die dielektrische Anisotropie (Δε = ε||- ε, wobei εll die Dielektrizitätskonstante parallel zu den Moleküllängsachsen und ε die Dielektrizitätskonstante senkrecht dazu bedeutet). Die elektrooptischen Daten wurden in einer TN-Zelle im 1. Minimum (d.h. bei einem d · Δn-Wert von 0,5 µm) bei 20 °C gemessen, sofern nicht ausdrücklich etwas anderes angegeben wird. Die optischen Daten wurden bei 20 °C gemessen, sofern nicht ausdrücklich etwas anderes angegeben wird.V 10 denotes the voltage for 10% transmission (viewing direction perpendicular to the plate surface). t on denotes the switch-on time and t off the switch-off time at an operating voltage corresponding to twice the value of V 10 . Δn denotes the optical anisotropy and n o the refractive index. Δε denotes the dielectric anisotropy (Δε = ε || - ε , where ε ll means the dielectric constant parallel to the longitudinal molecular axes and ε the dielectric constant perpendicular to it). The electro-optical data were measured in a TN cell in the 1st minimum (ie at a d · Δn value of 0.5 microns) at 20 ° C, unless expressly stated otherwise. The optical data were measured at 20 ° C unless expressly stated otherwise.

In der vorliegenden Anmeldung und in den folgenden Beispielen sind die Strukturen der Flüssigkristallverbindungen durch Acronyme angegeben, wobei die Transformation in chemische Formeln gemäß folgender Tabellen A und B erfolgt. Alle Reste CnH2n+1 und CmH2m+1 sind geradkettige Alkylreste mit n bzw. m C-Atomen. n und m bedeuten jeweils unabhängig voneinander 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 oder 15. Die Codierung gemäß Tabelle B versteht sich von selbst. In Tabelle A ist nur das Acronym für den Grundkörper angegeben. Im Einzelfall folgt getrennt vom Acronym für den Grundkörper mit einem Strich ein Code für die Substituenten R1, R2, L1 und L2: Code für R1, R2, L1, L2 R1 R2 L1 L2 nm CnH2n+1 CmH2m+1 H H nOm CnH2n+1 OCmH2m+1 H H nO.m OCnH2n+1 CmH2m+1 H H n CnH2n+1 CN H H nN.F CnH2n+1 CN H F nF CnH2n+1 F H H nOF OCnH2n+1 F H. H nCl CnH2n+1 Cl H H nF.F CnH2n+1 F H F nF.F.F CnH2n+1 F F F nCF3 CnH2n+1 CF3 H H nOCF3 CnH2n+1 OCF3 H H nOCF3.F CnH2n+1 OCF3 H F nOCF2 CnH2n+1 OCHF2 H H nS CnH2n+1 NCS H H rVsN CrH2r+1-CH=CH-CsH2s- CN H H rEsN CrH2r+1-O-C2H2s- CN H H nAm CnH2n+1 COOCmH2m+1 H H nOCCF2.F.F CnH2n+1 OCH2CF2H F F In the present application and in the following examples, the structures of the liquid crystal compounds are indicated by acronyms, wherein the transformation into chemical formulas according to following Tables A and B takes place. All radicals C n H 2n + 1 and C m H 2m + 1 are straight-chain alkyl radicals with n or m C atoms. n and m are each independently 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 or 15. The coding according to Table B is self-evident. In Table A only the acronym for the main body is given. In the individual case, a code for the substituents R 1 , R 2 , L 1 and L 2 follows separately from the acronym for the main body with a dash: Code for R 1 , R 2 , L 1 , L 2 R 1 R 2 L 1 L 2 nm C n H 2n + 1 C m H 2m + 1 H H n Om C n H 2n + 1 OC m H 2m + 1 H H nO.m OC n H 2n + 1 C m H 2m + 1 H H n C n H 2n + 1 CN H H nN.F C n H 2n + 1 CN H F nF C n H 2n + 1 F H H nOF OC n H 2n + 1 F H. H n Cl C n H 2n + 1 Cl H H nF.F C n H 2n + 1 F H F nF.FF C n H 2n + 1 F F F nCF 3 C n H 2n + 1 CF 3 H H nOCF 3 C n H 2n + 1 OCF 3 H H nOCF 3 .F C n H 2n + 1 OCF 3 H F nOCF 2 C n H 2n + 1 OCHF 2 H H nS C n H 2n + 1 NCS H H RVSN C r H 2r + 1 -CH = CH-C s H 2s - CN H H rESn C r H 2r + 1 -OC 2 H 2s - CN H H nAm C n H 2n + 1 COOC m H 2m + 1 H H nOCCF 2 .FF C n H 2n + 1 OCH 2 CF 2 H F F

Bevorzugte Mischungskomponenten finden sich in den Tabellen A und B. Tabelle A:

Figure imgb0126
Figure imgb0127
Figure imgb0128
Figure imgb0129
Figure imgb0130
Figure imgb0131
Figure imgb0132
Figure imgb0133
Figure imgb0134
Figure imgb0135
Figure imgb0136
Figure imgb0137
Figure imgb0138
Figure imgb0139
Figure imgb0140
Figure imgb0141
Figure imgb0142
Figure imgb0143
Figure imgb0144
Figure imgb0145
Figure imgb0146
Figure imgb0147
Figure imgb0148
Figure imgb0149
Tabelle B:
Figure imgb0150
Figure imgb0151
Figure imgb0152
Figure imgb0153
Figure imgb0154
Figure imgb0155
Figure imgb0156
Figure imgb0157
Figure imgb0158
Figure imgb0159
Figure imgb0160
Figure imgb0161
Figure imgb0162
Figure imgb0163
Figure imgb0164
Figure imgb0165
Figure imgb0166
Figure imgb0167
Figure imgb0168
Figure imgb0169
Figure imgb0170
Figure imgb0171
Figure imgb0172
Figure imgb0173
Figure imgb0174
Figure imgb0175
Figure imgb0176
Figure imgb0177
Figure imgb0178
Figure imgb0179
Figure imgb0180
Figure imgb0181
Figure imgb0182
Figure imgb0183
Figure imgb0184
Figure imgb0185
Figure imgb0186
Figure imgb0187
Figure imgb0188
Figure imgb0189
Figure imgb0190
Figure imgb0191
Figure imgb0192
Figure imgb0193
Figure imgb0194
Figure imgb0195
Figure imgb0196
Figure imgb0197
Figure imgb0198
Figure imgb0199
Figure imgb0200
Figure imgb0201
Figure imgb0202
Figure imgb0203
Figure imgb0204
Figure imgb0205
Figure imgb0206
Figure imgb0207
Figure imgb0208
Figure imgb0209
Figure imgb0210
Figure imgb0211
Figure imgb0212
Figure imgb0213
Figure imgb0214
Figure imgb0215
Figure imgb0216
Figure imgb0217
Figure imgb0218
Figure imgb0219
Figure imgb0220
Tabelle C: In der Tabelle C werden mögliche Dotierstoffe angegeben, die in der Regel den erfindungsgemäßen Mischungen in Mengen von 0,1 bis 10 Gew.% zugesetzt werden.
Figure imgb0221
Figure imgb0222
Figure imgb0223
Figure imgb0224
Figure imgb0225
Figure imgb0226
Figure imgb0227
Figure imgb0228
Figure imgb0229
Figure imgb0230
Figure imgb0231
Tabelle D Stabilisatoren, die beispielsweise den erfindungsgemäßen Mischungen zugesetzt werden können, werden nachfolgend genannt.
Figure imgb0232
Figure imgb0233
Figure imgb0234
Figure imgb0235
Figure imgb0236
Figure imgb0237
Figure imgb0238
Figure imgb0239
Figure imgb0240
Figure imgb0241
Figure imgb0242
Figure imgb0243
Figure imgb0244
Figure imgb0245
Figure imgb0246
Figure imgb0247
Figure imgb0248
Figure imgb0249
Figure imgb0250
Figure imgb0251
Figure imgb0252
Figure imgb0253
Figure imgb0254
Figure imgb0255
Figure imgb0256
Figure imgb0257
Figure imgb0258
Figure imgb0259
Figure imgb0260
Figure imgb0261
Figure imgb0262
Figure imgb0263
Preferred mixture components are given in Tables A and B. <b><u> Table A: </ u></b>
Figure imgb0126
Figure imgb0127
Figure imgb0128
Figure imgb0129
Figure imgb0130
Figure imgb0131
Figure imgb0132
Figure imgb0133
Figure imgb0134
Figure imgb0135
Figure imgb0136
Figure imgb0137
Figure imgb0138
Figure imgb0139
Figure imgb0140
Figure imgb0141
Figure imgb0142
Figure imgb0143
Figure imgb0144
Figure imgb0145
Figure imgb0146
Figure imgb0147
Figure imgb0148
Figure imgb0149
Figure imgb0150
Figure imgb0151
Figure imgb0152
Figure imgb0153
Figure imgb0154
Figure imgb0155
Figure imgb0156
Figure imgb0157
Figure imgb0158
Figure imgb0159
Figure imgb0160
Figure imgb0161
Figure imgb0162
Figure imgb0163
Figure imgb0164
Figure imgb0165
Figure imgb0166
Figure imgb0167
Figure imgb0168
Figure imgb0169
Figure imgb0170
Figure imgb0171
Figure imgb0172
Figure imgb0173
Figure imgb0174
Figure imgb0175
Figure imgb0176
Figure imgb0177
Figure imgb0178
Figure imgb0179
Figure imgb0180
Figure imgb0181
Figure imgb0182
Figure imgb0183
Figure imgb0184
Figure imgb0185
Figure imgb0186
Figure imgb0187
Figure imgb0188
Figure imgb0189
Figure imgb0190
Figure imgb0191
Figure imgb0192
Figure imgb0193
Figure imgb0194
Figure imgb0195
Figure imgb0196
Figure imgb0197
Figure imgb0198
Figure imgb0199
Figure imgb0200
Figure imgb0201
Figure imgb0202
Figure imgb0203
Figure imgb0204
Figure imgb0205
Figure imgb0206
Figure imgb0207
Figure imgb0208
Figure imgb0209
Figure imgb0210
Figure imgb0211
Figure imgb0212
Figure imgb0213
Figure imgb0214
Figure imgb0215
Figure imgb0216
Figure imgb0217
Figure imgb0218
Figure imgb0219
Figure imgb0220
In Table C possible dopants are given, which are usually added to the mixtures according to the invention in amounts of 0.1 to 10 wt.%.
Figure imgb0221
Figure imgb0222
Figure imgb0223
Figure imgb0224
Figure imgb0225
Figure imgb0226
Figure imgb0227
Figure imgb0228
Figure imgb0229
Figure imgb0230
Figure imgb0231
Stabilizers which can be added, for example, to the mixtures according to the invention are mentioned below.
Figure imgb0232
Figure imgb0233
Figure imgb0234
Figure imgb0235
Figure imgb0236
Figure imgb0237
Figure imgb0238
Figure imgb0239
Figure imgb0240
Figure imgb0241
Figure imgb0242
Figure imgb0243
Figure imgb0244
Figure imgb0245
Figure imgb0246
Figure imgb0247
Figure imgb0248
Figure imgb0249
Figure imgb0250
Figure imgb0251
Figure imgb0252
Figure imgb0253
Figure imgb0254
Figure imgb0255
Figure imgb0256
Figure imgb0257
Figure imgb0258
Figure imgb0259
Figure imgb0260
Figure imgb0261
Figure imgb0262
Figure imgb0263

Die folgenden Beispiele sollen die Erfindung erläutern, ohne sie zu begrenzen. Vor- und nachstehend bedeuten Prozentangaben Gewichtsprozent. Alle Temperaturen sind in Grad Celsius angegeben. Fp. bedeutet Schmelzpunkt, Kp. Klärpunkt. Ferner bedeuten K = kristalliner Zustand, N = nematische Phase, S = smektische Phase und I = isotrope Phase. Die Angaben zwischen diesen Symbolen stellen die Übergangstemperaturen dar. Δn bedeutet optische Anisotropie (589 nm, 20 °C), Δε die dielektrische Anisotropie 1kHz, 20 °C), die Fließviskosität ν20 (mm2/sec) wurde bei 20 °C bestimmt. Die Rotationsviskosität γ1 (mPa·s) wurde ebenfalls bei 20 °C bestimmt.The following examples are intended to illustrate the invention without limiting it. Above and below, percentages are by weight. All temperatures are in degrees Celsius. Mp means melting point, bp. Clearing point. Furthermore, K = crystalline state, N = nematic phase, S = smectic phase and I = isotropic phase. The data between these symbols represent the transition temperatures. Δn means optical anisotropy (589 nm, 20 ° C.), Δε the dielectric anisotropy 1 kHz, 20 ° C.), the flow viscosity ν 20 (mm 2 / sec) was determined at 20 ° C. , The rotational viscosity γ 1 (mPa · s) was also determined at 20 ° C.

"Übliche Aufarbeitung" bedeutet: man gibt gegebenenfalls Wasser hinzu, extrahiert mit Dichlormethan, Diethylether, Methyl-tert.Butylether oder Toluol, trennt ab, trocknet die organische Phase, dampft ein und reinigt das Produkt durch Destillation unter reduziertem Druck oder Kristallisation und/oder Chromatographie. Folgende Abkürzungen werden verwendet: n-BuLi 1,6 molare Lösung von n-Butyllithium in n-Hexan DMAP 4-(Dimethylamino)-pyridin THF Tetrahydrofuran DCC N,N'-Dicyclohexylcarbodiimid LDA Lithiumdimethylamid RT Raumtemperatur "Conventional work-up" means: water is optionally added, extracted with dichloromethane, diethyl ether, methyl tert-butyl ether or toluene, separated, the organic phase is dried, evaporated and the product is purified by distillation under reduced pressure or crystallization and / or chromatography. The following abbreviations are used: n-BuLi 1.6 molar solution of n-butyllithium in n-hexane DMAP 4- (dimethylamino) pyridine THF tetrahydrofuran DCC N, N'-dicyclohexylcarbodiimide LDA lithium dimethylamide RT room temperature

Beispiel 1example 1

Figure imgb0264
Figure imgb0264

Schritt 1.1Step 1.1

Figure imgb0265
Figure imgb0265

Die Herstellung von B erfolgt analog zu Lit. a) R. Baker, A. L. Boyes, C. J. Swain, J. Chem. Soc. Perkin Trans. 1, 1990, 1415-1421 ; b) H. Hagiwara, T. Okabe, H. Ono, V. P. Kamat. T. Hoshi, T. Suzuku, M. Ando, J Chem. Soc. Perkin Trans. 1, 2002, 895-900 .The preparation of B is carried out analogously to reference a) R. Baker, AL Boyes, CJ Swain, J. Chem. Soc. Perkin Trans. 1, 1990, 1415-1421 ; b) H. Hagiwara, T. Okabe, H. Ono, VP Kamat. T. Hoshi, T. Suzuku, M. Ando, J. Chem. Soc. Perkin Trans. 1, 2002, 895-900 ,

Schritt 1.2Step 1.2

Figure imgb0266
Figure imgb0266

Eine Lösung von 207 mmol 1,4-Dibrombenzol in 250 ml Diethylether wird bei -50 °C tropfenweise mit 207 mmol BuLi (15 % in Hexan) versetzt. Dann tropft man eine Lösung von 170 mmol B in 50 ml Diethylether bei derselben Temperatur zu, rührt 30 min nach, lässt auf 0 °C kommen und arbeitet wie üblich wässrig auf. Das Rohprodukt (51 g) wird in 400 ml CH2Cl2 gelöst und bei -75 °C mit 400 mmol Triethylsilan versetzt. Man tropft 400 mmol Bortrifluorid-Etherat zu, wobei die Temperatur nicht über -70 °C steigen darf. Danach lässt man auf -10 °C kommen, hydrolysiert mit ges. NaHCO3-Lösung und arbeitet wie üblich wässrig auf. Das Rohprodukt enthält die trans/cis-Isomere in einem Verhältnis 9:1. Man kristallisiert aus Pentan bei -20 °C µm.A solution of 207 mmol 1,4-dibromobenzene in 250 ml diethyl ether is added dropwise at -50 ° C with 207 mmol BuLi (15% in hexane). Then added dropwise to a solution of 170 mmol B in 50 ml of diethyl ether at the same temperature, stirred for 30 min, allowed to come to 0 ° C and worked up as usual on water. The crude product (51 g) is dissolved in 400 ml of CH 2 Cl 2 and treated at -75 ° C with 400 mmol of triethylsilane. 400 mmol of boron trifluoride etherate are added dropwise, during which the temperature must not rise above -70.degree. Then allowed to come to -10 ° C, hydrolyzed with sat. NaHCO 3 solution and worked up as usual aqueous. The crude product contains the trans / cis isomers in a ratio of 9: 1. It is crystallized from pentane at -20 ° C microns.

Schritt 1.3Step 1.3

Figure imgb0267
Figure imgb0267

73 mmol C werden in 200 ml THF gelöst und auf -70 °C gekühlt. Man tropft zuerst 73 mmol BuLi (15 % in Hexan) zu, gefolgt von 73 mmol Trimethylborat in 50 ml THF. Man lässt auf -20 °C kommen, stellt durch Zugabe von 2N HCl auf pH = 2 ein und arbeitet wässrig auf: Das Rohprodukt wird mit heißem Heptan digeriert und bei 0 °C kristallisiert.73 mmol C are dissolved in 200 ml THF and cooled to -70 ° C. 73 mmol of BuLi (15% in hexane) are added dropwise first, followed by 73 mmol of trimethyl borate in 50 ml of THF. It is allowed to come to -20 ° C, adjusted to pH = 2 by addition of 2N HCl and worked up in water: The crude product is digested with hot heptane and crystallized at 0 ° C.

Schritt 1.4Step 1.4

Figure imgb0268
Figure imgb0268

Eine Mischung von 60 mmol D , 300 ml Toluol, 120 mmol NaOH, 50 ml Wasser und 30 ml 30 % H2O2 wird 2 h bei 45 °C gerührt. Die Mischung wird mit 10 % HCl auf pH = 2 eingestellt und wässrig aufgearbeitet. Das Rohprodukt wird aus Heptan umkristallisiert.A mixture of 60 mmol D , 300 ml of toluene, 120 mmol of NaOH, 50 ml of water and 30 ml of 30% H 2 O 2 is stirred at 45 ° C for 2 h. The mixture is adjusted to pH = 2 with 10% HCl and worked up with water. The crude product is recrystallized from heptane.

Schritt 1.5Step 1.5

Figure imgb0269
Figure imgb0269

22 mmol E werden in 100 ml Xylol in Gegenwart von 1,5 g Wasser feuchtem 5 % Pd-C-Katalysator bei 5 bar und 130 °C für 27,5 h hydriert. Die Aufarbeitung erfolgt wie üblich. Man erhält ein farbloses Öl.22 mmol E are hydrogenated in 100 ml of xylene in the presence of 1.5 g of water wet 5% Pd-C catalyst at 5 bar and 130 ° C for 27.5 h. The work-up is done as usual. A colorless oil is obtained.

Schritt 1.6Step 1.6

Figure imgb0270
Figure imgb0270

Eine Lösung von 17 mmol 2-Trimethylsilyl-1,3-dithian in 75 ml THF wird bei -70 °C mit 17 mmol BuLi (15 % in Hexan) versetzt. Man lässt innerhalb von 4 h auf 0 °C kommen, kühlt dann wieder auf -70 °C und tropft 17 mmol F in 25 ml THF zu, man lässt auf Raumtemperatur kommen, rührt 18 h nach und arbeitet wie üblich wässrig auf. Das Rohprodukt wird aus Heptan kristallisiert. Man erhält farblose Kristalle.A solution of 17 mmol of 2-trimethylsilyl-1,3-dithiane in 75 ml of THF is added at -70 ° C with 17 mmol BuLi (15% in hexane). The mixture is allowed to come to 0 ° C within 4 h, then cooled again to -70 ° C and added dropwise 17 mmol F in 25 ml of THF, allowed to come to room temperature, stirred for 18 h and worked up as usual aqueous. The crude product is crystallized from heptane. This gives colorless crystals.

Schritt 1.7Step 1.7

Figure imgb0271
Figure imgb0271

Eine Lösung von 6,12 mmol G in 50 ml CH2Cl2 wird bei -20 °C tropfenweise mit 6,27 mmol Trifluormethansulfonsäure versetzt. Man lässt für 30 min auf Raumtemperatur kommen und kühlt dann auf-70°C. Nun werden zuerst eine Lösung von 9,1 mmol 3,4,5-Trifluorphenol und 10,1 mmol Triethylamin in 20l CH2Cl2, 5 min später 31 mmol Triethylamin-Tris(hydrofluorid) zugegeben. Nach weiteren 5 min gibt man in kleinen Portionen eine Suspension von 31,5 mmol DBH (1,3-Dibrom-5,5-dimethylhydanthoin) zu und rührt 1 h bei -70 °C nach. Man lässt auf -10 °C kommen und gießt die Reaktionsmischung in 400 ml eiskalte NaOH. Man arbeitet wie üblich wässrig auf und reinigt das Rohprodukt durch Chromatographie an Kieselgel (Heptan/Toluol 3:2) und Kristallisation aus Pentan bei -70 °C. Man erhält farblose Kristalle: K 35 N 66,3 I; Δn = 0,0570; Δε = 13,4A solution of 6.12 mmol G in 50 ml CH 2 Cl 2 is added dropwise at -20 ° C with 6.27 mmol trifluoromethanesulfonic acid. It is allowed to come to room temperature for 30 minutes and then cooled to -70 ° C. Now, first a solution of 9.1 mmol 3,4,5-trifluorophenol and 10.1 mmol of triethylamine in 20l CH 2 Cl 2 , 5 min later added 31 mmol triethylamine tris (hydrofluoride). After a further 5 minutes, a suspension of 31.5 mmol of DBH (1,3-dibromo-5,5-dimethylhydanthoin) is added in small portions and stirring is continued for 1 h at -70 ° C. It is allowed to come to -10 ° C and the reaction mixture is poured into 400 ml of ice-cold NaOH. It works as usual on aqueous and purified the crude product by chromatography on silica gel (heptane / toluene 3: 2) and crystallization from pentane at -70 ° C. Colorless crystals are obtained: K 35 N 66.3 I; Δn = 0.0570; Δε = 13.4

Analog werden die folgenden Verbindungen der Formel

Figure imgb0272
hergestellt: R1 X L1 L2 H F H H CH3 F H H C2H5 F H H n-C4H9 F H H n-C5H11 F H H n-C6H13 F H H H F F H CH3 F F H C2H5 F F H n-C3H7 F F H K 41 SB 51 N 95,9 I; Δε = 9,7; Δn = 0,0688 n-C4H9 F F H K 31 SB 64 N 97,1 I; Δε = 9,3; Δn = 0,0621 n-C5H11 F F H n-C6H13 F F H H F F F CH3 F F F K 54 I, Δε = 14,8; △n = 0,0490 C2H5 F F F K 48 N (34,7) I; △ε = 14,1; △n = 0,054.0 n-C3H7 F F F n-C4H9 F F F K 43 N 66,1 I, △ε = 13,3; △n = 0,0590 n-C5H11 F F F K 39 N 75,3 I; Δε =11,8; △n = 0,0568 n-C6H13 F F F H Cl H H CH3 Cl H H C2H5 Cl H H n-C3H7 Cl H H n-C4H9 Cl H H n-C5H11 Cl H H n-C6H13 Cl H H H Cl F H CH3 Cl F H C2H5 Cl F H n-C3H7 Cl F H n-C4H9 Cl F H n-C5H11 Cl F H n-C6H13 Cl F H H Cl F F CH3 Cl F F C2H5 Cl F F n-C3H7 Cl F F n-C4H9 Cl F F n-C5H11 Cl F F n-C6H13 Cl F F H OCF3 H H CH3 OCF3 H H C2H5 OCF3 H H n-C3H7 OCF3 H H K -41 SB 123 N 129,3 I; Δε = 9,1; Δn = 0,0780 n-C4H9 OCF3 H H KC -54 SB 129 I; Δε = 9,1; An = 0,0689 n-C5H11 OCF3 H H n-C6H13 OCF3 H H H OCF3 F H CH3 OCF3 F H C2H5 OCF3 F H n-C3H7 OCF3 F H SB 74 N 105,8 I; Δε = 11,7; Δn = 0,0701 n-C4H9 OCF3 F H SB 81 N 105,8 I; Δε =11,5; Δn = 0,0623 n-C5H11 OCF3 F H n-C6H13 OCF3 F H H OCF3 F F CH3 OCF3 F F C2H5 OCF3 F F n-C3H7 OCF3 F F n-C4H9 OCF3 F F n-C5H11 OCF3 F F n-C6H13 OCF3 F F H OCHF2 H H CH3 OCHF2 H H C2H5 OCHF2 H H n-C3H7 OCHF2 H H n-C4H9 OCHF2 H H n-C5H11 OCHF2 H H n-C6H13 OCHF2 H H H OCHF2 F H CH3 OCHF2 F H C2H5 OCHF2 F H n-C3H7 OCHF2 F H n-C4H9 OCHF2 F H n-C5H11 OCHF2 F H n-C6H13 OCHF2 F H H OCHF2 F F CH3 OCHF2 F F C2H5 OCHF2 F F n-C3H7 OCHF2 F F n-C4H9 OCHF2 F F n-C5H11 OCHF2 F F n-C6H13 OCHF2 F F H OCHFCF3 H H CH3 OCHFCF3 H H C2H5 OCHFCF3 H H n-C3H7 OCHFCF3 H H n-C4H9 OCHFCF3 H H n-C5H11 OCHFCF3 H H n-C5H13 OCHFCF3 H H H OCHFCF3 F H CH3 OCHFCF3 F H C2H5 OCHFCF3 F H n-C3H7 OCHFCF3 F H n-C4H9 OCHFCF3 F H n-C5H11 OCHFCF3 F H n-C6H13 OCHFCF3 F H H OCHFCF3 F F CH3 OCHFCF3 F F C2H5 OCHFCF3 F F n-C3H7 OCHFCF3 F F n-C4H9 OCHFCF3 F F n-C5H11 OCHFCF3 F F n-C6H13 OCHFCF3 F F H OCHFCF3 H H CH3 OCHFCF3 H H C2H5 OCHFCF3 H H n-C3H7 OCHFCF3 H H n-C4H9 OCHFCF3 H H n-C5H11 OCHFCF3 H H n-C6H13 OCHFCF3 H H H OCHFCF3 F H CH3 OCHFCF3 F H C2H5 OCHFCF3 F H n-C3H7 OCHFCF3 F H n-C4H9 OCHFCF3 F H n-C5H11 OCHFCF3 F H n-C6H13 OCHFCF3 F H H OCHFCF3 F F CH3 OCHFCF3 F F C2H5 OCHFCF3 F F n-C3H7 OCHFCF3 F F n-C4H9 OCHFCF3 F F n-C5H11 OCHFCF3 F F n-C6H13 OCHFCF3 F F H OCF2CHFCF3 H H CH3 OCF2CHFCF3 H H C2H5 OCF2CHFCF3 H H n-C3H7 OCF2CHFCF3 H H n-C4H9 OCF2CHFCF3 H H n-C5H11 OCF2CHFCF3 H H n-C6H13 OCF2CHFCF3 H H H OCF2CHFCF3 F H CH3 OCF2CHFCF3 F H C2H5 OCF2CHFCF3 F H n-C3H7 OCF2CHFCF3 F H n-C4H9 OCF2CHFCF3 F H n-C5H11 OCF2CHFCF3 F H n-C6H13 OCF2CHFCF3 F H H OCF2CHFCF3 F F CH3 OCF2CHFCF3 F F C2H5 OCF2CHFCF3 F F n-C3H7 OCF2CHFCF3 F F n-C4H9 OCF2CHFCF3 F F n-C5H11 OCF2CHFCF3 F F n-C6H13 OCF2CHFCF3 F F H NCS H H CH3 NCS H H C2H5 NCS H H n-C3H7 NCS H H n-C4H9 NCS H H n-C5H11 NCS H H n-C6H13 NCS H H H NCS F H CH3 NCS F H C2H5 NCS F H n-C3H7 NCS F H n-C4H9 NCS F H n-C5H11 NCS F H n-C6H13 NCS F H H NCS F F CH3 NCS F F C2H5 NCS F F n-C3H7 NCS F F n-C4H9 NCS F F n-C5H11 NCS F F n-C6H13 NCS F F H C2F5 H H CH3 C2F5 H H C2H5 C2F5 H H n-C3H7 C2F5 H H n-C4H9 C2F5 H H n-C5H11 C2F5 H H n-C6H13 C2F5 H H H C2F5 F H CH3 C2F5 F H C2H5 C2F5 F H n-C3H7 C2F5 F H n-C4H9 C2F5 F H n-C5H11 C2F5 F H n-C6H13 C2F5 F H H C2F5 F F CH3 C2F5 F F C2H5 C2F5 F F n-C3H7 C2F5 F F n-C4H9 C2F5 F F n-C5H11 C2F5 F F n-C6H13 C2F5 F F H C3F7 H H CH3 C3F7 H H C2H5 C3F7 H H n-C3H7 C3F7 H H n-C4H9 C3F7 H H n-C5H11 C3F7 H H n-C6H13 C3F7 H H H C3F7 F H CH3 C3F7 F H C2H5 C3F7 F H n-C3H7 C3F7 F H n-C4H9 C3F7 F H n-C5H11 C3F7 F H n-C6H13 C3F7 F H H C3F7 F F CH3 C3F7 F F C2H5 C3F7 F F n-C3H7 C3F7 F F n-C4H9 C3F7 F F n-C5H11 C3F7 F F n-C6H13 C3F7 F F H SF5 H H CH3 SF5 H H C2H5 SF5 H H n-C3H7 SF5 H H n-C4H9 SF5 H H n-C5H11 SF5 H H n-C6H13 SF5 H H H SF5 F H CH3 SF5 F H C2H5 SF5 F H n-C3H7 SF5 F H n-C4H9 SF5 F H n-C5H11 SF5 F H n-C6H13 SF5 F H H SF5 F F CH3 SF5 F F C2H5 SF5 F F n-C3H7 SF5 F F n-C4H9 SF5 F F n-C5H11 SF5 F F n-C6H13 SF5 F F H CN H H CH3 CN H H C2H5 CN H H n-C3H7 CN H H n-C4H9 CN H H n-C5H11 CN H H n-C6H13 CN H H H CN F H CH3 CN F H C2H5 CN F H n-C3H7 CN F H n-C4H9 CN F H n-C5H11 CN F H n-C6H13 CN F H H CN F F CH3 CN F F C2H5 CN F F n-C3H7 CN F F n-C4H9 CN F F n-C5H11 CN F F n-C6H13 CN F F Analogously, the following compounds of the formula
Figure imgb0272
produced: R 1 X L 1 L 2 H F H H CH 3 F H H C 2 H 5 F H H nC 4 H 9 F H H nc 5 H 11 F H H nc 6 H 13 F H H H F F H CH 3 F F H C 2 H 5 F F H nC 3 H 7 F F H K 41 S B 51 N 95.9 I; Δε = 9.7; Δn = 0.0688 nC 4 H 9 F F H K 31 S B 64 N 97.1 I; Δε = 9.3; Δn = 0.0621 nc 5 H 11 F F H nc 6 H 13 F F H H F F F CH 3 F F F K 54 I, Δε = 14.8; = N = 0.0490 C 2 H 5 F F F K 48 N (34,7) I; △ ε = 14.1; △n = 0.054.0 nC 3 H 7 F F F nC 4 H 9 F F F K 43 N 66.1 I, △ ε = 13.3; = N = 0.0590 nc 5 H 11 F F F K 39 N 75.3 I; Δε = 11.8; = N = 0.0568 nc 6 H 13 F F F H Cl H H CH 3 Cl H H C 2 H 5 Cl H H nC 3 H 7 Cl H H nC 4 H 9 Cl H H nc 5 H 11 Cl H H nc 6 H 13 Cl H H H Cl F H CH 3 Cl F H C 2 H 5 Cl F H nC 3 H 7 Cl F H nC 4 H 9 Cl F H nc 5 H 11 Cl F H nc 6 H 13 Cl F H H Cl F F CH 3 Cl F F C 2 H 5 Cl F F nC 3 H 7 Cl F F nC 4 H 9 Cl F F nc 5 H 11 Cl F F nc 6 H 13 Cl F F H OCF 3 H H CH 3 OCF 3 H H C 2 H 5 OCF 3 H H nC 3 H 7 OCF 3 H H K -41 S B 123 N 129.3 I; Δε = 9.1; Δn = 0.0780 nC 4 H 9 OCF 3 H H KC -54 S B 129 I; Δε = 9.1; An = 0.0689 nc 5 H 11 OCF 3 H H nc 6 H 13 OCF 3 H H H OCF 3 F H CH 3 OCF 3 F H C 2 H 5 OCF 3 F H nC 3 H 7 OCF 3 F H S B 74 N 105.8 I; Δε = 11.7; Δn = 0.0701 nC 4 H 9 OCF 3 F H S B 81 N 105.8 I; Δε = 11.5; Δn = 0.0623 nc 5 H 11 OCF 3 F H nc 6 H 13 OCF 3 F H H OCF 3 F F CH 3 OCF 3 F F C 2 H 5 OCF 3 F F nC 3 H 7 OCF 3 F F nC 4 H 9 OCF 3 F F nc 5 H 11 OCF 3 F F nc 6 H 13 OCF 3 F F H OCHF 2 H H CH 3 OCHF 2 H H C 2 H 5 OCHF 2 H H nC 3 H 7 OCHF 2 H H nC 4 H 9 OCHF 2 H H nc 5 H 11 OCHF 2 H H nc 6 H 13 OCHF 2 H H H OCHF 2 F H CH 3 OCHF 2 F H C 2 H 5 OCHF 2 F H nC 3 H 7 OCHF 2 F H nC 4 H 9 OCHF 2 F H nc 5 H 11 OCHF 2 F H nc 6 H 13 OCHF 2 F H H OCHF 2 F F CH 3 OCHF 2 F F C 2 H 5 OCHF 2 F F nC 3 H 7 OCHF 2 F F nC 4 H 9 OCHF 2 F F nc 5 H 11 OCHF 2 F F nc 6 H 13 OCHF 2 F F H OCHFCF 3 H H CH 3 OCHFCF 3 H H C 2 H 5 OCHFCF 3 H H nC 3 H 7 OCHFCF 3 H H nC 4 H 9 OCHFCF 3 H H nc 5 H 11 OCHFCF 3 H H nc 5 H 13 OCHFCF 3 H H H OCHFCF 3 F H CH 3 OCHFCF 3 F H C 2 H 5 OCHFCF 3 F H nC 3 H 7 OCHFCF 3 F H nC 4 H 9 OCHFCF 3 F H nc 5 H 11 OCHFCF 3 F H nc 6 H 13 OCHFCF 3 F H H OCHFCF3 F F CH 3 OCHFCF 3 F F C 2 H 5 OCHFCF 3 F F nC 3 H 7 OCHFCF 3 F F nC 4 H 9 OCHFCF 3 F F nc 5 H 11 OCHFCF 3 F F nc 6 H 13 OCHFCF 3 F F H OCHFCF 3 H H CH 3 OCHFCF 3 H H C 2 H 5 OCHFCF 3 H H nC 3 H 7 OCHFCF 3 H H nC 4 H 9 OCHFCF 3 H H nc 5 H 11 OCHFCF 3 H H nc 6 H 13 OCHFCF 3 H H H OCHFCF 3 F H CH 3 OCHFCF 3 F H C 2 H 5 OCHFCF 3 F H nC 3 H 7 OCHFCF 3 F H nC 4 H 9 OCHFCF 3 F H nc 5 H 11 OCHFCF 3 F H nc 6 H 13 OCHFCF 3 F H H OCHFCF 3 F F CH 3 OCHFCF 3 F F C 2 H 5 OCHFCF 3 F F nC 3 H 7 OCHFCF 3 F F nC 4 H 9 OCHFCF 3 F F nc 5 H 11 OCHFCF 3 F F nc 6 H 13 OCHFCF 3 F F H OCF 2 CHFCF 3 H H CH 3 OCF 2 CHFCF 3 H H C 2 H 5 OCF 2 CHFCF 3 H H nC 3 H 7 OCF 2 CHFCF 3 H H nC 4 H 9 OCF 2 CHFCF 3 H H nc 5 H 11 OCF 2 CHFCF 3 H H nc 6 H 13 OCF 2 CHFCF 3 H H H OCF 2 CHFCF 3 F H CH 3 OCF 2 CHFCF 3 F H C 2 H 5 OCF 2 CHFCF 3 F H nC 3 H 7 OCF 2 CHFCF 3 F H nC 4 H 9 OCF 2 CHFCF3 F H nc 5 H 11 OCF 2 CHFCF 3 F H nc 6 H 13 OCF 2 CHFCF 3 F H H OCF 2 CHFCF 3 F F CH 3 OCF 2 CHFCF 3 F F C 2 H 5 OCF 2 CHFCF 3 F F nC 3 H 7 OCF 2 CHFCF 3 F F nC 4 H 9 OCF 2 CHFCF 3 F F nc 5 H 11 OCF 2 CHFCF 3 F F nc 6 H 13 OCF 2 CHFCF 3 F F H NCS H H CH 3 NCS H H C 2 H 5 NCS H H nC 3 H 7 NCS H H nC 4 H 9 NCS H H nc 5 H 11 NCS H H nc 6 H 13 NCS H H H NCS F H CH 3 NCS F H C 2 H 5 NCS F H nC 3 H 7 NCS F H nC 4 H 9 NCS F H nc 5 H 11 NCS F H nc 6 H 13 NCS F H H NCS F F CH 3 NCS F F C 2 H 5 NCS F F nC 3 H 7 NCS F F nC 4 H 9 NCS F F nc 5 H 11 NCS F F nc 6 H 13 NCS F F H C 2 F 5 H H CH 3 C 2 F 5 H H C 2 H 5 C 2 F 5 H H nC 3 H 7 C 2 F 5 H H nC 4 H 9 C 2 F 5 H H nc 5 H 11 C 2 F 5 H H nc 6 H 13 C 2 F 5 H H H C 2 F 5 F H CH 3 C 2 F 5 F H C 2 H 5 C 2 F 5 F H nC 3 H 7 C 2 F 5 F H nC 4 H 9 C 2 F 5 F H nc 5 H 11 C 2 F 5 F H nc 6 H 13 C 2 F 5 F H H C 2 F 5 F F CH 3 C 2 F 5 F F C 2 H 5 C 2 F 5 F F nC 3 H 7 C 2 F 5 F F nC 4 H 9 C 2 F 5 F F nc 5 H 11 C 2 F 5 F F nc 6 H 13 C 2 F 5 F F H C 3 F 7 H H CH 3 C 3 F 7 H H C 2 H 5 C 3 F 7 H H nC 3 H 7 C 3 F 7 H H nC 4 H 9 C 3 F 7 H H nc 5 H 11 C 3 F 7 H H nc 6 H 13 C 3 F 7 H H H C 3 F 7 F H CH 3 C 3 F 7 F H C 2 H 5 C 3 F 7 F H nC 3 H 7 C 3 F 7 F H nC 4 H 9 C 3 F 7 F H nc 5 H 11 C 3 F 7 F H nc 6 H 13 C 3 F 7 F H H C 3 F 7 F F CH 3 C 3 F 7 F F C 2 H 5 C 3 F 7 F F nC 3 H 7 C 3 F 7 F F nC 4 H 9 C 3 F 7 F F nc 5 H 11 C 3 F 7 F F nc 6 H 13 C 3 F 7 F F H SF 5 H H CH 3 SF 5 H H C 2 H 5 SF 5 H H nC 3 H 7 SF 5 H H nC 4 H 9 SF 5 H H nc 5 H 11 SF 5 H H nc 6 H 13 SF 5 H H H SF 5 F H CH 3 SF 5 F H C 2H5 SF 5 F H nC 3 H 7 SF 5 F H nC 4 H 9 SF 5 F H nc 5 H 11 SF 5 F H nc 6 H 13 SF 5 F H H SF 5 F F CH 3 SF 5 F F C 2 H 5 SF 5 F F nC 3 H 7 SF 5 F F nC 4 H 9 SF 5 F F nc 5 H 11 SF 5 F F nc 6 H 13 SF 5 F F H CN H H CH 3 CN H H C 2 H 5 CN H H nC 3 H 7 CN H H nC 4 H 9 CN H H nc 5 H 11 CN H H nc 6 H 13 CN H H H CN F H CH 3 CN F H C 2 H 5 CN F H nC 3 H 7 CN F H nC 4 H 9 CN F H nc 5 H 11 CN F H nc 6 H 13 CN F H H CN F F CH 3 CN F F C 2 H 5 CN F F nC 3 H 7 CN F F nC 4 H 9 CN F F nc 5 H 11 CN F F nc 6 H 13 CN F F

Beispiel 2Example 2 Schritt 2.1Step 2.1

Figure imgb0273
Figure imgb0273

Eine Mischung aus 50 mmol I, 50 mmol J, 2,5 mmol Pd(PPh3)4, 300 ml Toluol und 300 ml Na-Boratpuffer (pH=9) wird 18 h bei 80 °C gerührt. Man gießt die Mischung in 500 ml 0,1 N HCl, extrahiert das Produkt mit CH2Cl2, trocknet über Na2SO4 und rotiert zur Trockene ein. Das Rohprodukt wird in n-Heptan über Kiegelgel chromatographiert und anschließend zweimal bei -20 °C aus n-Heptan umkristallisiert. K 78 N 93,1 I; Δn = 0,1493; Δε = 27,3A mixture of 50 mmol of I , 50 mmol of J , 2.5 mmol of Pd (PPh 3 ) 4 , 300 ml of toluene and 300 ml of Na borate buffer (pH = 9) is stirred at 80 ° C. for 18 h. The mixture is poured into 500 ml of 0.1 N HCl, the product is extracted with CH 2 Cl 2 , dried over Na 2 SO 4 and rotated to dryness. The crude product is in chromatographed on Kiegelgel n-heptane and then recrystallized twice at -20 ° C from n-heptane. K 78 N 93.1 I; Δn = 0.1493; Δε = 27.3

Analog werden die folgenden Verbindungen der Formel

Figure imgb0274
hergestellt: R1 X L1 L2 L3 L4 H F H H H H CH3 F H H H H C2H5 F H H H H C3H7 F H H H H n-C4H9 F H H H H n-C5H11 F H H H H n-C6H13 F H H H H H F F H H H CH3 F F H H H C2H5 F F H H H n-C3H7 F F H H H n-C4H9 F F H H H n-C5H11 F F H H H n-C6H13 F F H H H H F F F H H CH3 F F F H H n-C3H7 F F F H H K 75 N 118,0 I; Δε = 23,2; Δn = 0,1450 n-C4H9 F F F H H n-C5H11 F F F H H n-C6H13 F F F H H H Cl H H H H CH3 Cl H H H H C2H5 Cl H H H H n-C3H7 Cl H H H H n-C4H9 Cl H H H H n-C5H11 Cl H H H H n-C6H13 Cl H H H H H Cl F H H H CH3 Cl F H H H C2H5 Cl F H H H n-C3H7 Cl F H H H n-C4H9 Cl F H H H n-C5H11 Cl F H H H n-C6H13 Cl F H H H H Cl F F H H CH3 Cl F F H H C2H5 Cl F F H H n-C3H7 Cl F F H H n-C4H9 Cl F F H H n-C5H11 Cl F F H H n-C6H13 Cl F F H H H OCF3 H H H H CH3 OCF3 H H H H C2H5 OCF3 H H H H n-C3H7 OCF3 H H H H n-C4H9 OCF3 H H H H n-C5H11 OCF3 H H H H n-C6H13 OCF3 H H H H H OCF3 F H H H CH3 OCF3 F H H H C2H5 OCF3 F H H H n-C3H7 OCF3 F H H H n-C4H9 OCF3 F H H H n-C5H11 OCF3 F H H H n-C6H13 OCF3 F H H H H OCF3 F F H H CH3 OCF3 F F H H C2H5 OCF3 F F H H n-C3H7 OCF3 F F H H n-C4H9 OCF3 F F H H n-C5H11 OCF3 F F H H n-C6H13 OCF3 F F H H H OCHF2 H H H H CH3 OCHF2 H H H H C2H5 OCHF2 H H H H n-C3H7 OCHF2 H H H H n-C4H9 OCHF2 H H H H n-C5H11 OCHF2 H H H H n-C6H13 OCHF2 H H H H H OCHF2 F H H H CH3 OCHF2 F H H H C2H5 OCHF2 F H H H n-C3H7 OCHF2 F H H H n-C4H9 OCHF2 F H H H n-C5H11 OCHF2 F H H H n-C6H13 OCHF2 F H H H H OCHF2 F F H H CH3 OCHF2 F F H H C2H5 OCHF2 F F H H n-C3H7 OCHF2 F F H H n-C4H9 OCHF2 F F H H n-C5H11 OCHF2 F F H H n-C6H13 OCHF2 F F H H H OCHFCF3 H H H H CH3 OCHFCF3 H H H H C2H5 OCHFCF3 H H H H n-C3H7 OCHFCF3 H H H H n-C4H9 OCHFCF3 H H H H n-C5H11 OCHFCF3 H H H H n-C6H13 OCHFCF3 H H H H H OCHFCF3 F H H H CH3 OCHFCF3 F H H H C2H5 OCHFCF3 F H H H n-C3H7 OCHFCF3 F H H H n-C4H9 OCHFCF3 F H H H n-C5H11 OCHFCF3 F H H H n-C6H13 OCHFCF3 F H H H H OCHFCF3 F F H H CH3 OCHFCF3 F F H H C2H5 OCHFCF3 F F H H n-C3H7 OCHFCF3 F F H H n-C4H9 OCHFCF3 F F H H n-C5H11 OCHFCF3 F F H H n-C6H13 OCHFCF3 F F H H H OCHFCF3 H H H H CH3 OCHFCF3 H H H H C2H5 OCHFCF3 H H H H n-C3H7 OCHFCF3 H H H H n-C4H9 OCHFCF3 H H H H n-C5H11 OCHFCF3 H H H H n-C6H13 OCHFCF3 H H H H H OCHFCF3 F H H H CH3 OCHFCF3 F H H H C2H5 OCHFCF3 F H H H n-C3H7 OCHFCF3 F H H H n-C4H9 OCHFCF3 F H H H n-C5H11 OCHFCF3 F H H H n-C6H13 OCHFCF3 F H H H H OCHFCF3 F F H H CH3 OCHFCF3 F F H H C2H5 OCHFCF3 F F H H n-C3H7 OCHFCF3 F F H H n-C4H9 OCHFCF3 F F H H n-C5H11 OCHFCF3 F F H H n-C6H13 OCHFCF3 F F H H H OCF2CHFCF3 H H H H CH3 OCF2CHFCF3 H H H H C2H5 OCF2CHFCF3 H H H H n-C3H7 OCF2CHFCF3 H H H H n-C4H9 OCF2CHFCF3 H H H H n-C5H11 OCF2CHFCF3 H H H H n-C6H13 OCF2CHFCF3 H H H H H OCF2CHFCF3 F H H H CH3 OCF2CHFCF3 F H H H C2H5 OCF2CHFCF3 F H H H n-C3H7 OCF2CHFCF3 F H H H n-C4H9 OCF2CHFCF3 F H H H n-C5H11 OCF2CHFCF3 F H H H n-C6H13 OCF2CHFCF3 F H H H H OCF2CHFCF3 F F H H CH3 OCF2CHFCF3 F F H H C2H5 OCF2CHFCF3 F F H H n-C3H7 OCF2CHFCF3 F F H H n-C4H9 OCF2CHFCF3 F F H H n-C5H11 OCF2CHFCF3 F F H H n-C6H13 OCF2CHFCF3 F F H H H NCS H H H H CH3 NCS H H H H C2H5 NCS H H H H n-C3H7 NCS H H H H n-C4H9 NCS H H H H n-C5H11 NCS H H H H n-C6H13 NCS H H H H H NCS F H H H CH3 NCS F H H H C2H5 NCS F H H H n-C3H7 NCS F H H H n-C4H9 NCS F H H H n-C5H11 NCS F H H H n-C6H13 NCS F H H H H NCS F F H H CH3 NCS F F H H C2H5 NCS F F H H n-C3H7 NCS F F H H n-C4H9 NCS F F H H n-C5H11 NCS F F H H n-C6H13 NCS F F H H H C2F5 H H H H CH3 C2F5 H H H H C2H5 C2F5 H H H H n-C3H7 C2F5 H H H H n-C4H9 C2F5 H H H H n-C5H11 C2F5 H H H H n-C6H13 C2F5 H H H H H C2F5 F H H H CH3 C2F5 F H H H C2H5 C2F5 F H H H n-C3H7 C2F5 F H H H n-C4H9 C2F5 F H H H n-C5H11 C2F5 F H H H n-C6H13 C2F5 F H H H H C2F5 F F H H CH3 C2F5 F F H H C2H5 C2F5 F F H H n-C3H7 C2F5 F F H H n-C4H9 C2F5 F F H H n-C5H11 C2F5 F F H H n-C6H13 C2F5 F F H H H C3F7 H H H H CH3 C3F7 H H H H C2H5 C3F7 H H H H n-C3H7 C3F7 H H H H n-C4H9 C3F7 H H H H n-C5H11 C3F7 H H H H n-C6H13 C3F7 H H H H H C3F7 F H H H CH3 C3F7 F H H H C2H5 C3F7 F H H H n-C3H7 C3F7 F H H H n-C4H9 C3F7 F H H H n-C5H11 C3F7 F H H H n-C6H13 C3F7 F H H H H C3F7 F F H H CH3 C3F7 F F H H C2H5 C3F7 F F H H n-C3H7 C3F7 F F H H n-C4H9 C3F7 F F H H n-C5H11 C3F7 F F H H n-C6H13 C3F7 F F H H H SF5 H H H H CH3 SF5 H H H H C2H5 SF5 H H H H n-C3H7 SF5 H H H H n-C4H9 SF5 H H H H n-C5H11 SF5 H H H H n-C6H13 SF5 H H H H H SF5 F H H H CH3 SF5 F H H H C2H5 SF5 F H H H n-C3H7 SF5 F H H H n-C4H9 SF5 F H H H n-C5H11 SF5 F H H H n-C6H13 SF5 F H H H H SF5 F F H H CH3 SF5 F F H H C2H5 SF5 F F H H n-C3H7 SF5 F F H H n-C4H9 SF5 F F H H n-C5H11 SF5 F F H H n-C6H13 SF5 F F H H H CN H H H H CH3 CN H H H H C2H5 CN H H H H n-C3H7 CN H H H H n-C4H9 CN H H H H n-C5H11 CN H H H H n-C6H13 CN H H H H H CN F H H H CH3 CN F H H H C2H5 CN F H H H n-C3H7 CN F H H H n-C4H9 CN F H H H n-C5H11 CN F H H H n-C6H13 CN F H H H H CN F F H H CH3 CN F F H H C2H5 CN F F H H n-C3H7 CN F F H H n-C4H9 CN F F H H n-C5H11 CN F F H H n-C6H13 CN F F H H H F H H F H CH3 F H H F H C2H5 F H H F H C3H7 F H H F H n-C4H9 F H H F H n-C5H11 F H H F H n-C6H13 F H H F H H F F H F H CH3 F F H F H C2H5 F F H F H n-C3H7 F F H F H n-C4H9 F F H F H n-C5H11 F F H F H n-C6H13 F F H F H H F F F F H CH3 F F F F H C2H5 F F F F H K 89 N (76,8) I, Δε = 29,9; Δn = 0,1310 n-C3H7 F F F F H K 70 N 102,3 I; Δε = 29,7; Δn = 0,1364 n-C4H9 F F F F H n-C5H11 F F F F H n-C6H13 F F F F H H Cl H H F H CH3 Cl H H F H C2H5 Cl H H F H n-C3H7 Cl H H F H n-C4H9 Cl H H F H n-C5H11 Cl H H F H n-C6H13 Cl H H F H H Cl F H F H CH3 Cl F H F H C2H5 Cl F H F H n-C3H7 Cl F H F H n-C4H9 Cl F H F H n-C5H11 Cl F H F H n-C6H13 Cl F H F H H Cl F F F H CH3 Cl F F F H C2H5 Cl F F F H n-C3H7 Cl F F F H n-C4H9 Cl F F F H n-C5H11 Cl F F F H n-C6H13 Cl F F F H H OCF3 H H F H CH3 OCF3 H H F H C2H5 OCF3 H H F H n-C3H7 OCF3 H H F H n-C4H9 OCF3 H H F H n-C5H11 OCF3 H H F H n-C6H13 OCF3 H H F H H OCF3 F H F H CH3 OCF3 F H F H C2H5 OCF3 F H F H n-C3H7 OCF3 F H F H n-C4H9 OCF3 F H F H n-C5H11 OCF3 F H F H n-C6H13 OCF3 F H F H H OCF3 F F F H CH3 OCF3 F F F H C2H5 OCF3 F F F H n-C3H7 OCF3 F F F H n-C4Hs OCF3 F F F H n-C5H11 OCF3 F F F H n-C6H13 OCF3 F F F H H OCHF2 H H F H CH3 OCHF2 H H F H C2H5 OCHF2 H H F H n-C3H7 OCHF2 H H F H n-C4H9 OCHF2 H H F H n-C5H11 OCHF2 H H F H n-C6H13 OCHF2 H H F H H OCHF2 F H F H CH3 OCHF2 F H F H C2H5 OCHF2 F H F H n-C3H7 OCHF2 F H F H n-C4H9 OCHF2 F H F H n-C5H11 OCHF2 F H F H n-C6H13 OCHF2 F H F H H OCHF2 F F F H CH3 OCHF2 F F F H C2H5 OCHF2 F F F H n-C3H7 OCHF2 F F F H n-C4H9 OCHF2 F F F H n-C5H11 OCHF2 F F F H n-C6H13 OCHF2 F F F H H OCHFCF3 H H F H CH3 OCHFCF3 H H F H C2H5 OCHFCF3 H H F H n-C3H7 OCHFCF3 H H F H n-C4H9 OCHFCF3 H H F H n-C5H11 OCHFCF3 H H F H n-C6H13 OCHFCF3 H H F H H OCHFCF3 F H F H CH3 OCHFCF3 F H F H C2H5 OCHFCF3 F H F H n-C3H7 OCHFCF3 F H F H n-C4H9 OCHFCF3 F H F H n-C5H11 OCHFCF3 F H F H n-C6H13 OCHFCF3 F H F H H OCHFCF3 F F F H CH3 OCHFCF3 F F F H C2H5 OCHFCF3 F F F H n-C3H7 OCHFCF3 F F F H n-C4H9 OCHFCF3 F F F H n-C5H11 OCHFCF3 F F F H n-C6H13 OCHFCF3 F F F H H OCHFCF3 H H F H CH3 OCHFCF3 H H F H C2H5 OCHFCF3 H H F H n-C3H7 OCHFCF3 H H F H n-C4H9 OCHFCF3 H H F H n-C5H11 OCHFCF3 H H F H n-C6H13 OCHFCF3 H H F H H OCHFCF3 F H F H CH3 OCHFCF3 F H F H C2H5 OCHFCF3 F H F H n-C3H7 OCHFCF3 F H F H n-C4H9 OCHFCF3 F H F H n-C5H11 OCHFCF3 F H F H n-C6H13 OCHFCF3 F H F H H OCHFCF3 F F F H CH3 OCHFCF3 F F F H C2H5 OCHFCF3 F F F H n-C3H7 OCHFCF3 F F F H n-C4H9 OCHFCF3 F F F H n-C5H11 OCHFCF3 F F F H n-C6H13 OCHFCF3 F F F H H OCF2CHFCF3 H H F H CH3 OCF2CHFCF3 H H F H C2H5 OCF2CHFCF3 H H F H n-C3H7 OCF2CHFCF3 H H F H n-C4H9 OCF2CHFCF3 H H F H n-C5H11 OCF2CHFCF3 H H F H n-C6H13 OCF2CHFCF3 H H F H H OCF2CHFCF3 F H F H CH3 OCF2CHFCF3 F H F H C2H5 OCF2CHFCF3 F H F H n-C3H7 OCF2CHFCF3 F H F H n-C4H9 OCF2CHFCF3 F H F H n-C5H11 OCF2CHFCF3 F H F H n-C6H13 OCF2CHFCF3 F H F H H OCF2CHFCF3 F F F H CH3 OCF2CHFCF3 F F F H C2H5 OCF2CHFCF3 F F F H n-C3H7 OCF2CHFCF3 F F F H n-C4H9 OCF2CHFCF3 F F F H n-C5H11 OCF2CHFCF3 F F F H n-C6H13 OCF2CHFCF3 F F F H H NCS H H F H CH3 NCS H H F H C2H5 NCS H H F H n-C3H7 NCS H H F H n-C4H9 NCS H H F H n-C5H11 NCS H H F H n-C6H13 NCS H H F H H NCS F H F H CH3 NCS F H F H C2H5 NCS F H F H n-C3H7 NCS F H F H n-C4H9 NCS F H F H n-C5H11 NCS F H F H n-C6H13 NCS F H F H H NCS F F F H CH3 NCS F F F H C2H5 NCS F F F H n-C3H7 NCS F F F H n-C4H9 NCS F F F H n-C5H11 NCS F F F H n-C6H13 NCS F F F H H C2F5 H H F H CH3 C2F5 H H F H C2H5 C2F5 H H F H n-C3H7 C2F5 H H F H n-C4H9 C2F5 H H F H n-C5H11 C2F5 H H F H n-C6H13 C2F5 H H F H H C2F5 F H F H CH3 C2F5 F H F H C2H5 C2F5 F H F H n-C3H7 C2F5 F H F H n-C4H9 C2F5 F H F H n-C5H11 C2F5 F H F H n-C6H13 C2F5 F H F H H C2F5 F F F H CH3 C2F5 F F F H C2H5 C2F5 F F F H n-C3H7 C2F5 F F F H n-C4H9 C2F5 F F F H n-C5H11 C2F5 F F F H n-C6H13 C2F5 F F F H H C3F7 H H F H CH3 C3F7 H H F H C2H5 C3F7 H H F H n-C3H7 C3F7 H H F H n-C4H9 C3F7 H H F H n-C5H11 C3F7 H H F H n-C6H13 C3F7 H H F H H C3F7 F H F H CH3 C3F7 F H F H C2H5 C3F7 F H F H n-C3H7 C3F7 F H F H n-C4H9 C3F7 F H F H n-C5H11 C3F7 F H F H n-C6H13 C3F7 F H F H H C3F7 F F F H CH3 C3F7 F F F H C2H5 C3F7 F F F H n-C3H7 C3F7 F F F H n-C4H9 C3F7 F F F H n-C5H11 C3F7 F F F H n-C6H13 C3H7 F F F H H SF5 H H F H CH3 SF5 H H F H C2H5 SF5 H H F H n-C3H7 SF5 H H F H n-C4H9 SF5 H H F H n-C5H11 SF5 H H F H n-C6H13 SF5 H H F H H SF5 F H F H CH3 SF5 F H F H C2H5 SF5 F H F H n-C3H7 SF5 F H F H n-C4H9 SF5 F H F H n-C5H11 SF5 F H F H n-C6H13 SF5 F H F H H SF5 F F F H CH3 SF5 F F F H C2H5 SF5 F F F H n-C3H7 SF5 F F F H n-C4H9 SF5 F F F H n-C5H11 SF5 F F F H n-C6H13 SF5 F F F H H CN H H F H CH3 CN H H F H C2H5 CN H H F H n-C3H7 CN H H F H n-C4H9 CN H H F H n-C5H11 CN H H F H n-C6H13 CN H H F H H CN F H F H CH3 CN F H F H C2H5 CN F H F H n-C3H7 CN F H F H n-C4H9 CN F H F H n-C5H11 CN F H F H n-C6H13 CN F H F H H CN F F F H CH3 CN F F F H C2H5 CN F F F H n-C3H7 CN F F F H n-C4H9 CN F F F H n-C5H11 CN F F F H n-C6H13 CN F F F H H F H H F F CH3 F H H F F C2H5 F H H F F n-C4H9 F H H F F n-C5H11 F H H F F n-C6H13 F H H F F H F F F H F F CH3 F F H F F C2H5 F F H F F n-C3H7 F F H F F n-C4H9 F F H F F n-C5H11 F F H F F n-C6H13 F F H F F H F F F F F CH3 F F F F F C2H5 F F F F F C2H5 F F F F F K 91 N (58,8) I; Δε = 35, 0; Δn = 0,1149 n-C3H7 F F F F F K 83 N (83,0) I; Δε = 34,9; Δn = 0,1231 n-C4H9 F F F F F K 90 N 79,4 I; Δε = 32,4; Δn = 0,1171 n-C5H11 F F F F F K 82 N 84,3 I; Δε = 31,9; Δn = 0,1205 n-C6H13 F F F F F K 89 N (83,4) I; Δε = 30,6; Δn = 0,1116 n-C7H15 F F F F F K 82 N 84,3 I; Δε =30,3; Δn = 0,1130 H Cl H H F F CH3 Cl H H F F C2H5 Cl H H F F n-C3H7 Cl H H F F n-C4H9 Cl H H F F n-C5H11 Cl H H F F n-C6H13 Cl H H F F H Cl F H F F CH3 Cl F H F F C2H5 Cl F H F F n-C3H7 Cl F H F F n-C4H9 Cl F H F F n-C5H11 Cl F H F F n-C6H13 Cl F H F F H Cl F F F F CH3 Cl F F F F C2H5 Cl F F F F n-C3H7 Cl F F F F K 80 N 106,7 I; Δε = 31,5; Δn = 0,1372 n-C4H9 Cl F F F F n-C5H11 Cl F F F F n-C6H13 Cl F F F F H OCF3 H H F F CH3 OCF3 H H F F C2H5 OCF3 H H F F n-C3H7 OCF3 H H F F K 80 N 119,8 I; Δε = 25,3; Δn = 0,1330 n-C4H9 OCF3 H H F F n-C5H11 OCF3 H H F F n-C6H13 OCF3 H H F F H OCF3 F H F F CH3 OCF3 F H F F C2H5 OCF3 F H F F n-C3H7 OCF3 F H F F K 48 SA (46) N 105,1 I; Δε = 29,8; An = 0,1180 n-C4H9 OCF3 F H F F n-C5H11 OCF3 F H F F n-C6H13 OCF3 F H F F H OCF3 F F F F CH3 OCF3 F F F F C2H5 OCF3 F F F F n-C3H7 OCF3 F F F F K 73 N 97,5 I; Δε = 35,6; Δn = 0,1158 n-C4H9 OCF3 F F F F n-C5H11 OCF3 F F F F n-C6H13 OCF3 F F F F H OCHF2 H H F F CH3 OCHF2 H H F F C2H5 OCHF2 H H F F n-C3H7 OCHF2 H H F F n-C4H9 OCHF2 H H F F n-C5H11 OCHF2 H H F F n-C6H13 OCHF2 H H F F H OCHF2 F H F F CH3 OCHF2 F H F F C2H5 OCHF2 F H F F n-C3H7 OCHF2 F H F F n-C4H9 OCHF2 F H F F n-C5H11 OCHF2 F H F F n-C6H13 OCHF2 F H F F H OCHF2 F F F F CH3 OCHF2 F F F F C2H5 OCHF2 F F F F n-C3H7 OCHF2 F F F F n-C4H9 OCHF2 F F F F n-C5H11 OCHF2 F F F F n-C6H13 OCHF2 F F F F H OCHFCF3 H H F F CH3 OCHFCF3 H H F F C2H5 OCHFCF3 H H F F n-C3H7 OCHFCF3 H H F F n-C4H9 OCHFCF3 H H F F n-C5H11 OCHFCF3 H H F F n-C6H13 OCHFCF3 H H F F H OCHFCF3 F H F F CH3 OCHFCF3 F H F F C2H5 OCHFCF3 F H F F n-C3H7 OCHFCF3 F H F F n-C4H9 OCHFCF3 F H F F n-C5H11 OCHFCF3 F H F F n-C6H13 OCHFCF3 F H F F H OCHFCF3 F F F F CH3 OCHFCF3 F F F F C2H5 OCHFCF3 F F F F n-C3H7 OCHFCF3 F F F F n-C4H9 OCHFCF3 F F F F n-C5H11 OCHFCF3 F F F F n-C6H13 OCHFCF3 F F F F H OCHFCF3 H H F F CH3 OCHFCF3 H H F F C2H5 OCHFCF3 H H F F n-C3H7 OCHFCF3 H H F F n-C4H9 OCHFCF3 H H F F n-C5H11 OCHFCF3 H H F F n-C6H13 OCHFCF3 H H F F H OCHFCF3 F H F F CH3 OCHFCF3 F H F F C2H5 OCHFCF3 F H F F n-C3H7 OCHFCF3 F H F F n-C4H9 OCHFCF3 F H F F n-C5H11 OCHFCF3 F H F F n-C6H13 OCHFCF3 F H F F H OCHFCF3 F F F F CH3 OCHFCF3 F F F F C2H5 OCHFCF3 F F F F n-C3H7 OCHFCF3 F F F F n-C4H9 OCHFCF3 F F F F n-C5H11 OCHFCF3 F F F F n-C6H13 OCHFCF3 F F F F H OCF2CHFCF3 . H H F F CH3 OCF2CHFCF3 H H F F C2H5 OCF2CHFCF3 H H F F n-C3H7 OCF2CHFCF3 H H F F n-C4H9 OCF2CHFCF3 H H F F n-C5H11 OCF2CHFCF3 H H F F n-C6H13 OCF2CHFCF3 H H F F H OCF2CHFCF3 F H F F CH3 OCF2CHFCF3 F H F F C2H5 OCF2CHFCF3 F H F F n-C3H7 OCF2CHFCF3 F H F F n-C4H9 OCF2CHFCF3 F H F F n-C5H11 OCF2CHFCF3 F H F F n-C6H13 OCF2CHFCF3 F H F F H OCF2CHFCF3 F F F F CH3 OCF2CHFCF3 F F F F C2H5 OCF2CHFCF3 F F F F n-C3H7 OCF2CHFCF3 F F F F n-C4H9 OCF2CHFCF3 F F F F n-C5H11 OCF2CHFCF3 F F F F n-C6H13 OCF2CHFCF3 F F F F H NCS H H F F CH3 NCS H H F F C2H5 NCS H H F F n-C3H7 NCS H H F F K 107 N 185,5 I; Δε = 31,4; Δn = 0,2052 n-C4H9 NCS H H F F n-C5H11 NCS H H F F n-C6H13 NCS H H F F H NCS F H F F CH3 NCS F H F F C2H5 NCS F H F F n-C3H7 NCS F H F F n-C4H9 NCS F H F F n-C5H11 NCS F H F F n-C6H13 NCS F H F F H NCS F F F F CH3 NCS F F F F C2H5 NCS F F F F n-C3H7 NCS F F F F n-C4H9 NCS F F F F n-C5H11 NCS F F F F n-C6H13 NCS F F F F H C2F5 H H F F CH3 C2F5 H H F F C2H5 C2F5 H H F F n-C3H7 C2F5 H H F F n-C4H9 C2F5 H H F F n-C5H11 C2F5 H H F F n-C6H13 C2F5 H H F F H C2F5 F H F F CH3 C2F5 F H F F C2H5 C2F5 F H F F n-C3H7 C2F5 F H F F n-C4H9 C2F5 F H F F n-C5H11 C2F5 F H F F n-C6H13 C2F5 F H F F H C2F5 F F F F CH3 C2F5 F F F F C2H5 C2F5 F F F F n-C3H7 C2F5 F F F F n-C4H9 C2F5 F F F F n-C5H11 C2F5 F F F F n-C6H13 C2F5 F F F F H C3F7 H H F F CH3 C3F7 H H F F C2H5 C3F7 H H F F n-C3H7 C3F7 H H F F n-C4H9 C3F7 H H F F n-C5H11 C3F7 H H F F n-C6H13 C3F7 H H F F H C3F7 F H F F CH3 C3F7 F H F F C2H5 C3F7 F H F F n-C3H7 C3F7 F H F F n-C4H9 C3F7 F H F F n-C5H11 C3F7 F H F F n-C6H13 C3F7 F H F F H C3F7 F F F F CH3 C3F7 F F F F C2H5 C3F7 F F F F n-C3H7 C3F7 F F F F n-C4H9 C3F7 F F F F n-C5H11 C3F7 F F F F n-C6H13 C3F7 F F F F H SF5 H H F F CH3 SF5 H H F F C2H5 SF5 H H F F n-C3H7 SF5 H H F F n-C4H9 SF5 H H F F n-C5H11 SF5 H H F F n-C6H13 SF5 H H F F H SF5 F H F F CH3 SF5 F H F F C2H5 SF5 F H F F n-C3H7 SF5 F H F F n-C4H9 SF5 F H F F n-C5H11 SF5 F H F F n-C6H13 SF5 F H F F H SF5 F F F F CH3 SF5 F F F F C2H5 SF5 F F F F n-C3H7 SF5 F F F F K 110 N (83,4) I; △ε = 33,8; Δn = 0,121 I n-C4H9 SF5 F F F F n-C5H11 SF5 F F F F n-C6H13 SF5 F F F F H CN H H F F CH3 CN H H F F C2H5 CN H H F F n-C3H7 CN H H F F n-C4H9 CN H H F F n-C5H11 CN H H F F n-C6H13 CN H H F F H CN F H F F CH3 CN F H F F C2H5 CN F H F F n-C3H7 CN F H F F n-C4H9 CN F H F F n-C5H11 CN F H F F n-C6H13 CN F H F F H CN F F F F CH3 CN F F F F C2H5 CN F F F F K 98 NRe (71) Sc (84) N 127,6I Δs = 67,8; △n = 0,1459 n-C3H7 CN F F F F K 75 Sc? (65) N 144,1 I Δn = 0,1561; As = 66,5 n-C4H9 CN F F F F K 79 N 139,3 I; Δε = 64,2; Δn = 0,1477 n-C5H11 CN F F F F K 65 Sc (44) N 141,5 I; Δε = 61,8; △n = 0,1490 n-C6H13 CN F F F F n-C7H15 CN F F F F K 51 N 130,8 I; Δε = 58,4; △n = 0,1459 H CF3 H H F F C2Hs CF3 H H F F n-C3H7 CF3 H H F F K 95 N (87,5) I; Δε = 31,5; △n = 0,1330 n-C4H9 CF3 H H F F n-C5H11 CF3 H H F F n-C6H13 CF3 H H F F CH2=CH CF3 H H F F H CF3 F F F F C2H5 CF3 F F F F n-C3H7 CF3 F F F F K 91 I; Δn = 0,1190; Δε = 40,8 n-C4H9 CF3 F F F F n-C5H11 CF3 F F F F n-C6H13 CF3 F F F F CH2=CH CF3 F F F F H F H H F F C2H5 F H H F F n-C3H7 F H H F F n-C4H9 F H H F F n-C5H11 F H H F F n-C6H13 F H H F F CH2=CH F H H F F Analogously, the following compounds of the formula
Figure imgb0274
produced: R 1 X L 1 L 2 L 3 L 4 H F H H H H CH 3 F H H H H C 2 H 5 F H H H H C 3 H 7 F H H H H nC 4 H 9 F H H H H nc 5 H 11 F H H H H nc 6 H 13 F H H H H H F F H H H CH 3 F F H H H C 2 H 5 F F H H H nC 3 H 7 F F H H H nC 4 H 9 F F H H H nc 5 H 11 F F H H H nc 6 H 13 F F H H H H F F F H H CH 3 F F F H H nC 3 H 7 F F F H H K 75 N 118.0 I; Δε = 23.2; Δn = 0.1450 nC 4 H 9 F F F H H nc 5 H 11 F F F H H nc 6 H 13 F F F H H H Cl H H H H CH 3 Cl H H H H C 2 H 5 Cl H H H H nC 3 H 7 Cl H H H H nC 4 H 9 Cl H H H H nc 5 H 11 Cl H H H H nc 6 H 13 Cl H H H H H Cl F H H H CH 3 Cl F H H H C 2 H 5 Cl F H H H nC 3 H 7 Cl F H H H nC 4 H 9 Cl F H H H nc 5 H 11 Cl F H H H nc 6 H 13 Cl F H H H H Cl F F H H CH 3 Cl F F H H C 2 H 5 Cl F F H H nC 3 H 7 Cl F F H H nC 4 H 9 Cl F F H H nc 5 H 11 Cl F F H H nc 6 H 13 Cl F F H H H OCF 3 H H H H CH 3 OCF 3 H H H H C 2 H 5 OCF 3 H H H H nC 3 H 7 OCF 3 H H H H nC 4 H 9 OCF 3 H H H H nc 5 H 11 OCF 3 H H H H nc 6 H 13 OCF 3 H H H H H OCF 3 F H H H CH 3 OCF 3 F H H H C 2 H 5 OCF 3 F H H H nC 3 H 7 OCF 3 F H H H nC 4 H 9 OCF 3 F H H H nc 5 H 11 OCF 3 F H H H nc 6 H 13 OCF 3 F H H H H OCF 3 F F H H CH 3 OCF 3 F F H H C 2 H 5 OCF 3 F F H H nC 3 H 7 OCF 3 F F H H nC 4 H 9 OCF 3 F F H H nc 5 H 11 OCF 3 F F H H nc 6 H 13 OCF 3 F F H H H OCHF 2 H H H H CH 3 OCHF 2 H H H H C 2 H 5 OCHF 2 H H H H nC 3 H 7 OCHF 2 H H H H nC 4 H 9 OCHF 2 H H H H nc 5 H 11 OCHF 2 H H H H nc 6 H 13 OCHF 2 H H H H H OCHF 2 F H H H CH 3 OCHF 2 F H H H C 2 H 5 OCHF 2 F H H H nC 3 H 7 OCHF 2 F H H H nC 4 H 9 OCHF 2 F H H H nc 5 H 11 OCHF 2 F H H H nc 6 H 13 OCHF 2 F H H H H OCHF 2 F F H H CH 3 OCHF 2 F F H H C 2 H 5 OCHF 2 F F H H nC 3 H 7 OCHF 2 F F H H nC 4 H 9 OCHF 2 F F H H nc 5 H 11 OCHF 2 F F H H nc 6 H 13 OCHF 2 F F H H H OCHFCF 3 H H H H CH 3 OCHFCF 3 H H H H C 2 H 5 OCHFCF 3 H H H H nC 3 H 7 OCHFCF 3 H H H H nC 4 H 9 OCHFCF 3 H H H H nc 5 H 11 OCHFCF 3 H H H H nc 6 H 13 OCHFCF 3 H H H H H OCHFCF 3 F H H H CH 3 OCHFCF 3 F H H H C 2 H 5 OCHFCF 3 F H H H nC 3 H 7 OCHFCF 3 F H H H nC 4 H 9 OCHFCF 3 F H H H nc 5 H 11 OCHFCF 3 F H H H nc 6 H 13 OCHFCF 3 F H H H H OCHFCF 3 F F H H CH 3 OCHFCF 3 F F H H C 2 H 5 OCHFCF 3 F F H H nC 3 H 7 OCHFCF 3 F F H H nC 4 H 9 OCHFCF 3 F F H H nc 5 H 11 OCHFCF 3 F F H H nc 6 H 13 OCHFCF 3 F F H H H OCHFCF 3 H H H H CH 3 OCHFCF 3 H H H H C 2 H 5 OCHFCF 3 H H H H nC 3 H 7 OCHFCF 3 H H H H nC 4 H 9 OCHFCF 3 H H H H nc 5 H 11 OCHFCF 3 H H H H nc 6 H 13 OCHFCF 3 H H H H H OCHFCF 3 F H H H CH 3 OCHFCF 3 F H H H C 2 H 5 OCHFCF 3 F H H H nC 3 H 7 OCHFCF 3 F H H H nC 4 H 9 OCHFCF 3 F H H H nc 5 H 11 OCHFCF 3 F H H H nc 6 H 13 OCHFCF 3 F H H H H OCHFCF 3 F F H H CH 3 OCHFCF 3 F F H H C 2 H 5 OCHFCF 3 F F H H nC 3 H 7 OCHFCF 3 F F H H nC 4 H 9 OCHFCF 3 F F H H nc 5 H 11 OCHFCF 3 F F H H nc 6 H 13 OCHFCF 3 F F H H H OCF 2 CHFCF 3 H H H H CH 3 OCF 2 CHFCF 3 H H H H C 2 H 5 OCF 2 CHFCF 3 H H H H nC 3 H 7 OCF 2 CHFCF 3 H H H H nC 4 H 9 OCF 2 CHFCF 3 H H H H nc 5 H 11 OCF 2 CHFCF 3 H H H H nc 6 H 13 OCF 2 CHFCF 3 H H H H H OCF 2 CHFCF 3 F H H H CH 3 OCF 2 CHFCF 3 F H H H C 2 H 5 OCF 2 CHFCF 3 F H H H nC 3 H 7 OCF 2 CHFCF 3 F H H H nC 4 H 9 OCF 2 CHFCF 3 F H H H nc 5 H 11 OCF 2 CHFCF 3 F H H H nc 6 H 13 OCF 2 CHFCF 3 F H H H H OCF 2 CHFCF 3 F F H H CH 3 OCF 2 CHFCF 3 F F H H C 2 H 5 OCF 2 CHFCF 3 F F H H nC 3 H 7 OCF 2 CHFCF 3 F F H H nC 4 H 9 OCF 2 CHFCF 3 F F H H nc 5 H 11 OCF 2 CHFCF 3 F F H H nc 6 H 13 OCF 2 CHFCF 3 F F H H H NCS H H H H CH 3 NCS H H H H C 2 H 5 NCS H H H H nC 3 H 7 NCS H H H H nC 4 H 9 NCS H H H H nc 5 H 11 NCS H H H H nc 6 H 13 NCS H H H H H NCS F H H H CH 3 NCS F H H H C 2 H 5 NCS F H H H nC 3 H 7 NCS F H H H nC 4 H 9 NCS F H H H nc 5 H 11 NCS F H H H nc 6 H 13 NCS F H H H H NCS F F H H CH 3 NCS F F H H C 2 H 5 NCS F F H H nC 3 H 7 NCS F F H H nC 4 H 9 NCS F F H H nc 5 H 11 NCS F F H H nc 6 H 13 NCS F F H H H C 2 F 5 H H H H CH 3 C 2 F 5 H H H H C 2 H 5 C 2 F 5 H H H H nC 3 H 7 C 2 F 5 H H H H nC 4 H 9 C 2 F 5 H H H H nc 5 H 11 C 2 F 5 H H H H nc 6 H 13 C 2 F 5 H H H H H C 2 F 5 F H H H CH 3 C 2 F 5 F H H H C 2 H 5 C 2 F 5 F H H H nC 3 H 7 C 2 F 5 F H H H nC 4 H 9 C 2 F 5 F H H H nc 5 H 11 C 2 F 5 F H H H nc 6 H 13 C 2 F 5 F H H H H C 2 F 5 F F H H CH 3 C 2 F 5 F F H H C 2 H 5 C 2 F 5 F F H H nC 3 H 7 C 2 F 5 F F H H nC 4 H 9 C 2 F 5 F F H H nc 5 H 11 C 2 F 5 F F H H nc 6 H 13 C 2 F 5 F F H H H C 3 F 7 H H H H CH 3 C 3 F 7 H H H H C 2 H 5 C 3 F 7 H H H H nC 3 H 7 C 3 F 7 H H H H nC 4 H 9 C 3 F 7 H H H H nc 5 H 11 C 3 F 7 H H H H nc 6 H 13 C 3 F 7 H H H H H C 3 F 7 F H H H CH 3 C 3 F 7 F H H H C 2 H 5 C 3 F 7 F H H H nC 3 H 7 C 3 F 7 F H H H nC 4 H 9 C 3 F 7 F H H H nc 5 H 11 C 3 F 7 F H H H nc 6 H 13 C 3 F 7 F H H H H C 3 F 7 F F H H CH 3 C 3 F 7 F F H H C 2 H 5 C 3 F 7 F F H H nC 3 H 7 C 3 F 7 F F H H nC 4 H 9 C 3 F 7 F F H H nc 5 H 11 C 3 F 7 F F H H nc 6 H 13 C 3 F 7 F F H H H SF 5 H H H H CH 3 SF 5 H H H H C 2 H 5 SF 5 H H H H nC 3 H 7 SF 5 H H H H nC 4 H 9 SF 5 H H H H nc 5 H 11 SF 5 H H H H nc 6 H 13 SF 5 H H H H H SF 5 F H H H CH 3 SF 5 F H H H C 2 H 5 SF 5 F H H H nC 3 H 7 SF 5 F H H H nC 4 H 9 SF 5 F H H H nc 5 H 11 SF 5 F H H H nc 6 H 13 SF 5 F H H H H SF 5 F F H H CH 3 SF 5 F F H H C 2 H 5 SF 5 F F H H nC 3 H 7 SF 5 F F H H nC 4 H 9 SF 5 F F H H nc 5 H 11 SF 5 F F H H nc 6 H 13 SF 5 F F H H H CN H H H H CH 3 CN H H H H C 2 H 5 CN H H H H nC 3 H 7 CN H H H H nC 4 H 9 CN H H H H nc 5 H 11 CN H H H H nc 6 H 13 CN H H H H H CN F H H H CH 3 CN F H H H C 2 H 5 CN F H H H nC 3 H 7 CN F H H H nC 4 H 9 CN F H H H nc 5 H 11 CN F H H H nc 6 H 13 CN F H H H H CN F F H H CH 3 CN F F H H C 2 H 5 CN F F H H nC 3 H 7 CN F F H H nC 4 H 9 CN F F H H nc 5 H 11 CN F F H H nc 6 H 13 CN F F H H H F H H F H CH 3 F H H F H C 2 H 5 F H H F H C 3 H 7 F H H F H nC 4 H 9 F H H F H nc 5 H 11 F H H F H nc 6 H 13 F H H F H H F F H F H CH 3 F F H F H C 2 H 5 F F H F H nC 3 H 7 F F H F H nC 4 H 9 F F H F H nc 5 H 11 F F H F H nc 6 H 13 F F H F H H F F F F H CH 3 F F F F H C 2 H 5 F F F F H K 89 N (76,8) I, Δε = 29.9; Δn = 0.1310 nC 3 H 7 F F F F H K 70 N 102.3 I; Δε = 29.7; Δn = 0.1364 nC 4 H 9 F F F F H nc 5 H 11 F F F F H nc 6 H 13 F F F F H H Cl H H F H CH 3 Cl H H F H C 2 H 5 Cl H H F H nC 3 H 7 Cl H H F H nC 4 H 9 Cl H H F H nc 5 H 11 Cl H H F H nc 6 H 13 Cl H H F H H Cl F H F H CH 3 Cl F H F H C 2 H 5 Cl F H F H nC 3 H 7 Cl F H F H nC 4 H 9 Cl F H F H nc 5 H 11 Cl F H F H nc 6 H 13 Cl F H F H H Cl F F F H CH 3 Cl F F F H C 2 H 5 Cl F F F H nC 3 H 7 Cl F F F H nC 4 H 9 Cl F F F H nc 5 H 11 Cl F F F H nc 6 H 13 Cl F F F H H OCF 3 H H F H CH 3 OCF 3 H H F H C 2 H 5 OCF 3 H H F H nC 3 H 7 OCF 3 H H F H nC 4 H 9 OCF 3 H H F H nc 5 H 11 OCF 3 H H F H nc 6 H 13 OCF 3 H H F H H OCF 3 F H F H CH 3 OCF 3 F H F H C 2 H 5 OCF 3 F H F H nC 3 H 7 OCF 3 F H F H nC 4 H 9 OCF 3 F H F H nC 5 H11 OCF 3 F H F H nc 6 H 13 OCF 3 F H F H H OCF 3 F F F H CH 3 OCF 3 F F F H C 2 H 5 OCF 3 F F F H nC 3 H 7 OCF 3 F F F H nC 4 H s OCF 3 F F F H nc 5 H 11 OCF 3 F F F H nc 6 H 13 OCF 3 F F F H H OCHF 2 H H F H CH 3 OCHF 2 H H F H C 2 H 5 OCHF 2 H H F H nC 3 H 7 OCHF 2 H H F H nC 4 H 9 OCHF 2 H H F H nc 5 H 11 OCHF 2 H H F H nc 6 H 13 OCHF 2 H H F H H OCHF 2 F H F H CH 3 OCHF 2 F H F H C 2 H 5 OCHF 2 F H F H nC 3 H 7 OCHF 2 F H F H nC 4 H 9 OCHF 2 F H F H nc 5 H 11 OCHF 2 F H F H nc 6 H 13 OCHF 2 F H F H H OCHF 2 F F F H CH 3 OCHF 2 F F F H C 2 H 5 OCHF 2 F F F H nC 3 H 7 OCHF 2 F F F H nC 4 H 9 OCHF 2 F F F H nc 5 H 11 OCHF 2 F F F H nc 6 H 13 OCHF 2 F F F H H OCHFCF 3 H H F H CH 3 OCHFCF 3 H H F H C 2 H 5 OCHFCF 3 H H F H nC 3 H 7 OCHFCF 3 H H F H nC 4 H 9 OCHFCF 3 H H F H nc 5 H 11 OCHFCF 3 H H F H nc 6 H 13 OCHFCF 3 H H F H H OCHFCF 3 F H F H CH 3 OCHFCF 3 F H F H C 2 H 5 OCHFCF 3 F H F H nC 3 H 7 OCHFCF 3 F H F H nC 4 H 9 OCHFCF 3 F H F H nc 5 H 11 OCHFCF 3 F H F H nc 6 H 13 OCHFCF 3 F H F H H OCHFCF 3 F F F H CH 3 OCHFCF 3 F F F H C 2 H 5 OCHFCF 3 F F F H nC 3 H 7 OCHFCF 3 F F F H nC 4 H 9 OCHFCF 3 F F F H nc 5 H 11 OCHFCF 3 F F F H nc 6 H 13 OCHFCF 3 F F F H H OCHFCF 3 H H F H CH 3 OCHFCF 3 H H F H C 2 H 5 OCHFCF 3 H H F H nC 3 H 7 OCHFCF 3 H H F H nC 4 H 9 OCHFCF 3 H H F H nc 5 H 11 OCHFCF 3 H H F H nc 6 H 13 OCHFCF 3 H H F H H OCHFCF 3 F H F H CH 3 OCHFCF 3 F H F H C 2 H 5 OCHFCF 3 F H F H nC 3 H 7 OCHFCF 3 F H F H nC 4 H 9 OCHFCF 3 F H F H nc 5 H 11 OCHFCF 3 F H F H nc 6 H 13 OCHFCF 3 F H F H H OCHFCF 3 F F F H CH 3 OCHFCF 3 F F F H C 2 H 5 OCHFCF 3 F F F H nC 3 H 7 OCHFCF 3 F F F H nC 4 H 9 OCHFCF 3 F F F H nc 5 H 11 OCHFCF 3 F F F H nc 6 H 13 OCHFCF 3 F F F H H OCF 2 CHFCF 3 H H F H CH 3 OCF 2 CHFCF 3 H H F H C 2 H 5 OCF 2 CHFCF 3 H H F H nC 3 H 7 OCF 2 CHFCF 3 H H F H nC 4 H 9 OCF 2 CHFCF 3 H H F H nc 5 H 11 OCF 2 CHFCF 3 H H F H nc 6 H 13 OCF 2 CHFCF 3 H H F H H OCF 2 CHFCF 3 F H F H CH 3 OCF 2 CHFCF 3 F H F H C 2 H 5 OCF 2 CHFCF 3 F H F H nC 3 H 7 OCF 2 CHFCF 3 F H F H nC 4 H 9 OCF 2 CHFCF 3 F H F H nc 5 H 11 OCF 2 CHFCF 3 F H F H nc 6 H 13 OCF 2 CHFCF 3 F H F H H OCF 2 CHFCF 3 F F F H CH 3 OCF 2 CHFCF 3 F F F H C 2 H 5 OCF 2 CHFCF 3 F F F H nC 3 H 7 OCF 2 CHFCF 3 F F F H nC 4 H 9 OCF 2 CHFCF 3 F F F H nc 5 H 11 OCF 2 CHFCF 3 F F F H nc 6 H 13 OCF 2 CHFCF 3 F F F H H NCS H H F H CH 3 NCS H H F H C 2 H 5 NCS H H F H nC 3 H 7 NCS H H F H nC 4 H 9 NCS H H F H nc 5 H 11 NCS H H F H nc 6 H 13 NCS H H F H H NCS F H F H CH 3 NCS F H F H C 2 H 5 NCS F H F H nC 3 H 7 NCS F H F H nC 4 H 9 NCS F H F H nc 5 H 11 NCS F H F H nc 6 H 13 NCS F H F H H NCS F F F H CH 3 NCS F F F H C 2 H 5 NCS F F F H nC 3 H 7 NCS F F F H nC 4 H 9 NCS F F F H nc 5 H 11 NCS F F F H nc 6 H 13 NCS F F F H H C 2 F 5 H H F H CH 3 C 2 F 5 H H F H C 2 H 5 C 2 F 5 H H F H nC 3 H 7 C 2 F 5 H H F H nC 4 H 9 C 2 F 5 H H F H nc 5 H 11 C 2 F 5 H H F H nc 6 H 13 C 2 F 5 H H F H H C 2 F 5 F H F H CH 3 C 2 F 5 F H F H C 2 H 5 C 2 F 5 F H F H nC 3 H 7 C 2 F 5 F H F H nC 4 H 9 C 2 F 5 F H F H nc 5 H 11 C 2 F 5 F H F H nc 6 H 13 C 2 F 5 F H F H H C 2 F 5 F F F H CH 3 C 2 F 5 F F F H C 2 H 5 C 2 F 5 F F F H nC 3 H 7 C 2 F 5 F F F H n-C4H9 C 2 F 5 F F F H nc 5 H 11 C 2 F 5 F F F H nc 6 H 13 C 2 F 5 F F F H H C 3 F 7 H H F H CH 3 C 3 F 7 H H F H C 2 H 5 C 3 F 7 H H F H nC 3 H 7 C 3 F 7 H H F H nC 4 H 9 C 3 F 7 H H F H nc 5 H 11 C 3 F 7 H H F H nc 6 H 13 C 3 F 7 H H F H H C 3 F 7 F H F H CH 3 C 3 F 7 F H F H C 2 H 5 C 3 F 7 F H F H nC 3 H 7 C 3 F 7 F H F H nC 4 H 9 C 3 F 7 F H F H nc 5 H 11 C 3 F 7 F H F H nc 6 H 13 C 3 F 7 F H F H H C 3 F 7 F F F H CH 3 C 3 F 7 F F F H C 2 H 5 C 3 F 7 F F F H nC 3 H 7 C 3 F 7 F F F H nC 4 H 9 C 3 F 7 F F F H nc 5 H 11 C 3 F 7 F F F H nc 6 H 13 C 3 H 7 F F F H H SF 5 H H F H CH 3 SF 5 H H F H C 2 H 5 SF 5 H H F H nC 3 H 7 SF 5 H H F H nC 4 H 9 SF 5 H H F H nc 5 H 11 SF 5 H H F H nc 6 H 13 SF 5 H H F H H SF 5 F H F H CH 3 SF 5 F H F H C 2 H 5 SF 5 F H F H nC 3 H 7 SF 5 F H F H nC 4 H 9 SF 5 F H F H nc 5 H 11 SF 5 F H F H nc 6 H 13 SF 5 F H F H H SF 5 F F F H CH 3 SF 5 F F F H C 2 H 5 SF 5 F F F H nC 3 H 7 SF 5 F F F H nC 4 H 9 SF 5 F F F H nc 5 H 11 SF 5 F F F H nc 6 H 13 SF 5 F F F H H CN H H F H CH 3 CN H H F H C 2 H 5 CN H H F H nC 3 H 7 CN H H F H nC 4 H 9 CN H H F H nc 5 H 11 CN H H F H nc 6 H 13 CN H H F H H CN F H F H CH 3 CN F H F H C 2 H 5 CN F H F H nC 3 H 7 CN F H F H nC 4 H 9 CN F H F H nc 5 H 11 CN F H F H nc 6 H 13 CN F H F H H CN F F F H CH 3 CN F F F H C 2 H 5 CN F F F H nC 3 H 7 CN F F F H nC 4 H 9 CN F F F H nc 5 H 11 CN F F F H nc 6 H 13 CN F F F H H F H H F F CH 3 F H H F F C 2 H 5 F H H F F nC 4 H 9 F H H F F nc 5 H 11 F H H F F nc 6 H 13 F H H F F HF F F H F F CH 3 F F H F F C 2 H 5 F F H F F nC 3 H 7 F F H F F nC 4 H 9 F F H F F nc 5 H 11 F F H F F nc 6 H 13 F F H F F H F F F F F CH 3 F F F F F C 2 H 5 F F F F F C 2 H 5 F F F F F K 91 N (58.8) I; Δε = 35, 0; Δn = 0.1149 nC 3 H 7 F F F F F K 83 N (83.0) I; Δε = 34.9; Δn = 0.1231 nC 4 H 9 F F F F F K 90 N 79.4 I; Δε = 32.4; Δn = 0.1171 nc 5 H 11 F F F F F K 82 N 84.3 I; Δε = 31.9; Δn = 0.1205 nc 6 H 13 F F F F F K 89 N (83.4) I; Δε = 30.6; Δn = 0.1116 nC 7 H 15 F F F F F K 82 N 84.3 I; Δε = 30.3; Δn = 0.1130 H Cl H H F F CH 3 Cl H H F F C 2 H 5 Cl H H F F nC 3 H 7 Cl H H F F nC 4 H 9 Cl H H F F nc 5 H 11 Cl H H F F nc 6 H 13 Cl H H F F H Cl F H F F CH 3 Cl F H F F C 2 H 5 Cl F H F F nC 3 H 7 Cl F H F F nC 4 H 9 Cl F H F F nc 5 H 11 Cl F H F F nc 6 H 13 Cl F H F F H Cl F F F F CH 3 Cl F F F F C 2 H 5 Cl F F F F nC 3 H 7 Cl F F F F K 80 N 106.7 I; Δε = 31.5; Δn = 0.1372 nC 4 H 9 Cl F F F F nc 5 H 11 Cl F F F F nc 6 H 13 Cl F F F F H OCF 3 H H F F CH 3 OCF 3 H H F F C 2 H 5 OCF 3 H H F F nC 3 H 7 OCF 3 H H F F K 80 N 119.8 I; Δε = 25.3; Δn = 0.1330 nC 4 H 9 OCF 3 H H F F nc 5 H 11 OCF 3 H H F F nc 6 H 13 OCF 3 H H F F H OCF 3 F H F F CH 3 OCF 3 F H F F C 2 H 5 OCF 3 F H F F nC 3 H 7 OCF 3 F H F F K 48 S A (46) N 105.1 I; Δε = 29.8; An = 0.1180 nC 4 H 9 OCF 3 F H F F nc 5 H 11 OCF 3 F H F F nc 6 H 13 OCF 3 F H F F H OCF 3 F F F F CH 3 OCF 3 F F F F C 2 H 5 OCF 3 F F F F nC 3 H 7 OCF 3 F F F F K 73 N 97.5 I; Δε = 35.6; Δn = 0.1158 nC 4 H 9 OCF 3 F F F F nc 5 H 11 OCF 3 F F F F nc 6 H 13 OCF 3 F F F F H OCHF 2 H H F F CH 3 OCHF 2 H H F F C 2 H 5 OCHF 2 H H F F nC 3 H 7 OCHF 2 H H F F nC 4 H 9 OCHF 2 H H F F nc 5 H 11 OCHF 2 H H F F nc 6 H 13 OCHF 2 H H F F H OCHF 2 F H F F CH 3 OCHF 2 F H F F C 2 H 5 OCHF 2 F H F F nC 3 H 7 OCHF 2 F H F F nC 4 H 9 OCHF 2 F H F F nc 5 H 11 OCHF 2 F H F F nc 6 H 13 OCHF 2 F H F F H OCHF 2 F F F F CH 3 OCHF 2 F F F F C 2 H 5 OCHF 2 F F F F nC 3 H 7 OCHF 2 F F F F nC 4 H 9 OCHF 2 F F F F nc 5 H 11 OCHF 2 F F F F nc 6 H 13 OCHF 2 F F F F H OCHFCF 3 H H F F CH 3 OCHFCF 3 H H F F C 2 H 5 OCHFCF 3 H H F F nC 3 H 7 OCHFCF 3 H H F F nC 4 H 9 OCHFCF 3 H H F F nc 5 H 11 OCHFCF 3 H H F F nc 6 H 13 OCHFCF 3 H H F F H OCHFCF 3 F H F F CH 3 OCHFCF 3 F H F F C 2 H 5 OCHFCF 3 F H F F nC 3 H 7 OCHFCF 3 F H F F nC 4 H 9 OCHFCF 3 F H F F nc 5 H 11 OCHFCF 3 F H F F nc 6 H 13 OCHFCF 3 F H F F H OCHFCF 3 F F F F CH 3 OCHFCF 3 F F F F C 2 H 5 OCHFCF 3 F F F F nC 3 H 7 OCHFCF 3 F F F F nC 4 H 9 OCHFCF 3 F F F F nc 5 H 11 OCHFCF 3 F F F F nc 6 H 13 OCHFCF 3 F F F F H OCHFCF 3 H H F F CH 3 OCHFCF 3 H H F F C 2 H 5 OCHFCF 3 H H F F nC 3 H 7 OCHFCF 3 H H F F nC 4 H 9 OCHFCF 3 H H F F nc 5 H 11 OCHFCF 3 H H F F nc 6 H 13 OCHFCF 3 H H F F H OCHFCF 3 F H F F CH 3 OCHFCF 3 F H F F C 2 H 5 OCHFCF 3 F H F F nC 3 H 7 OCHFCF 3 F H F F nC 4 H 9 OCHFCF 3 F H F F nc 5 H 11 OCHFCF 3 F H F F nc 6 H 13 OCHFCF 3 F H F F H OCHFCF 3 F F F F CH 3 OCHFCF 3 F F F F C 2 H 5 OCHFCF 3 F F F F nC 3 H 7 OCHFCF 3 F F F F nC 4 H 9 OCHFCF 3 F F F F nc 5 H 11 OCHFCF 3 F F F F nc 6 H 13 OCHFCF 3 F F F F H OCF 2 CHFCF 3 . H H F F CH 3 OCF 2 CHFCF 3 H H F F C 2 H 5 OCF 2 CHFCF 3 H H F F nC 3 H 7 OCF 2 CHFCF 3 H H F F nC 4 H 9 OCF 2 CHFCF 3 H H F F nc 5 H 11 OCF 2 CHFCF 3 H H F F nc 6 H 13 OCF 2 CHFCF 3 H H F F H OCF 2 CHFCF 3 F H F F CH 3 OCF 2 CHFCF 3 F H F F C 2 H 5 OCF 2 CHFCF 3 F H F F nC 3 H 7 OCF 2 CHFCF 3 F H F F nC 4 H 9 OCF 2 CHFCF 3 F H F F nc 5 H 11 OCF 2 CHFCF 3 F H F F nc 6 H 13 OCF 2 CHFCF 3 F H F F H OCF 2 CHFCF 3 F F F F CH 3 OCF 2 CHFCF 3 F F F F C 2 H 5 OCF 2 CHFCF 3 F F F F nC 3 H 7 OCF 2 CHFCF 3 F F F F nC 4 H 9 OCF 2 CHFCF 3 F F F F nc 5 H 11 OCF 2 CHFCF 3 F F F F nc 6 H 13 OCF 2 CHFCF 3 F F F F H NCS H H F F CH 3 NCS H H F F C 2 H 5 NCS H H F F nC 3 H 7 NCS H H F F K 107 N 185.5 I; Δε = 31.4; Δn = 0.2052 nC 4 H 9 NCS H H F F nc 5 H 11 NCS H H F F nc 6 H 13 NCS H H F F H NCS F H F F CH 3 NCS F H F F C 2 H 5 NCS F H F F nC 3 H 7 NCS F H F F nC 4 H 9 NCS F H F F nc 5 H 11 NCS F H F F nc 6 H 13 NCS F H F F H NCS F F F F CH 3 NCS F F F F C 2 H 5 NCS F F F F nC 3 H 7 NCS F F F F nC 4 H 9 NCS F F F F nc 5 H 11 NCS F F F F nc 6 H 13 NCS F F F F H C 2 F 5 H H F F CH 3 C 2 F 5 H H F F C 2 H 5 C 2 F 5 H H F F nC 3 H 7 C 2 F 5 H H F F nC 4 H 9 C 2 F 5 H H F F nc 5 H 11 C 2 F 5 H H F F nc 6 H 13 C 2 F 5 H H F F H C 2 F 5 F H F F CH 3 C 2 F 5 F H F F C 2 H 5 C 2 F 5 F H F F nC 3 H 7 C 2 F 5 F H F F nC 4 H 9 C 2 F 5 F H F F nc 5 H 11 C 2 F 5 F H F F nc 6 H 13 C 2 F 5 F H F F H C 2 F 5 F F F F CH 3 C 2 F 5 F F F F C 2 H 5 C 2 F 5 F F F F nC 3 H 7 C 2 F 5 F F F F nC 4 H 9 C 2 F 5 F F F F nc 5 H 11 C 2 F 5 F F F F nc 6 H 13 C 2 F 5 F F F F H C 3 F 7 H H F F CH 3 C 3 F 7 H H F F C 2 H 5 C 3 F 7 H H F F nC 3 H 7 C 3 F 7 H H F F nC 4 H 9 C 3 F 7 H H F F nc 5 H 11 C 3 F 7 H H F F nc 6 H 13 C 3 F 7 H H F F H C 3 F 7 F H F F CH 3 C 3 F 7 F H F F C 2 H 5 C 3 F 7 F H F F nC 3 H 7 C 3 F 7 F H F F nC 4 H 9 C 3 F 7 F H F F nc 5 H 11 C 3 F 7 F H F F nc 6 H 13 C 3 F 7 F H F F H C 3 F 7 F F F F CH 3 C 3 F 7 F F F F C 2 H 5 C 3 F 7 F F F F nC 3 H 7 C 3 F 7 F F F F nC 4 H 9 C 3 F 7 F F F F nc 5 H 11 C 3 F 7 F F F F nc 6 H 13 C 3 F 7 F F F F H SF 5 H H F F CH 3 SF 5 H H F F C 2 H 5 SF 5 H H F F nC 3 H 7 SF 5 H H F F nC 4 H 9 SF 5 H H F F nc 5 H 11 SF 5 H H F F nc 6 H 13 SF 5 H H F F H SF 5 F H F F CH 3 SF 5 F H F F C 2 H 5 SF 5 F H F F nC 3 H 7 SF 5 F H F F nC 4 H 9 SF 5 F H F F nc 5 H 11 SF 5 F H F F nc 6 H 13 SF 5 F H F F H SF 5 F F F F CH 3 SF 5 F F F F C 2 H 5 SF 5 F F F F nC 3 H 7 SF 5 F F F F K 110 N (83.4) I; △ ε = 33.8; Δn = 0.121 l nC 4 H 9 SF 5 F F F F nc 5 H 11 SF 5 F F F F nc 6 H 13 SF 5 F F F F H CN H H F F CH 3 CN H H F F C 2 H 5 CN H H F F nC 3 H 7 CN H H F F nC 4 H 9 CN H H F F nc 5 H 11 CN H H F F nc 6 H 13 CN H H F F H CN F H F F CH 3 CN F H F F C 2 H 5 CN F H F F nC 3 H 7 CN F H F F nC 4 H 9 CN F H F F nc 5 H 11 CN F H F F nc 6 H 13 CN F H F F H CN F F F F CH 3 CN F F F F C 2 H 5 CN F F F F K 98 N Re (71) Sc (84) N 127.6I Δs = 67.8; = N = 0.1445 nC 3 H 7 CN F F F F K 75 S c ? (65) N 144.1 I Δn = 0.1561; As = 66.5 nC 4 H 9 CN F F F F K 79 N 139.3 I; Δε = 64.2; Δn = 0.1477 nc 5 H 11 CN F F F F K 65 S c (44) N 141.5 I; Δε = 61.8; = N = 0.1490 nc 6 H 13 CN F F F F nC 7 H 15 CN F F F F K 51 N 130.8 I; Δε = 58.4; = N = 0.1445 H CF 3 H H F F C 2 Hs CF 3 H H F F nC 3 H 7 CF 3 H H F F K 95 N (87.5) I; Δε = 31.5; = N = 0.1330 nC 4 H 9 CF 3 H H F F nc 5 H 11 CF 3 H H F F nc 6 H 13 CF 3 H H F F CH 2 = CH CF 3 H H F F H CF 3 F F F F C 2 H 5 CF 3 F F F F nC 3 H 7 CF 3 F F F F K 91 I; Δn = 0.1190; Δε = 40.8 nC 4 H 9 CF 3 F F F F nc 5 H 11 CF 3 F F F F nc 6 H 13 CF 3 F F F F CH 2 = CH CF 3 F F F F H F H H F F C 2 H 5 F H H F F nC 3 H 7 F H H F F nC 4 H 9 F H H F F nc 5 H 11 F H H F F nc 6 H 13 F H H F F CH 2 = CH F H H F F

Beispiel 3Example 3

Figure imgb0275
Figure imgb0275

Schritt 3.1Step 3.1

Figure imgb0276
Figure imgb0276

Eine Lösung von 61,2 mmol L in 500 ml CH2Cl2 wird bei -20 °C tropfenweise mit 62,7 mmol Trifluormethansulfonsäure versetzt. Man lässt für 30 min auf Raumtemperatur kommen und kühlt dann auf -70 °C. Nun werden zuerst eine Lösung von 91 mmol 4-Brom-3-fluorphenol und 101 mmol Triethylamin in 200 ml CH2Cl2, 5 min später 310 mmol Triethylamin-Tris(hydrofluorid) zugegeben. Nach weiteren 5 min gibt man in kleinen Portionen eine Suspension von 315 mmol 1,3-Dibrom-5,5-dimethylhydanthoin zu und rührt 1 h bei -70 °C nach. Man lässt auf -10 °C kommen und gießt die Reaktionsmischung in eiskalte NaOH. Man arbeitet wie üblich wässrig auf und reinigt das Rohprodukt durch Chromatographie an Kieselgel (Heptan/MTB-Ether 4:1) und Kristallisation aus Ethanol bei -20 °C.A solution of 61.2 mmol L in 500 ml CH 2 Cl 2 is added dropwise at -20 ° C with 62.7 mmol trifluoromethanesulfonic acid. It is allowed to come to room temperature for 30 minutes and then cooled to -70 ° C. Now, first a solution of 91 mmol of 4-bromo-3-fluorophenol and 101 mmol of triethylamine in 200 ml of CH 2 Cl 2 , 5 min later added 310 mmol of triethylamine tris (hydrofluoride). After a further 5 minutes, a suspension of 315 mmol of 1,3-dibromo-5,5-dimethylhydanthoin is added in small portions and the mixture is stirred at -70 ° C. for a further 1 h. It is allowed to -10 ° C come and pour the reaction mixture into ice-cold NaOH. The reaction is carried out as usual in water and the crude product is purified by chromatography on silica gel (heptane / MTB ether 4: 1) and crystallization from ethanol at -20 ° C.

Schritt 3.2Step 3.2

Figure imgb0277
Figure imgb0277

Eine Mischung aus 50 mmol M , 50 mmol 3,4,5-Trifluorbenzolboronsäure, 2,5 mmol Pd(PPh3)4, 300 ml Toluol und 300 ml Na-Boratpuffer (pH=9) wird 18 h bei 80 °C gerührt. Man gießt die Mischung in 500 ml 0,1 N HCl, extrahiert das Produkt mit CH2Cl2, trocknet über Na2SO4 und rotiert zur Trockene ein. Das Rohprodukt wird in n-Heptan über Kieselgel chromatographiert und anschließend bei -20 °C aus n-Heptan umkristallisiert. K 61 N 191,8 I; Δn = 0,1220; Δε = 19,1A mixture of 50 mmol of M , 50 mmol of 3,4,5-trifluorobenzeneboronic acid, 2.5 mmol of Pd (PPh 3 ) 4 , 300 ml of toluene and 300 ml of Na borate buffer (pH = 9) is stirred at 80 ° C. for 18 h , The mixture is poured into 500 ml of 0.1 N HCl, the product is extracted with CH 2 Cl 2 , dried over Na 2 SO 4 and rotated to dryness. The crude product is chromatographed on silica gel in n-heptane and then recrystallized from n-heptane at -20 ° C. K 61 N 191.8 I; Δn = 0.1220; Δε = 19.1

Analog werden die folgenden Verbindungen der Formel

Figure imgb0278
hergestellt: R1 X L1 L2 H F H H CH3 F H H C2H5 F H H n-C3H7 F H H K 84 N 232,4 I; Δε = 9,4; Δn = 0,1390 n-C4H9 F H H n-C5H11 F H H n-C6H13 F H H H F F H CH3 F F H C2H5 F F H n-C3H7 F F H K 44 SM? 45 N 212,6 I; Δε = 13,4; Δn = 0,1328 n-C4H9 F F H n-C5H11 F F H n-C6H13 F F H H F F F CH3 F F F C2H5 F F F n-C4H9 F F F n-C5H11 F F F n-C6H13 F F F H Cl H H CH3 Cl H H C2H5 Cl H H n-C3H7 Cl H H n-C4H9 Cl H H n-C5H11 Cl H H n-C6H13 Cl H H H Cl F H CH3 Cl F H C2H5 Cl F H n-C3H7 Cl F H n-C4H9 Cl F H n-C5H11 Cl F H n-C6H13 Cl F H H Cl F F CH3 Cl F F C2H5 Cl F F n-C3H7 Cl F F n-C4H9 Cl F F n-C5H11 Cl F F n-C6H13 Cl F F H OCF3 H H CH3 OCF3 H H C2H5 OCF3 H H n-C3H7 OCF3 H H n-C4H9 OCF3 H H n-C5H11 OCF3 H H n-C6H13 OCF3 H H H OCF3 F H CH3 OCF3 F H C2H5 OCF3 F H n-C3H7 OCF3 F H n-C4H9 OCF3 F H n-C5H11 OCF3 F H n-C6H13 OCF3 F H H OCF3 F F CH3 OCF3 F F C2H5 OCF3 F F n-C3H7 OCF3 F F n-C4H9 . OCF3 F F n-C5H11 OCF3 F F n-C6H13 OCF3 F F H OCHF2 H H CH3 OCHF2 H H C2H5 OCHF2 H H n-C3H7 OCHF2 H H n-C4H9 OCHF2 H H n-C5H11 OCHF2 H H n-C6H13 OCHF2 H H H OCHF2 F H CH3 OCHF2 F H C2H5 OCHF2 F H n-C3H7 OCHF2 F H n-C4H9 OCHF2 F H n-C5H11 OCHF2 F H n-C6H13 OCHF2 F H H OCHF2 F F CH3 OCHF2 F F C2H5 OCHF2 F F n-C3H7 OCHF2 F F n-C4H9 OCHF2 F F n-C5H11 OCHF2 F F n-C6H13 OCHF2 F F H OCHFCF3 H H CH3 OCHFCF3 H H C2H5 OCHFCF3 H H n-C3H7 OCHFCF3 H H n-C4H9 OCHFCF3 H H n-C5H11 OCHFCF3 H H n-C6H13 OCHFCF3 H H H OCHFCF3 F H CH3 OCHFCF3 F H C2H5 OCHFCF3 F H n-C3H7 OCHFCF3 F H n-C4Hg OCHFCF3 F H n-C5H11 OCHFCF3 F H n-C6H13 OCHFCF3 F H H OCHFCF3 F F CH3 OCHFCF3 F F C2Hs OCHFCF3 F F n-C3H7 OCHFCF3 F F n-C4H9 OCHFCF3 F F n-C5H11 OCHFCF3 F F n-C6H13 OCHFCF3 F F H OCHFCF3 H H CH3 OCHFCF3 H H C2H5 OCHFCF3 H H n-C3H7 OCHFCF3 H H n-C4H9 OCHFCF3 H H n-C5H11 OCHFCF3 H H n-C6H13 OCHFCF3 H H H OCHFCF3 F H CH3 OCHFCF3 F H C2H5 OCHFCF3 F H n-C3H7 OCHFCF3 F H n-C4H9 OCHFCF3 F H n=C5H11 OCHFCF3 F H n-C6H13 OCHFCF3 F H H OCHFCF3 F F CH3 OCHFCF3 F F C2H5 OCHFCF3 F F n-C3H7 OCHFCF3 F F n-C4H9 OCHFCF3 F F n-C5H11 OCHFCF3 F F n-C6H13 OCHFCF3 F F H OCF2CHFCF3 H H CH3 OCF2CHFCF3 H H C2H5 OCF2CHFCF3 H H n-C3H7 OCF2CHFCF3 H H n-C4H9 OCF2CHFCF3 H H n-C5H11 OCF2CHFCF3 H H n-C6H13 OCF2CHFCF3 H H H OCF2CHFCF3 F H CH3 OCF2CHFCF3 F H C2H5 OCF2CHFCF3 F H n-C3H7 OCF2CHFCF3 F H n-C4H9 OCF2CHFCF3 F H n-C5H11 OCF2CHFCF3 F H n-C6H13 OCF2CHFCF3 F H H OCF2CHFCF3 F F CH3 OCF2CHFCF3 F F C2H5 OCF2CHFCF3 F F n-C3H7 OCF2CHFCF3 F F n-C4H9 OCF2CHFCF3 F F n-C5H11 OCF2CHFCF3 F F n-C6H13 OCF2CHFCF3 F F H NCS H H CH3 NCS H H C2H5 NCS H H n-C3H7 NCS H H n-C4H9 NCS H H n-C5H11 NCS H H n-C6H13 NCS H H H NCS F H CH3 NCS F H C2H5 NCS F H n-C3H7 NCS F H n-C4H9 NCS F H n-C5H11 NCS F H n-C6H13 NCS F H H NCS F F CH3 NCS F F C2H5 NCS F F n-C3H7 NCS F F n-C4H9 NCS F F n-C5H11 NCS F F n-C6H13 NCS F F H C2F5 H H CH3 C2F5 H H C2H5 C2F5 H H n-C3H7 C2F5 H H n-C4H9 C2F5 H H n-C5H11 C2F5 H H n-C6H13 C2F5 H H H C2F5 F H CH3 C2F5 F H C2H5 C2F5 F H n-C3H7 C2F5 F H n-C4H9 C2F5 F H n-C5H11 C2F5 F H n-C6H13 C2F5 F H H C2F5 F F CH3 C2F5 F F C2H5 C2F5 F F n-C3H7 C2F5 F F n-C4H9 C2F5 F F n-C5H11 C2F5 F F n-C6H13 C2F5 F F H C3F7 H H CH3 C3F7 H H C2H5 C3F7 H H n-C3H7 C3F7 H H n-C4H9 C3F7 H H n-C5H11 C3F7 H H n-C6H13 C3F7 H H H C3F7 F H CH3 C3F7 F H C2H5 C3F7 F H n-C3H7 C3F7 F H n-C4H9 C3F7 F H n-C5H11 C3F7 F H n-C6H13 C3F7 F H H C3F7 F F CH3 C3F7 F F C2H5 C3F7 F F n-C3H7 C3F7 F F n-C4H9 C3F7 F F n-C5H11 C3F7 F F n-C6H13 C3F7 F F H SF5 H H CH3 SF5 H H C2H5 SF5 H H n-C3H7 SF5 H H n-C4H9 SF5 H H n-C5H11 SF5 H H n-C6H13 SF5 H H H SF5 F H CH3 SF5 F H C2H5 SF5 F H n-C3H7 SF5 F H n-C4H9 SF5 F H n-C5H11 SF5 F H n-C6H13 SF5 F H H SF5 F F CH3 SF5 F F C2H5 SF5 F F n-C3H7 SF5 F F n-C4H9 SF5 F F n-C5H11 SF5 F F n-C6H13 SF5 F F H CN H H CH3 CN H H C2H5 CN H H n-C3H7 CN H H n-C4H9 CN H H n-C5H11 CN H H n-C6H13 CN H H H CN F H CH3 CN F H C2H5 CN F H n-C3H7 CN F H n-C4H9 CN F H Analogously, the following compounds of the formula
Figure imgb0278
produced: R 1 X L 1 L 2 HF H H CH 3 F H H C 2 H 5 F H H nC 3 H 7 F H H K 84 N 232.4 I; Δε = 9.4; Δn = 0.1390 nC 4 H 9 F H H nc 5 H 11 F H H nc 6 H 13 F H H H F F H CH 3 F F H C 2 H 5 F F H nC 3 H 7 F F H K 44 S M ? 45 N 212.6 I; Δε = 13.4; Δn = 0.1328 nC 4 H 9 F F H nc 5 H 11 F F H nc 6 H 13 F F H H F F F CH 3 F F F C 2 H 5 F F F nC 4 H 9 F F F nc 5 H 11 F F F nc 6 H 13 F F F H Cl H H CH 3 Cl H H C 2 H 5 Cl H H nC 3 H 7 Cl H H nC 4 H 9 Cl H H nc 5 H 11 Cl H H nc 6 H 13 Cl H H H Cl F H CH 3 Cl F H C 2 H 5 Cl F H nC 3 H 7 Cl F H nC 4 H 9 Cl F H nc 5 H 11 Cl F H nc 6 H 13 Cl F H H Cl F F CH 3 Cl F F C 2 H 5 Cl F F nC 3 H 7 Cl F F nC 4 H 9 Cl F F nc 5 H 11 Cl F F nc 6 H 13 Cl F F H OCF 3 H H CH 3 OCF 3 H H C 2 H 5 OCF 3 H H nC 3 H 7 OCF 3 H H nC 4 H 9 OCF 3 H H nc 5 H 11 OCF 3 H H nc 6 H 13 OCF 3 H H H OCF 3 F H CH 3 OCF 3 F H C 2 H 5 OCF 3 F H nC 3 H 7 OCF 3 F H nC 4 H 9 OCF 3 F H nc 5 H 11 OCF 3 F H nc 6 H 13 OCF 3 F H H OCF 3 F F CH 3 OCF 3 F F C 2 H 5 OCF 3 F F nC 3 H 7 OCF 3 F F nC 4 H 9 , OCF 3 F F nc 5 H 11 OCF 3 F F nc 6 H 13 OCF 3 F F H OCHF 2 H H CH 3 OCHF 2 H H C 2 H 5 OCHF 2 H H nC 3 H 7 OCHF 2 H H nC 4 H 9 OCHF 2 H H nc 5 H 11 OCHF 2 H H nc 6 H 13 OCHF 2 H H H OCHF 2 F H CH 3 OCHF 2 F H C 2 H 5 OCHF 2 F H nC 3 H 7 OCHF 2 F H nC 4 H 9 OCHF 2 F H nc 5 H 11 OCHF 2 F H nc 6 H 13 OCHF 2 F H H OCHF 2 F F CH 3 OCHF 2 F F C 2 H 5 OCHF 2 F F nC 3 H 7 OCHF 2 F F nC 4 H 9 OCHF 2 F F nc 5 H 11 OCHF 2 F F nc 6 H 13 OCHF 2 F F H OCHFCF 3 H H CH 3 OCHFCF 3 H H C 2 H 5 OCHFCF 3 H H nC 3 H 7 OCHFCF 3 H H nC 4 H 9 OCHFCF 3 H H nc 5 H 11 OCHFCF 3 H H nc 6 H 13 OCHFCF 3 H H H OCHFCF 3 F H CH 3 OCHFCF 3 F H C 2 H 5 OCHFCF 3 F H nC 3 H 7 OCHFCF 3 F H nc 4 Hg OCHFCF 3 F H nc 5 H 11 OCHFCF 3 F H nc 6 H 13 OCHFCF 3 F H H OCHFCF 3 F F CH 3 OCHFCF 3 F F C 2 Hs OCHFCF 3 F F nC 3 H 7 OCHFCF 3 F F nC 4 H 9 OCHFCF 3 F F nc 5 H 11 OCHFCF 3 F F nc 6 H 13 OCHFCF 3 F F H OCHFCF 3 H H CH 3 OCHFCF 3 H H C 2 H 5 OCHFCF 3 H H nC 3 H 7 OCHFCF 3 H H nC 4 H 9 OCHFCF 3 H H nc 5 H 11 OCHFCF 3 H H nc 6 H 13 OCHFCF 3 H H H OCHFCF 3 F H CH 3 OCHFCF 3 F H C 2 H 5 OCHFCF 3 F H nC 3 H 7 OCHFCF 3 F H nC 4 H 9 OCHFCF 3 F H n = C 5 H 11 OCHFCF 3 F H nc 6 H 13 OCHFCF 3 F H H OCHFCF 3 F F CH 3 OCHFCF 3 F F C 2 H 5 OCHFCF 3 F F nC 3 H 7 OCHFCF 3 F F nC 4 H 9 OCHFCF 3 F F nc 5 H 11 OCHFCF 3 F F nc 6 H 13 OCHFCF 3 F F H OCF 2 CHFCF 3 H H CH 3 OCF 2 CHFCF 3 H H C 2 H 5 OCF 2 CHFCF 3 H H nC 3 H 7 OCF 2 CHFCF 3 H H nC 4 H 9 OCF 2 CHFCF 3 H H nc 5 H 11 OCF 2 CHFCF 3 H H nc 6 H 13 OCF 2 CHFCF 3 H H H OCF 2 CHFCF 3 F H CH 3 OCF 2 CHFCF 3 F H C 2 H 5 OCF 2 CHFCF 3 F H nC 3 H 7 OCF 2 CHFCF 3 F H nC 4 H 9 OCF 2 CHFCF 3 F H nc 5 H 11 OCF 2 CHFCF 3 F H nc 6 H 13 OCF 2 CHFCF 3 F H H OCF 2 CHFCF 3 F F CH 3 OCF 2 CHFCF 3 F F C 2 H 5 OCF 2 CHFCF 3 F F nC 3 H 7 OCF 2 CHFCF 3 F F nC 4 H 9 OCF 2 CHFCF 3 F F nc 5 H 11 OCF 2 CHFCF 3 F F nc 6 H 13 OCF 2 CHFCF 3 F F H NCS H H CH 3 NCS H H C 2 H 5 NCS H H nC 3 H 7 NCS H H nC 4 H 9 NCS H H nc 5 H 11 NCS H H nc 6 H 13 NCS H H H NCS F H CH 3 NCS F H C 2 H 5 NCS F H nC 3 H 7 NCS F H nC 4 H 9 NCS F H nc 5 H 11 NCS F H nc 6 H 13 NCS F H H NCS F F CH 3 NCS F F C 2 H 5 NCS F F nC 3 H 7 NCS F F nC 4 H 9 NCS F F nc 5 H 11 NCS F F nc 6 H 13 NCS F F H C 2 F 5 H H CH 3 C 2 F 5 H H C 2 H 5 C 2 F 5 H H nC 3 H 7 C 2 F 5 H H nC 4 H 9 C 2 F 5 H H nc 5 H 11 C 2 F 5 H H nc 6 H 13 C 2 F 5 H H H C 2 F 5 F H CH 3 C 2 F 5 F H C 2 H 5 C 2 F 5 F H nC 3 H 7 C 2 F 5 F H nC 4 H 9 C 2 F 5 F H nc 5 H 11 C 2 F 5 F H nc 6 H 13 C 2 F 5 F H H C 2 F 5 F F CH 3 C 2 F 5 F F C 2 H 5 C 2 F 5 F F nC 3 H 7 C 2 F 5 F F nC 4 H 9 C 2 F 5 F F nc 5 H 11 C 2 F 5 F F nc 6 H 13 C 2 F 5 F F H C 3 F 7 H H CH 3 C 3 F 7 H H C 2 H 5 C 3 F 7 H H nC 3 H 7 C 3 F 7 H H nC 4 H 9 C 3 F 7 H H nc 5 H 11 C 3 F 7 H H nc 6 H 13 C 3 F 7 H H H C 3 F 7 F H CH 3 C 3 F 7 F H C 2 H 5 C 3 F 7 F H n-C3H7 C 3 F 7 F H nC 4 H 9 C 3 F 7 F H nc 5 H 11 C 3 F 7 F H nc 6 H 13 C 3 F 7 F H H C 3 F 7 F F CH 3 C 3 F 7 F F C 2 H 5 C 3 F 7 F F nC 3 H 7 C 3 F 7 F F nC 4 H 9 C 3 F 7 F F nc 5 H 11 C 3 F 7 F F nc 6 H 13 C 3 F 7 F F H SF 5 H H CH 3 SF 5 H H C 2 H 5 SF 5 H H nC 3 H 7 SF 5 H H nC 4 H 9 SF 5 H H nc 5 H 11 SF 5 H H nc 6 H 13 SF 5 H H H SF 5 F H CH 3 SF 5 F H C 2 H 5 SF 5 F H nC 3 H 7 SF 5 F H nC 4 H 9 SF 5 F H nc 5 H 11 SF 5 F H nc 6 H 13 SF 5 F H H SF 5 F F CH 3 SF 5 F F C 2 H 5 SF 5 F F nC 3 H 7 SF 5 F F nC 4 H 9 SF 5 F F nc 5 H 11 SF 5 F F nc 6 H 13 SF 5 F F H CN H H CH 3 CN H H C 2 H 5 CN H H nC 3 H 7 CN H H nC 4 H 9 CN H H nc 5 H 11 CN H H nc 6 H 13 CN H H H CN F H CH 3 CN F H C 2 H 5 CN F H nC 3 H 7 CN F H nC 4 H 9 CN F H

Beispiel 4Example 4

Figure imgb0279
Figure imgb0279

Schritt 4.1Step 4.1

Figure imgb0280
Figure imgb0280

Eine Lösung von 61,2 mmol N in 500 ml CH2Cl2 wird bei -20 °C tropfenweise mit 62,7 mmol Trifluormethansulfonsäure versetzt. Man lässt für 30 min auf Raumtemperatur kommen und kühlt dann auf -70 °C. Nun werden zuerst eine Lösung von 91 mmol 4-Brom-phenol und 101 mmol Triethylamin in 200 ml CH2Cl2, 5 min später 310 mmol Triethylamin-Tris(hydrofluorid) zugegeben. Nach weiteren 5 min gibt man in kleinen Portionen eine Suspension von 315 mmol 1,3-Dibrom-5,5-dimethylhydanthoin zu und rührt 1 h bei -70 °C nach. Man lässt auf -10 °C kommen und gießt die Reaktionsmischung in eiskalte NaOH. Man arbeitet wie üblich wässrig auf und reinigt das Rohprodukt durch Chromatographie an Kieselgel (Heptan/MTB-Ether 4:1) und Kristallisation aus Ethanol bei -20 °C.A solution of 61.2 mmol N in 500 ml of CH 2 Cl 2 is added dropwise at -20 ° C with 62.7 mmol of trifluoromethanesulfonic acid. It is allowed to come to room temperature for 30 minutes and then cooled to -70 ° C. Now, a solution of 91 mmol of 4-bromo-phenol and 101 mmol of triethylamine in 200 ml of CH 2 Cl 2 , 5 min later added 310 mmol of triethylamine-tris (hydrofluoride). After a further 5 minutes, a suspension of 315 mmol of 1,3-dibromo-5,5-dimethylhydanthoin is added in small portions and the mixture is stirred at -70 ° C. for a further 1 h. It is allowed to come to -10 ° C and the reaction mixture is poured into ice-cold NaOH. The reaction is carried out as usual in water and the crude product is purified by chromatography on silica gel (heptane / MTB ether 4: 1) and crystallization from ethanol at -20 ° C.

Schritt 4.2Step 4.2

Figure imgb0281
Figure imgb0281

Eine Mischung aus 50 mmol O , 50 mmol 3,4,5-Trifluorbenzolboronsäure, 2,5 mmol Pd(PPh3)4, 300 ml Toluol und 300 ml Na-Boratpuffer (pH=9) wird 18 h bei 80 °C gerührt. Man gießt die Mischung in 500 ml 0,1 N HCl, extrahiert das Produkt mit CH2Cl2, trocknet über Na2SO4 und rotiert zur Trockene ein. Das Rohprodukt wird in n-Heptan über Kieselgel chromatographiert und anschließend bei -20 °C aus n-Heptan umkristallisiert. K 60 SB 81 N 206,6 I; Δn =0,1291; Δε = 15,7A mixture of 50 mmol of O , 50 mmol of 3,4,5-trifluorobenzeneboronic acid, 2.5 mmol of Pd (PPh 3 ) 4 , 300 ml of toluene and 300 ml of Na borate buffer (pH = 9) is stirred at 80 ° C. for 18 h , The mixture is poured into 500 ml of 0.1 N HCl, the product is extracted with CH 2 Cl 2 , dried over Na 2 SO 4 and rotated to dryness. The crude product is chromatographed on silica gel in n-heptane and then recrystallized from n-heptane at -20 ° C. K 60 S B 81 N 206.6 I; Δn = 0.1291; Δε = 15.7

Analog werden die folgenden Verbindungen der Formel

Figure imgb0282
hergestellt: R1 X L1 L2 H F H H CH3 F H H C2H5 F H H n-C3H7 F H H n-C4H9 F H H n-C5H11 F H H n-C6H13 F H H H F F H CH3 F F H C2H5 F F H n-C3H7 F F H K 47 SB 91 N 238,0 I; Δε = 10,7; Δn = 0,1370 n-C4H9 F F H n-C5H11 F F H n-C6H13 F F H H F F F CH3 F F F C2H5 F F F n-C4H9 F F F n-C5H11 F F F n-C6H13 F F F H Cl H H CH3 Cl H H C2H5 Cl H H n-C3H7 Cl H H n-C4H9 Cl H H n-C5H11 Cl H H n-C6H13 Cl H H H Cl F H CH3 Cl F H C2H5 Cl F H n-C3H7 Cl F H n-C4H9 Cl F H n-C5H11 Cl F H n-C6H13 Cl F H H Cl F F CH3 Cl F F C2H5 Cl F F n-C3H7 Cl F F n-C4H9 Cl F F n-C5H11 Cl F F n-C6H13 Cl F F H OCF3 H H CH3 OCF3 H H C2H5 OCF3 H H n-C3H7 OCF3 H H n-C4H9 OCF3 H H n-C5H11 OCF3 H H n-C6H13 OCF3 H H H OCF3. F H CH3 OCF3 F H C2H5 OCF3 F H n-C3H7 OCF3 F H n-C4H9 OCF3 F H n-C5H11 OCF3 F H n-C6H13 OCF3 F H H OCF3 F F CH3 OCF3 F F C2H5 OCF3 F F n-C3H7 OCF3 F F n-C4H9 OCF3 F F n-C5H11 OCF3 F F n-C6H13 OCF3 F F H OCHF2 H H CH3 OCHF2 H H C2H5 OCHF2 H H n-C3H7 OCHF2 H H n-C4H9 OCHF2 H H n-CSH11 OCHF2 H H n-C6H13 OCHF2 H H H OCHF2 F H CH3 OCHF2 F H C2H5 OCHF2 F H n-C3H7 OCHF2 F H n-C4H9 OCHF2 F H n-C5H11 OCHF2 F H n-C6H13 OCHF2 F H H OCHF2 F F CH3 OCHF2 F F C2H5 OCHF2 F F n-C3H7 OCHF2 F F n-C4H9 OCHF2 F F n-C5H11 OCHF2 F F n-C6H13 OCHF2 F F H OCHFCF3 H H CH3 OCHFCF3 H H C2H5 OCHFCF3 H H n-C3H7 OCHFCF3 H H n-C4H9 OCHFCF3 H H n-C5H11 OCHFCF3 H H n-C6H13 OCHFCF3 H H H OCHFCF3 F H CH3 OCHFCF3 F H C2H5 OCHFCF3 F H n-C3H7 OCHFCF3 F H n-C4H9 OCHFCF3 F H n-C5H11 OCHFCF3 F H n-C6H13 OCHFCF3 F H H OCHFCF3 F F CH3 OCHFCF3 F F C2H5 OCHFCF3 F F n-C3H7 OCHFCF3 F F n-C4H9 OCHFCF3 F F n-C5H11 OCHFCF3 F F n-C6H13 OCHFCF3 F F H OCHFCF3 H H CH3 OCHFCF3 H H C2H5 OCHFCF3 H H n-C3H7 OCHFCF3 H H n-C4H9 OCHFCF3 H H n-C5H11 OCHFCF3 H H n-C6H13 OCHFCF3 H H H OCHFCF3 F H CH3 OCHFCF3 F H C2H5 OCHFCF3 F H n-C3H7 OCHFCF3 F H n-C4H9 OCHFCF3 F H n-C5H11 OCHFCF3 F H n-C6H13 OCHFCF3 F H H OCHFCF3 F F CH3 OCHFCF3 F F C2H5 OCHFCF3 F F n-C5H7 OCHFCF3 F F n-C4H9 OCHFCF3 F F n-C5H11 OCHFCF3 F F n-C6H13 OCHFCF3 F F H OCF2CHFCF3 H H CH3 OCF2CHFCF3 H H C2H5 OCF2CHFCF3 H H n-C3H7 OCF2CHFCF3 H H n-C4H9 OCF2CHFCF3 H H n-C5H11 OCF2CHFCF3 H H n-C6H13 OCF2CHFCF3 H H H OCF2CHFCF3 F H CH3 OCF2CHFCF3 F H C2H5 OCF2CHFCF3 F H n-C3H7 OCF2CHFCF3 F H n-C4H9 OCF2CHFCF3 F H n-C5H11 OCF2CHFCF3 F H n-C6H13 OCF2CHFCF3 F H H OCF2CHFCF3 F F CH3 OCF2CHFCF3 F F C2H5 OCF2CHFCF3 F F n-C3H7 OCF2CHFCF3 F F n-C4H9 OCF2CHFCF3 F F n-C5H11 OCF2CHFCF3 F F n-C6H13 OCF2CHFCF3 F F H NCS H H CH3 NCS H H C2H5 NCS H H n-C3H7 NCS H H n-C4H9 NCS H H n-C5H11 NCS H H n-C6H13 NCS H H H NCS F H CH3 NCS F H C2H5 NCS F H n-C3H7 NCS F H n-C4H9 NCS F H n-C5H11 NCS F H n-C6H13 NCS F H H NCS F F CH3 NCS F F C2H5 NCS F F n-C3H7 NCS F F n-C4H9 NCS F F n-C5H11 NCS . F F n-C6H13 NCS F F H C2F5 H H CH3 C2F5 H H C2H5 C2F5 H H n-C3H7 C2F5 H H n-C4H9 C2F5 H H n-C5H11 C2F5 H H n-C6H13 C2F5 H H H C2F5 F H CH3 C2F5 F H C2H5 C2F5 F H n-C3H7 C2F5 F H n-C4H9 C2F5 F H n-C5H11 C2F5 F H n-C6H13 C2F5 F H H C2F5 F F CH3 C2F5 F F C2H5 C2F5 F F n-C3H7 C2F5 F F n-C4H9 C2F5 F F n-C5H11 C2F5 F F n-C6H13 C2F5 F F H C3F7 H H CH3 C3F7 H H C2H5 C3F7 H H n-C3H7 C3F7 H H n-C4H9 C3F7 H H n-C5H11 C3F7 H H n-C6H13 C3F7 H H H C3F7 F H CH3 C3F7 F H C2H5 C3F7 F H n-C3H7 C3F7 F H n-C4H9 C3F7 F H n-C5H11 C3F7 F H n-C6H13 C3F7 F H H C3F7 F F CH3 C3F7 F F C2H5 C3F7 F F n-C3H7 C3F7 F F n-C4H9 C3F7 F F n-C5H11 C3F7 F F n-C6H13 C3F7 F F H SF5 H H CH3 SF5 H H C2H5 SF5 H H n-C3H7 SF5 H H n-C4H9 SF5 H H n-C5H11 SF5 H H n-C6H13 SF5 H H H SF5 F H CH3 SF5 F H C2H5 SF5 F H n-C3H7 SF5 F H n-C4H9 SF5 F H n-C5H11 SF5 F H n-C6H13 SF5 F H H SF5 F F CH3 SF5 F F C2H5 SF5 F F n-C3H7 SF5 F F n-C4H9 SF5 F F n-C5H11 SF5 F F n-C6H13 SF5 F F H CN H H CH3 CN H H C2H5 CN H H n-C3H7 CN H H n-C4H9 CN H H n-C5H11 CN H H n-C6H13 CN H H Analogously, the following compounds of the formula
Figure imgb0282
produced: R 1 X L 1 L 2 H F H H CH 3 F H H C 2 H 5 F H H nC 3 H 7 F H H nC 4 H 9 F H H nc 5 H 11 F H H nc 6 H 13 F H H H F F H CH 3 F F H C 2 H 5 F F H nC 3 H 7 F F H K 47 S B 91 N 238.0 I; Δε = 10.7; Δn = 0.1370 nC 4 H 9 F F H nc 5 H 11 F F H nc 6 H 13 F F H H F F F CH 3 F F F C 2 H 5 F F F nC 4 H 9 F F F nc 5 H 11 F F F nc 6 H 13 F F F H Cl H H CH 3 Cl H H C 2 H 5 Cl H H nC 3 H 7 Cl H H nC 4 H 9 Cl H H nc 5 H 11 Cl H H nc 6 H 13 Cl H H H Cl F H CH 3 Cl F H C 2 H 5 Cl F H nC 3 H 7 Cl F H nC 4 H 9 Cl F H nc 5 H 11 Cl F H nc 6 H 13 Cl F H H Cl F F CH 3 Cl F F C 2 H 5 Cl F F nC 3 H 7 Cl F F nC 4 H 9 Cl F F nc 5 H 11 Cl F F nc 6 H 13 Cl F F H OCF 3 H H CH 3 OCF 3 H H C 2 H 5 OCF 3 H H nC 3 H 7 OCF 3 H H nC 4 H 9 OCF 3 H H nc 5 H 11 OCF 3 H H nc 6 H 13 OCF 3 H H H OCF 3 . F H CH 3 OCF 3 F H C 2 H 5 OCF 3 F H nC 3 H 7 OCF 3 F H nC 4 H 9 OCF 3 F H nc 5 H 11 OCF 3 F H nc 6 H 13 OCF 3 F H H OCF 3 F F CH 3 OCF 3 F F C 2 H 5 OCF 3 F F nC 3 H 7 OCF 3 F F nC 4 H 9 OCF 3 F F nc 5 H 11 OCF 3 F F nc 6 H 13 OCF 3 F F H OCHF 2 H H CH 3 OCHF 2 H H C 2 H 5 OCHF 2 H H nC 3 H 7 OCHF 2 H H nC 4 H 9 OCHF 2 H H nC S H 11 OCHF 2 H H nc 6 H 13 OCHF 2 H H H OCHF 2 F H CH 3 OCHF 2 F H C 2 H 5 OCHF 2 F H nC 3 H 7 OCHF 2 F H nC 4 H 9 OCHF 2 F H nc 5 H 11 OCHF 2 F H nc 6 H 13 OCHF 2 F H H OCHF 2 F F CH 3 OCHF 2 F F C 2 H 5 OCHF 2 F F nC 3 H 7 OCHF 2 F F nC 4 H 9 OCHF 2 F F nc 5 H 11 OCHF 2 F F nc 6 H 13 OCHF 2 F F H OCHFCF 3 H H CH 3 OCHFCF 3 H H C 2 H 5 OCHFCF 3 H H nC 3 H 7 OCHFCF 3 H H nC 4 H 9 OCHFCF 3 H H nc 5 H 11 OCHFCF 3 H H nc 6 H 13 OCHFCF 3 H H H OCHFCF 3 F H CH 3 OCHFCF 3 F H C 2 H 5 OCHFCF 3 F H nC 3 H 7 OCHFCF 3 F H nC 4 H 9 OCHFCF 3 F H nc 5 H 11 OCHFCF 3 F H nc 6 H 13 OCHFCF 3 F H H OCHFCF 3 F F CH 3 OCHFCF 3 F F C 2 H 5 OCHFCF 3 F F nC 3 H 7 OCHFCF 3 F F nC 4 H 9 OCHFCF 3 F F nc 5 H 11 OCHFCF 3 F F nc 6 H 13 OCHFCF 3 F F H OCHFCF 3 H H CH 3 OCHFCF 3 H H C 2 H 5 OCHFCF 3 H H nC 3 H 7 OCHFCF 3 H H nC 4 H 9 OCHFCF 3 H H nc 5 H 11 OCHFCF 3 H H nc 6 H 13 OCHFCF 3 H H H OCHFCF 3 F H CH 3 OCHFCF 3 F H C 2 H 5 OCHFCF 3 F H nC 3 H 7 OCHFCF 3 F H nC 4 H 9 OCHFCF 3 F H nc 5 H 11 OCHFCF 3 F H nc 6 H 13 OCHFCF 3 F H H OCHFCF 3 F F CH 3 OCHFCF 3 F F C 2 H 5 OCHFCF 3 F F nc 5 H 7 OCHFCF 3 F F nC 4 H 9 OCHFCF 3 F F nc 5 H 11 OCHFCF 3 F F nc 6 H 13 OCHFCF 3 F F H OCF 2 CHFCF 3 H H CH 3 OCF 2 CHFCF 3 H H C 2 H 5 OCF 2 CHFCF 3 H H nC 3 H 7 OCF 2 CHFCF 3 H H nC 4 H 9 OCF 2 CHFCF 3 H H nc 5 H 11 OCF 2 CHFCF 3 H H nc 6 H 13 OCF 2 CHFCF 3 H H H OCF 2 CHFCF 3 F H CH 3 OCF 2 CHFCF 3 F H C 2 H 5 OCF 2 CHFCF 3 F H nC 3 H 7 OCF 2 CHFCF 3 F H nC 4 H 9 OCF 2 CHFCF 3 F H nc 5 H 11 OCF 2 CHFCF 3 F H nc 6 H 13 OCF 2 CHFCF 3 F H H OCF 2 CHFCF 3 F F CH 3 OCF 2 CHFCF 3 F F C 2 H 5 OCF 2 CHFCF 3 F F nC 3 H 7 OCF 2 CHFCF 3 F F nC 4 H 9 OCF 2 CHFCF 3 F F nc 5 H 11 OCF 2 CHFCF 3 F F nc 6 H 13 OCF 2 CHFCF 3 F F H NCS H H CH 3 NCS H H C 2 H 5 NCS H H nC 3 H 7 NCS H H nC 4 H 9 NCS H H nc 5 H 11 NCS H H nc 6 H 13 NCS H H H NCS F H CH 3 NCS F H C 2 H 5 NCS F H nC 3 H 7 NCS F H nC 4 H 9 NCS F H nc 5 H 11 NCS F H nc 6 H 13 NCS F H H NCS F F CH 3 NCS F F C 2 H 5 NCS F F nC 3 H 7 NCS F F nC 4 H 9 NCS F F nc 5 H 11 NCS. F F nc 6 H 13 NCS F F H C 2 F 5 H H CH 3 C 2 F 5 H H C 2 H 5 C 2 F 5 H H nC 3 H 7 C 2 F 5 H H nC 4 H 9 C 2 F 5 H H nc 5 H 11 C 2 F 5 H H nc 6 H 13 C 2 F 5 H H H C 2 F 5 F H CH 3 C 2 F 5 F H C 2 H 5 C 2 F 5 F H nC 3 H 7 C 2 F 5 F H nC 4 H 9 C 2 F 5 F H nc 5 H 11 C 2 F 5 F H nc 6 H 13 C 2 F 5 F H H C 2 F 5 F F CH 3 C 2 F 5 F F C 2 H 5 C 2 F 5 F F nC 3 H 7 C 2 F 5 F F nC 4 H 9 C 2 F 5 F F nc 5 H 11 C 2 F 5 F F nc 6 H 13 C 2 F 5 F F H C 3 F 7 H H CH 3 C 3 F 7 H H C 2 H 5 C 3 F 7 H H nC 3 H 7 C 3 F 7 H H nC 4 H 9 C 3 F 7 H H nc 5 H 11 C 3 F 7 H H nc 6 H 13 C 3 F 7 H H H C 3 F 7 F H CH 3 C 3 F 7 F H C 2 H 5 C 3 F 7 F H nC 3 H 7 C 3 F 7 F H nC 4 H 9 C 3 F 7 F H nc 5 H 11 C 3 F 7 F H nc 6 H 13 C 3 F 7 F H H C 3 F 7 F F CH 3 C 3 F 7 F F C 2 H 5 C 3 F 7 F F nC 3 H 7 C 3 F 7 F F nC 4 H 9 C 3 F 7 F F nc 5 H 11 C 3 F 7 F F nc 6 H 13 C 3 F 7 F F H SF 5 H H CH 3 SF 5 H H C 2 H 5 SF 5 H H nC 3 H 7 SF 5 H H nC 4 H 9 SF 5 H H nc 5 H 11 SF 5 H H nc 6 H 13 SF 5 H H H SF 5 F H CH 3 SF 5 F H C 2 H 5 SF 5 F H nC 3 H 7 SF 5 F H nC 4 H 9 SF 5 F H nc 5 H 11 SF 5 F H nc 6 H 13 SF 5 F H H SF 5 F F CH 3 SF 5 F F C 2 H 5 SF 5 F F nC 3 H 7 SF 5 F F nC 4 H 9 SF 5 F F nc 5 H 11 SF 5 F F nc 6 H 13 SF 5 F F H CN H H CH 3 CN H H C 2 H 5 CN H H nC 3 H 7 CN H H nC 4 H 9 CN H H nc 5 H 11 CN H H nc 6 H 13 CN H H

Beispiel 5Example 5

Figure imgb0283
Figure imgb0283

Schritt 5.1 1Step 5.1 1

Figure imgb0284
Figure imgb0284

Zu einer auf -70 °C abgekühlten Lösung von 65 mmol P in 100 ml Dichlormethan wird ein Gemisch aus 98 mmol Q und 16,3 ml Triethylamin (117 mmol) in 80 ml Dichlormethan unter Rühren zugetropft. Nach beendeter Zugabe wird noch 1 h bei -70 °C gerührt. Anschließend wird mit 325 mmol Triethylamintrishydrofluorid bei derselben Temperatur tropfenweise versetzt. Anschließend werden 325 mmol Brom bei -70 °C tropfenweise zugegeben. Nach 1 h Rühren bei -70 °C lässt man auf -10 °C erwärmen und gießt das Reaktionsgemisch in eine Mischung aus 500 ml Eiswasser und 95 ml 32%ige Natronlauge. Die Phasen werden getrennt und die wässrige Phase wird mit Dichlormethan extrahiert. Die vereinigten organischen Phasen werden wie üblich aufgearbeitet.To a cooled to -70 ° C solution of 65 mmol P in 100 ml of dichloromethane, a mixture of 98 mmol of Q and 16.3 ml of triethylamine (117 mmol) in 80 ml of dichloromethane is added dropwise with stirring. After complete addition, the mixture is stirred at -70 ° C for a further 1 h. Subsequently, 325 mmol Triethylamintrishydrofluorid added dropwise at the same temperature. Subsequently, 325 mmol of bromine are added dropwise at -70 ° C. After 1 h stirring at -70 ° C is allowed to warm to -10 ° C and the reaction mixture is poured into a mixture of 500 ml of ice water and 95 ml of 32% sodium hydroxide solution. The phases are separated and the aqueous phase is extracted with dichloromethane. The combined organic phases are worked up as usual.

Schritt 5.2Step 5.2

Figure imgb0285
Figure imgb0285

Eine Mischung aus 10 mmol S und 10 mmol 2,6-Difluor-4-(trans-5'-propyltetrahydropyranyl-(2))-phenylboronsäure in 60 ml Toluol und 60 ml Natriumborat-Puffertösung (pH = 9) wird mit 0,5 mmol Pd(PPh3)4 unter Rühren 16 h bei 80 °C erwärmt. Nach dem Erkalten wird das zweiphasige Reaktionsgemisch unter Rühren auf 100 ml 0,1 N HCl gegossen, die organische Phase abgetrennt und die wässrige Phase mit Toluol zweimal extrahiert. Die vereinigten Toluolphasen werden nach dem Trocknen eingedampft, und der Rückstand wird über Kieselgel (Heptan/Methyl-tert.-butylether) filtriert. Zuletzt wird erst aus Ethanol und dann aus n-Heptan umkristallisiert.
K 115 N 197,7 I; Δε = 35,4; An = 0,1706
A mixture of 10 mmol S and 10 mmol of 2,6-difluoro-4- (trans-5'-propyltetrahydropyranyl (2)) -phenylboronic acid in 60 ml of toluene and 60 ml of sodium borate buffer solution (pH = 9) is assigned 0, 5 mmol of Pd (PPh 3 ) 4 with stirring for 16 h at 80 ° C heated. After cooling, the biphasic reaction mixture is poured with stirring onto 100 ml of 0.1 N HCl, the organic phase separated and the aqueous phase extracted twice with toluene. The combined toluene phases are evaporated after drying and the residue is filtered through silica gel (heptane / methyl tert-butyl ether). Finally, it is first recrystallized from ethanol and then from n-heptane.
K 115 N 197.7 I; Δ∈ = 35.4; An = 0.1706

Analog werden die folgenden Verbindungen der Formel

Figure imgb0286
hergestellt. R1 X L1 L2 L3 L4 H F H H H H CH3 F H H H H C2H5 F H H H H C3H7 F H H H H n-C4H9 F H H H H n-C5H11 F H H H H n-C6H13 F H H H H H F F H H H CH3 F F H H H C2H5 F F H H H n-C3H7 F F H H H n-C4H9 F F H H H n-C5H11 F F H H H n-C6H13 F F H H H H F F F H H CH3 F F F H H n-C4H9 F F F H H n-C5H11 F F F H H n-C6H13 F F F H H H Cl H H H H CH3 Cl H H H H C2H5 Cl H H H H n-C3H7 Cl H H H H n-C4H9 Cl H H H H n-C5H11 Cl H H H H n-C6H13 Cl H H H H H Cl F H H H CH3 Cl F H H H C2H5 Cl F H H H n-C3H7 Cl F H H H n-C4H9 Cl F H H H n-C5H11 Cl F H H H n-C6H13 Cl F H H H H Cl F F H H CH3 Cl F F H H C2H5 Cl F F H H n-C3H7 Cl F F H H n-C4H9 Cl F F H H n-C5H11 Cl F F H H n-C6H13 Cl F F H H H OCF3 H H H H CH3 OCF3 H H H H C2H5 OCF3 H H H H n-C3H7 OCF3 H H H H n-C4H9 OCF3 H H H H n-C5H11 OCF3 H H H H n-C6H13 OCF3 H H H H H OCF3 F H H H CH3 OCF3 F H H H C2H5 OCF3 F H H H n-C3H7 OCF3 F H H H n-C4H9 OCF3 F H H H n-C5H11 OCF3 F H H H n-C6H13 OCF3 F H H H H OCF3 F F H H CH3 OCF3 F F H H C2H5 OCF3 F F H H n-C3H7 OCF3 F F H H n-C4H9 OCF3 F F H H n-C5H11 OCF3 F F H H n-C6H13 OCF3 F F H H H OCHF2 H H H H CH3 OCHF2 H H H H C2H5 OCHF2 H H H H n-C3H7 OCHF2 H H H H n-C4H9 OCHF2 H H H H n-C5H11 OCHF2 H H H H n-C6H13 OCHF2 H H H H H OCHF2 F H H H CH3 OCHF2 F H H H C2H5 OCHF2 F H H H n-C3H7 OCHF2 F H H H n-C4H9 OCHF2 F H H H n-C5H11 OCHF2 F H H H n-C6H13 OCHF2 F H H H H OCHF2 F F H H CH3 OCHF2 F F H H C2H5 OCHF2 F F H H n-C3H7 OCHF2 F F H H n-C4H9 OCHF2 F F H H n-C5H11 OCHF2 F F H H n-C6H13 OCHF2 F F H H H OCHFCF3 H H H H CH3 OCHFCF3 H H H H C2H5 OCHFCF3 H H H H n-C3H7 OCHFCF3 H H H H n-C4H9 OCHFCF3 H H H H n-C5H11 OCHFCF3 H H H H n-C6H13 OCHFCF3 H H H H H OCHFCF3 F H H H CH3 OCHFCF3 F H H H C2H5 OCHFCF3 F H H H n-C3H7 OCHFCF3 F H H H n-C4H9 OCHFCF3 F H H H n-C5H11 OCHFCF3 F H H H n-C6H13 OCHFCF3 F H H H H OCHFCF3 F F H H CH3 OCHFCF3 F F H H C2H5 OCHFCF3 F F H H n-C3H7 OCHFCF3 F F H H n-C4H9 OCHFCF3 F F H H n-C5H11 OCHFCF3 F F H H n-C6H13 OCHFCF3 F F H H H OCHFCF3 H H H H CH3 OCHFCF3 H H H H C2H5 OCHFCF3 H H H H n-C3H7 OCHFCF3 H H H H n-C4H9 OCHFCF3 H H H H n-C5H11 OCHFCF3 H H H H n-C6H13 OCHFCF3 H H H H H OCHFCF3 F H H H CH3 OCHFCF3 F H H H C2H5 OCHFCF3 F H H H n-C3H7 OCHFCF3 F H H H n-C4Hg. OCHFCF3 F H H H n-C5H11 OCHFCF3 F H H H n-C6H13 OCHFCF3 F H H H H OCHFCF3 F F H H CH3 OCHFCF3 F F H H C2H5 OCHFCF3 F F H H n-C3H7 OCHFCF3 F F H H n-C4H9 OCHFCF3 F F H H n-C5H11 OCHFCF3 F F H H n-C6H13 OCHFCF3 F F H H H OCF2CHFCF3 H H H H CH3 OCF2CHFCF3 H H H H C2H5 OCF2CHFCF3 H H H H n-C3H7 OCF2CHFCF3 H H H H n-C4H9 OCF2CHFCF3 H H H H n-C5H11 OCF2CHFCF3 H H H H n-C6H13 OCF2CHFCF3 H H H H H OCF2CHFCF3 F H H H CH3 OCF2CHFCF3 F H H H C2H5 OCF2CHFCF3 F H H H n-C3H7 OCF2CHFCF3 F H H H n-C4H9 OCF2CHFCF3 F H H H n-C5H11 OCF2CHFCF3 F H H H n-C6H13 OCF2CHFCF3 F H H H H OCF2CHFCF3 F F H H CH3 OCF2CHFCF3 F F H H C2H5 OCF2CHFCF3 F F H H n-C3H7 OCF2CHFCF3 F F H H n-C4H9 OCF2CHFCF3 F F H H n-C5H11 OCF2CHFCF3 F F H H n-C6H13 OCF2CHFCF3 F F H H H NCS H H H H CH3 NCS H H H H C2H5 NCS H H H H n-C3H7 NCS H H H H n-C4H9 NCS H H H H n-C5H11 NCS H H H H n-C6H13 NCS H H H H H NCS F H H H CH3 NCS F H H H C2H5 NCS F H H H n-C3H7 NCS F H H H n-C4H9 NCS F H H H n-C5H11 NCS F H H H n-C6H13 NCS F H H H H NCS F F H H CH3 NCS F F H H C2H5 NCS F F H H n-C3H7 NCS F F H H n-C4H9 NCS F F H H n-C5H11 NCS F F H H n-C6H13 NCS F F H H H C2F5 H H H H CH3 C2F5 H H H H C2H5 C2F5 H H H H n-C3H7 C2F5 H H H H n-C4H9 C2F5 H H H H n-C5H11 C2F5 H H H H n-C6H13 C2F5 H H H H H C2F5 F H H H CH3 C2F5 F H H H C2H5 C2F5 F H H H n-C3H7 C2F5 F H H H n-C4H9 C2F5 F H H H n-C5H11 C2F5 F H H H n-C6H13 C2F5 F H H H H C2F5 F F H H CH3 C2F5 F F H H C2H5 C2F5 F F H H n-C3H7 C2F5 F F H H n-C4H9 C2F5 F F H H n-C5H11 C2F5 F F H H n-C6H13 C2F5 F F H H H C3F7 H H H H CH3 C3F7 H H H H C2H5 C3F7 H H H H n-C3H7 C3F7 H H H H n-C4H9 C3F7 H H H H n-C5H11 C3F7 H H H H n-C6H13 C3F7 H H H H H C3F7 F H H H CH3 C3F7 F H H H C2H5 C3F7 F H H H n-C3H7 C3F7 F H H H n-C4H9 C3F7 F H H H n-C5H11 C3F7 F H H H n-C6H13 C3F7 F H H H H C3F7 F F H H CH3 C3F7 F F H H C2H5 C3F7 F F H H n-C3H7 C3F7 F F H H n-C4H9 C3F7 F F H H n-C5H11 C3F7 F F H H n-C6H13 C3F7 F F H H H SF5 H H H H CH3 SF5 H H H H C2H5 SF5 H H H H n-C3H7 SF5 H H H H n-C4H9 SF5 H H H H n-C5H11 SF5 H H H H n-C6H13 SF5 H H H H H SF5 F H H H CH3 SF5 F H H H C2H5 SF5 F H H H n-C3H7 SF5 F H H H n-C4H9 SF5 F H H H n-C5H11 SF5 F H H H n-C6H13 SF5 F H H H H SF5 F F H H CH3 SF5 F F H H C2H5 SF5 F F H H n-C3H7 SF5 F F H H n-C4H9 SF5 F F H H n-C5H11 SF5 F F H H n-C6H13 SF5 F F H H H CN H H H H CH3 CN H H H H C2H5 CN H H H H n-C3H7 CN H H H H n-C4H9 CN H H H H n-C5H11 CN H H H H n-C6H13 CN H H H H H CN F H H H CH3 CN F H H H C2H5 CN F H H H n-C3H7 CN F H H H n-C4H9 CN F H H H n-C5H11 CN F H H H n-C6H13 CN F H H H H CN F F H H CH3 CN F F H H C2H5 CN F F H H n-C3H7 CN F F H H n-C4H9 CN F F H H n-C5H11 CN F F H H n-C6H13 CN F F H H H F H H F H CH3 F H H F H C2H5 F H H F H C3H7 F H H F H n-C4H9 F H H F H n-C5H11 F H H F H n-C6H13 F H H F H H F F H F H CH3 F F H F H C2H5 F F H F H n-C3H7 F F H F H n-C4H9 F F H F H n-C5H11 F F H F H n-C6H13 F F H F H H F F F F H CH3 F F F F H C2H5 F F F F H n-C3H7 F F F F H K 98 N 193,0 I, Δε = 37,9; Δn = 0,1649 n-C4H9 F F F F H n-C5H11 F F F F H n-C6H13 F F F F H H Cl H H F H CH3 Cl H H F H C2H5 Cl H H F H n-C3H7 Cl H H F H n-C4H9 Cl H H F H n-C5H11 Cl H H F H n-C6H13 Cl H H F H H Cl F H F H CH3 Cl F H F H C2H5 Cl F H F H n-C3H7 Cl F H F H n-C4H9 Cl F H F H n-C5H11 Cl F H F H n-C6H13 Cl F H F H H Cl F F F H CH3 Cl F F F H C2H5 Cl F F F H n-C3H7 Cl F F F H n-C4H9 Cl F F F H n-C5H11 Cl F F F H n-C6H13 Cl F F F H H OCF3 H H F H CH3 OCF3 H H F H C2H5 OCF3 H H F H n-C3H7 OCF3 H H F H n-C4H9 OCF3 H H F H n-C5H11 OCF3 H H F H n-C6H13 OCF3 H H F H H OCF3 F H F H CH3 OCF3 F H F H C2H5 OCF3 F H F H n-C3H7 OCF3 F H F H n-C4H9 OCF3 F H F H n-C5H11 OCF3 F H F H n-C6H13 OCF3 F H F H H OCF3 F F F H CH3 OCF3 F F F H C2H5 OCF3 F F F H n-C3H7 OCF3 F F F H n-C4H9 OCF3 F F F H n-C5H11 OCF3 F F F H n-C6H13 OCF3 F F F H H OCHF2 H H F H CH3 OCHF2 H H F H C2H5 OCHF2 H H F H n-C3H7 OCHF2 H H F H n-C4H9 OCHF2 H H F H n-C5H11 OCHF2 H H F H n-C6H13 OCHF2 H H F H H OCHF2 F H F H CH3 OCHF2 F H F H C2H5 OCHF2 F H F H n-C3H7 OCHF2 F H F H n-C4H9 OCHF2 F H F H n-C5H11 OCHF2 F H F H n-C6H13 OCHF2 F H F H H OCHF2 F F F H CH3 OCHF2 F F F H C2H5 OCHF2 F F F H n-C3H7 OCHF2 F F F H n-C4H9 OCHF2 F F F H n-C5H11 OCHF2 F F F H n-C6H13 OCHF2 F F F H H OCHFCF3 H H F H CH3 OCHFCF3 H H F H C2H5 OCHFCF3 H H F H n-C3H7 OCHFCF3 H H F H n-C4H9 OCHFCF3 H H F H n-C5H11 OCHFCF3 H H F H n-C6H13 OCHFCF3 H H F H H OCHFCF3 F H F H CH3 OCHFCF3 F H F H C2H5 OCHFCF3 F H F H n-C3H7 OCHFCF3 F H F H n-C4H9 OCHFCF3 F H F H n-C5H11 OCHFCF3 F H F H n-C6H13 OCHFCF3 F H F H H OCHFCF3 F F F H CH3 OCHFCF3 F F F H C2H5 OCHFCF3 F F F H n-C3H7 OCHFCF3 F F F H n-C4H9 OCHFCF3 F F F H n-C5H11 OCHFCF3 F F F H n-C6H13 OCHFCF3 F F F H H OCHFCF3 H H F H CH3 OCHFCF3 H H F H C2H5 OCHFCF3 H H F H n-C3H7 OCHFCF3 H H F H n-C4H9 OCHFCF3 H H F H n-C5H11 OCHFCF3 H H F H n-C6H13 OCHFCF3 H H F H H OCHFCF3 F H F H CH3 OCHFCF3 F H F H C2H5 OCHFCF3 F H F H n-C3H7 OCHFCF3 F H F H n-C4H9 OCHFCF3 F H F H n-C5H11 OCHFCF3 F H F H n-C6H13 OCHFCF3 F H F H H OCHFCF3 F F F H CH3 OCHFCF3 F F F H C2H5 OCHFCF3 F F F H n-C3H7 OCHFCF3 F F F H n-C4H9 OCHFCF3 F F F H n-C5H11 OCHFCF3 F F F H n-C6H13 OCHFCF3 F F F H H OCF2CHFCF3 H H F H CH3 OCF2CHFCF3 H H F H C2H5 OCF2CHFCF3 H H F H n-C3H7 OCF2CHFCF3 H H F H n-C4H9 OCF2CHFCF3 H H F H n-C5H11 OCF2CHFCF3 H H F H n-C6H13 OCF2CHFCF3 H H F H H OCF2CHFCF3 F H F H CH3 OCF2CHFCF3 F H F H C2H5 OCF2CHFCF3 F H F H n-C3H7 OCF2CHFCF3 F H F H n-C4H9 OCF2CHFCF3 F H F H n-C5H11 OCF2CHFCF3 F H F H n-C6H13 OCF2CHFCF3 F H F H H OCF2CHFCF3 F F F H CH3 OCF2CHFCF3 F F F H C2H5 OCF2CHFCF3 F F F H n-C3H7 OCF2CHFCF3 F F F H n-C4H9 OCF2CHFCF3 F F F H n-C5H11 OCF2CHFCF3 F F F H n-C6H13 OCF2CHFCF3 F F F H H NCS H H F H CH3 NCS H H F H C2H5 NCS H H F H n-C3H7 NCS H H F H n-C4H9 NCS H H F H n-C5H11 NCS H H F H n-C6H13 NCS H H F H H NCS F H F H CH3 NCS F H F H C2H5 NCS F H F H n-C3H7 NCS F H F H n-C4H9 NCS F H F H n-C5H11 NCS F H F H n-C6H13 NCS F H F H H NCS F F F H CH3 NCS F F F H C2H5 NCS F F F H n-C3H7 NCS F F F H n-C4H9 NCS F F F H n-C5H11 NCS F F F H n-C6H13 NCS F F F H H C2F5 H H F H CH3 C2F5 H H F H C2H5 C2F5 H H F H n-C3H7 C2F5 H H F H n-C4H9 C2F5 H H F H n-C5H11 C2F5 H H F H n-C6H13 C2F5 H H F H H C2F5 F H F H CH3 C2F5 F H F H C2H5 C2F5 F H F H n-C3H7 C2F5 F H F H n-C4H9 C2F5 F H F H n-C5H11 C2F5 F H F H n-C6H13 C2F5 F H F H H C2F5 F F F H CH3 C2F5 F F F H C2H5 C2F5 F F F H n-C3H7 C2F5 F F F H n-C4H9 C2F5 F F F H n-C5H11 C2F5 F F F H n-C6H,3 C2F5 F F F H H C3F7 H H F H CH3 C3F7 H H F H C2H5 C3F7 H H F H n-C3H7 C3F7 H H F H n-C4H9 C3F7 H H F H n-C5H11 C3F7 H H F H n-C6H13 C3F7 H H F H H C3F7 F H F H CH3 C3F7 F H F H C2H5 C3F7 F H F H n-C3H7 C3F7 F H F H n-C4H9 C3F7 F H F H n-C5H11 C3F7 F H F H n-C6H13 C3F7 F H F H H C3F7 F F F H CH3 C3F7 F F F H C2H5 C3F7 F F F H n-C3H7 C3F7 F F F H n-C4H9 C3F7 F F F H n-C5H11 C3F7 F F F H n-C6H13 C3H7 F F F H H SF5 H H F H CH3 SF5 H H F H C2H5 SF5 H H F H n-C3H7 SF5 H H F H n-C4H9 SF5 H H F H n-C5H11 SF5 H H F H n-C6H13 SF5 H H F H H SF5 F H F H CH3 SF5 F H F H C2H5 SF5 F H F H n-C3H7 SF5 F H F H n-C4H9 SF5 F H F H n-C5H11 SF5 F H F H n-C6H13 SF5 F H F H H SF5 F F F H CH3 SF5 F F F H C2H5 SF5 F F F H n-C3H7 SF5 F F F H n-C4H9 SF5 F F F H n-C5H11 SF5 F F F H n-C6H13 SF5 F F F H H CN H H F H CH3 CN H H F H C2H5 CN H H F H n-C3H7 CN H H F H n-C4H9 CN H H F H n-C5H11 CN H H F H n-C6H13 CN H H F H H CN F H F H CH3 CN F H F H C2H5 CN F H F H n-C3H7 CN F H F H n-C4H9 CN F H F H n-C5H11 CN F H F H n-C6H13 CN F H F H H CN F F F H CH3 CN F F F H C2H5 CN F F F H n-C3H7 CN F F F H n-C4H9 CN F F F H n-C5H11 CN F F F H n-C6H13 CN F F F H H F H H F F CH3 F H H F F C2H5 F H H F F n-C4H9 F H H F F n-C5H11 F H H F F n-C6H13 F H H F F H F F H F F CH3 F F H F F C2H5 F F H F F n-C3H7 F F H F F n-C4H9 F F H F F n-C5H11 F F H F F n-C6H13 F F H F F H F F F F F CH3 F F F F F C2H5 F F F F F C2H5 F F F F F n-C3H7 F F F F F K 144 N 181,4 I; Δε = 42,1; Δn = 0,1510 n-C4H9 F F F F F n-C5H11 F F F F F n-C6H13 F F F F F H Cl H H F F CH3 Cl H H F F C2H5 Cl H H F F n-C3H7 Cl H H F F n-C4H9 Cl H H F F n-C5H11 Cl H H F F n-C6H13 Cl H H F F H Cl F H F F CH3 Cl F H F F C2H5 Cl F H F F n-C3H7 Cl F H F F n-C4H9 Cl F H F F n-C5H11 Cl F H F F n-C6H13 Cl F H F F H Cl F F F F CH3 Cl F F F F C2H5 Cl F F F F n-C3H7 Cl F F F F n-C4H9 Cl F F F F n-C5H11 Cl F F F F n-C6H13 Cl F F F F H OCF3 H H F F CH3 OCF3 H H F F C2H5 OCF3 H H F F n-C3H7 OCF3 H H F F n-C4H9 OCF3 H H F -F n-C5H11 OCF3 H H F F n-C6H13 OCF3 H H F F H OCF3 F H F F CH3 OCF3 F H F F C2H5 OCF3 F H F F n-C3H7 OCF3 F H F F K 121 N 205,2 I; Δε = 37,7; Δn = 0,1634 n-C4H9 OCF3 F H F F n-C5H11 OCF3 F H F F n-C6H13 OCF3 F H F F H OCF3 F F F F CH3 OCF3 F F F F C2H5 OCF3 F F F F n-C3H7 OCF3 F F F F K 128 N 201,2 I; Δε = 43,8; Δn = 0,1411 n-C4H9 OCF3 F F F F n-C5H11 OCF3 F F F F n-C6H13 OCF3 F F F F H OCHF2 H H F F CH3 OCHF2 H H F F C2H5 OCHF2 H H F F n-C3H7 OCHF2 H H F F n-C4H9 OCHF2 H H F F n-C5H11 OCHF2 H H F F n-C6H13 OCHF2 H H F F H OCHF2 F H F F CH3 OCHF2 F H F F C2H5 OCHF2 F H F F n-C3H7 OCHF2 F H F F n-C4H9 OCHF2 F H F F n-C5H11 OCHF2 F H F F n-C6H13 OCHF2 F H F F H OCHF2 F F F F CH3 OCHF2 F F F F C2H5 OCHF2 F F F F n-C3H7 OCHF2 F F F F n-C4H9 OCHF2 F F F F n-C5H11 OCHF2 F F F F n-C6H13 OCHF2 F F F F H OCHFCF3 H H F F CH3 OCHFCF3 H H F F C2H5 OCHFCF3 H H F F n-C3H7 OCHFCF3 H H F F n-C4H9 OCHFCF3 H H F F n-C5H11 OCHFCF3 H H F F n-C6H13 OCHFCF3 H H F F H OCHFCF3 F H F F CH3 OCHFCF3 F H F F C2H5 OCHFCF3 F H F F n-C3H7 OCHFCF3 F H F F n-C4H9 OCHFCF3 F H F F n-C5H11 OCHFCF3 F H F F n-C6H13 OCHFCF3 F H F F H OCHFCF3 F F F F CH3 OCHFCF3 F F F F C2H5 OCHFCF3 F F F F n-C3H7 OCHFCF3 F F F F n-C4H9 OCHFCF3 F F F F n-C5H11 OCHFCF3 F F F F n-C6H13 OCHFCF3 F F F F H OCHFCF3 H H F F CH3 OCHFCF3 H H F F C2H5 OCHFCF3 H H F F n-C3H7 OCHFCF3 H H F F n-C4H9 OCHFCF3 H H F F n-C5H11 OCHFCF3 H H F F n-C6H13 OCHFCF3 H H F F H OCHFCF3 F H F F CH3 OCHFCF3 F H F F C2H5 OCHFCF3 F H F F n-C3H7 OCHFCF3 F H F F n-C4H9 OCHFCF3 F H F F n-C5H11 OCHFCF3 F H F F n-C6H13 OCHFCF3 F H F F H OCHFCF3 F F F F CH3 OCHFCF3 F F F F C2H5 OCHFCF3 F F F F n-C3H7 OCHFCF3 F F F F n-C4H9 OCHFCF3 F F F F n-C5H11 OCHFCF3 F F F F n-C6H13 OCHFCF3 F F F F H OCF2CHFCF3 H H F F CH3 OCF2CHFCF3 H H F F C2H5 OCF2CHFCF3 H H F F n-C3H7 OCF2CHFCF3 H H F F n-C4H9 OCF2CHFCF3 H H F F n-C5H11 OCF2CHFCF3 H H F F n-C6H13 OCF2CHFCF3 H H F F H OCF2CHFCF3 F H F F CH3 OCF2CHFCF3 F H F F C2H5 OCF2CHFCF3 F H F F n-C3H7 OCF2CHFCF3 F H F F n-C4H9 OCF2CHFCF3 F H F F n-C5H11 OCF2CHFCF3 F H F F n-C6H13 OCF2CHFCF3 F H F F H OCF2CHFCF3 F F F F CH3 OCF2CHFCF3 F F F F C2H5 OCF2CHFCF3 F F F F n-C3H7 OCF2CHFCF3 F F F F n-C4H9 OCF2CHFCF3 F F F F n-C5H11 OCF2CHFCF3 F F F F n-C6H13 OCF2CHFCF3 F F F F H NCS H H F F CH3 NCS H H F F C2H5 NCS H H F F n-C3H7 NCS H H F F n-C4H9 NCS H H F F n-C5H11 NCS H H F F n-C6H13 NCS H H F F H NCS F H F F CH3 NCS F H F F C2H5 NCS F H F F n-C3H7 NCS F H F F n-C4H9 NCS F H F F n-C5H11 NCS F H F F n-C6H13 NCS F H F F H NCS F F F F CH3 NCS F F F F C2H5 NCS F F F F n-C3H7 NCS F F F F n-C4H9 NCS F F F F n-C5H11 NCS F F F F n-C6H13 NCS F F F F H C2F5 H H F F CH3 C2F5 H H F F C2H5 C2F5 H H F F n-C3H7 C2F5 H H F F n-C4H9 C2F5 H H F F n-C5H11 C2F5 H H F F n-C6H13 C2F5 H H F F H C2F5 F H F F CH3 C2Fs F H F F C2H5 C2F5 F H F F n-C3H7 C2F5 F H F F n-C4H9 C2F5 F H F F n-C5H11 C2F5 F H F F n-C6H13 C2F5 F H F F H C2F5 F F F F CH3 C2F5 F F F F C2H5 C2F5 F F F F n-C3H7 C2F5 F F F F n-C4H9 C2F5 F F F F n-C5H11 C2F5 F F F F n-C6H13 C2F5 F F F F H C3F7 H H F F CH3 C3F7 H H F F C2H5 C3F7 H H F F n-C3H7 C3F7 H H F F n-C4H9 C3F7 H H F F n-C5H11 C3F7 H H F F n-C5H13 C3F7 H H F F H C3F7 F H F F CH3 C3F7 F H F F C2H5 C3F7 F H F F n-C3H7 C3F7 F H F F n-C4H9 C3F7 F H F F n-C5H11 C3F7 F H F F n-C6H13 C3F7 F H F F H C3F7 F F F F CH3 C3F7 F F F F C2H5 C3F7 F F F F n-C3H7 C3F7 F F F F n-C4H9 C3F7 F F F F n-C5H11 C3F7 F F F F n-C6H13 C3F7 F F F F H SF5 H H F F CH3 SF5 H H F F C2H5 SF5 H H F F n-C3H7 SF5 H H F F n-C4H9 SF5 H H F F n-C5H11 SF5 H H F F n-C6H13 SF5 H H F F H SF5 F H F F CH3 SF5 F H F F C2H5 SF5 F H F F n-C3H7 SF5 F H F F n-C4H9 SF5 F H F F n-C5H11 SF5 F H F F n-C6H13 SF5 F H F F H SF5 F F F F CH3 SF5 F F F F C2H5 SF5 F F F F n-C3H7 SF5 F F F F n-C4H9 SF5 F F F F n-C5H11 SF5 F F F F n-C6H13 SF5 F F F F H CN H H F F CH3 CN H H F F C2H5 CN H H F F n-C3H7 CN H H F F n-C4H9 CN H H F F n-C5H11 CN H H F F n-C6H13 CN H H F F H CN F H F F CH3 CN F H F F C2H5 CN F H F F n-C3H7 CN F H F F n-C4H9 CN F H F F n-C5H11 CN F H F F n-C6H13 CN F H F F H CN F F F F CH3 CN F F F F C2H5 CN F F F F n-C3H7 CN F F F F n-C4H9 CN F F F F n-C5H11 CN F F F F n-C6H13 CN F F F F H CF3 H H F F C2H5 CF3 H H F F n-C3H7 CF3 H H F F n-C4H9 CF3 H H F F n-C5H11 CF3 H H F F n-C6H13 CF3 H H F F CH2=CH CF3 H H F F H CF3 F F F F C2H5 CF3 F F F F n-C3H7 CF3 F F F F n-C4H9 CF3 F F F F n-C5H11 CF3 F F F F n-C6H13 CF3 F F F F CH2=CH CF3 F F F F H F H H F F C2H5 F H H F F n-C3H7 F H H F F n-C4H9 F H H F F n-C5H11 F H H F F n-C6H13 F H H F F CH2=CH F H H F F Analogously, the following compounds of the formula
Figure imgb0286
produced. R 1 X L 1 L 2 L 3 L 4 H F H H H H CH 3 F H H H H C 2 H 5 F H H H H C 3 H 7 F H H H H nC 4 H 9 F H H H H nc 5 H 11 F H H H H nc 6 H 13 F H H H H H F F H H H CH 3 F F H H H C 2 H 5 F F H H H nC 3 H 7 F F H H H nC 4 H 9 F F H H H nc 5 H 11 F F H H H nc 6 H 13 F F H H H H F F F H H CH 3 F F F H H nC 4 H 9 F F F H H nc 5 H 11 F F F H H nc 6 H 13 F F F H H H Cl H H H H CH 3 Cl H H H H C 2 H 5 Cl H H H H nC 3 H 7 Cl H H H H nC 4 H 9 Cl H H H H nc 5 H 11 Cl H H H H nc 6 H 13 Cl H H H H H Cl F H H H CH 3 Cl F H H H C 2 H 5 Cl F H H H nC 3 H 7 Cl F H H H nC 4 H 9 Cl F H H H nc 5 H 11 Cl F H H H nc 6 H 13 Cl F H H H H Cl F F H H CH 3 Cl F F H H C 2 H 5 Cl F F H H nC 3 H 7 Cl F F H H nC 4 H 9 Cl F F H H nc 5 H 11 Cl F F H H nc 6 H 13 Cl F F H H H OCF 3 H H H H CH 3 OCF 3 H H H H C 2 H 5 OCF 3 H H H H nC 3 H 7 OCF 3 H H H H nC 4 H 9 OCF 3 H H H H nc 5 H 11 OCF 3 H H H H nc 6 H 13 OCF 3 H H H H H OCF 3 F H H H CH 3 OCF 3 F H H H C 2 H 5 OCF 3 F H H H nC 3 H 7 OCF 3 F H H H nC 4 H 9 OCF 3 F H H H nc 5 H 11 OCF 3 F H H H nc 6 H 13 OCF 3 F H H H H OCF 3 F F H H CH 3 OCF 3 F F H H C 2 H 5 OCF 3 F F H H nC 3 H 7 OCF 3 F F H H nC 4 H 9 OCF 3 F F H H nc 5 H 11 OCF 3 F F H H nc 6 H 13 OCF 3 F F H H H OCHF 2 H H H H CH 3 OCHF 2 H H H H C 2 H 5 OCHF 2 H H H H nC 3 H 7 OCHF 2 H H H H nC 4 H 9 OCHF 2 H H H H nc 5 H 11 OCHF 2 H H H H nc 6 H 13 OCHF 2 H H H H H OCHF 2 F H H H CH 3 OCHF 2 F H H H C 2 H 5 OCHF 2 F H H H nC 3 H 7 OCHF 2 F H H H nC 4 H 9 OCHF 2 F H H H nc 5 H 11 OCHF 2 F H H H nc 6 H 13 OCHF 2 F H H H H OCHF 2 F F H H CH 3 OCHF 2 F F H H C 2 H 5 OCHF 2 F F H H nC 3 H 7 OCHF 2 F F H H nC 4 H 9 OCHF 2 F F H H nc 5 H 11 OCHF 2 F F H H nc 6 H 13 OCHF 2 F F H H H OCHFCF 3 H H H H CH 3 OCHFCF 3 H H H H C 2 H 5 OCHFCF 3 H H H H nC 3 H 7 OCHFCF 3 H H H H nC 4 H 9 OCHFCF 3 H H H H nc 5 H 11 OCHFCF 3 H H H H nc 6 H 13 OCHFCF 3 H H H H H OCHFCF 3 F H H H CH 3 OCHFCF 3 F H H H C 2 H 5 OCHFCF 3 F H H H nC 3 H 7 OCHFCF 3 F H H H nC 4 H 9 OCHFCF 3 F H H H nc 5 H 11 OCHFCF 3 F H H H nc 6 H 13 OCHFCF 3 F H H H H OCHFCF 3 F F H H CH 3 OCHFCF 3 F F H H C 2 H 5 OCHFCF 3 F F H H nC 3 H 7 OCHFCF 3 F F H H nC 4 H 9 OCHFCF 3 F F H H nc 5 H 11 OCHFCF 3 F F H H nc 6 H 13 OCHFCF 3 F F H H H OCHFCF 3 H H H H CH 3 OCHFCF 3 H H H H C 2 H 5 OCHFCF 3 H H H H nC 3 H 7 OCHFCF 3 H H H H nC 4 H 9 OCHFCF 3 H H H H nc 5 H 11 OCHFCF 3 H H H H nc 6 H 13 OCHFCF 3 H H H H H OCHFCF 3 F H H H CH 3 OCHFCF 3 F H H H C 2 H 5 OCHFCF 3 F H H H nC 3 H 7 OCHFCF 3 F H H H nc 4 Hg. OCHFCF 3 F H H H nc 5 H 11 OCHFCF 3 F H H H nc 6 H 13 OCHFCF 3 F H H H H OCHFCF 3 F F H H CH 3 OCHFCF 3 F F H H C 2 H 5 OCHFCF 3 F F H H nC 3 H 7 OCHFCF 3 F F H H nC 4 H 9 OCHFCF 3 F F H H nc 5 H 11 OCHFCF 3 F F H H nc 6 H 13 OCHFCF 3 F F H H H OCF 2 CHFCF 3 H H H H CH 3 OCF 2 CHFCF 3 H H H H C 2 H 5 OCF 2 CHFCF 3 H H H H nC 3 H 7 OCF 2 CHFCF 3 H H H H nC 4 H 9 OCF 2 CHFCF 3 H H H H nc 5 H 11 OCF 2 CHFCF 3 H H H H nc 6 H 13 OCF 2 CHFCF 3 H H H H H OCF 2 CHFCF 3 F H H H CH 3 OCF 2 CHFCF 3 F H H H C 2 H 5 OCF 2 CHFCF 3 F H H H nC 3 H 7 OCF 2 CHFCF 3 F H H H nC 4 H 9 OCF 2 CHFCF 3 F H H H nc 5 H 11 OCF 2 CHFCF 3 F H H H nc 6 H 13 OCF 2 CHFCF 3 F H H H H OCF 2 CHFCF 3 F F H H CH 3 OCF 2 CHFCF 3 F F H H C 2 H 5 OCF 2 CHFCF 3 F F H H nC 3 H 7 OCF 2 CHFCF 3 F F H H nC 4 H 9 OCF 2 CHFCF 3 F F H H nc 5 H 11 OCF 2 CHFCF 3 F F H H nc 6 H 13 OCF 2 CHFCF 3 F F H H H NCS H H H H CH 3 NCS H H H H C 2 H 5 NCS H H H H nC 3 H 7 NCS H H H H nC 4 H 9 NCS H H H H nc 5 H 11 NCS H H H H nc 6 H 13 NCS H H H H H NCS F H H H CH 3 NCS F H H H C 2 H 5 NCS F H H H nC 3 H 7 NCS F H H H nC 4 H 9 NCS F H H H nc 5 H 11 NCS F H H H nc 6 H 13 NCS F H H H H NCS F F H H CH 3 NCS F F H H C 2 H 5 NCS F F H H nC 3 H 7 NCS F F H H nC 4 H 9 NCS F F H H nc 5 H 11 NCS F F H H nc 6 H 13 NCS F F H H H C 2 F 5 H H H H CH 3 C 2 F 5 H H H H C 2 H 5 C 2 F 5 H H H H nC 3 H 7 C 2 F 5 H H H H nC 4 H 9 C 2 F 5 H H H H nc 5 H 11 C 2 F 5 H H H H nc 6 H 13 C 2 F 5 H H H H H C 2 F 5 F H H H CH 3 C 2 F 5 F H H H C 2 H 5 C 2 F 5 F H H H nC 3 H 7 C 2 F 5 F H H H nC 4 H 9 C 2 F 5 F H H H nc 5 H 11 C 2 F 5 F H H H nc 6 H 13 C 2 F 5 F H H H H C 2 F 5 F F H H CH 3 C 2 F 5 F F H H C 2 H 5 C 2 F 5 F F H H nC 3 H 7 C 2 F 5 F F H H nC 4 H 9 C 2 F 5 F F H H nc 5 H 11 C 2 F 5 F F H H nc 6 H 13 C 2 F 5 F F H H H C 3 F 7 H H H H CH 3 C 3 F 7 H H H H C 2 H 5 C 3 F 7 H H H H nC 3 H 7 C 3 F 7 H H H H nC 4 H 9 C 3 F 7 H H H H nc 5 H 11 C 3 F 7 H H H H nc 6 H 13 C 3 F 7 H H H H H C 3 F 7 F H H H CH 3 C 3 F 7 F H H H C 2 H 5 C 3 F 7 F H H H nC 3 H 7 C 3 F 7 F H H H nC 4 H 9 C 3 F 7 F H H H nc 5 H 11 C 3 F 7 F H H H nc 6 H 13 C 3 F 7 F H H H H C 3 F 7 F F H H CH 3 C 3 F 7 F F H H C 2 H 5 C 3 F 7 F F H H nC 3 H 7 C 3 F 7 F F H H nC 4 H 9 C 3 F 7 F F H H nc 5 H 11 C 3 F 7 F F H H nc 6 H 13 C 3 F 7 F F H H H SF 5 H H H H CH 3 SF 5 H H H H C 2 H 5 SF 5 H H H H nC 3 H 7 SF 5 H H H H nC 4 H 9 SF 5 H H H H nc 5 H 11 SF 5 H H H H nc 6 H 13 SF 5 H H H H H SF 5 F H H H CH 3 SF 5 F H H H C 2 H 5 SF 5 F H H H nC 3 H 7 SF 5 F H H H nC 4 H 9 SF 5 F H H H nc 5 H 11 SF 5 F H H H nc 6 H 13 SF 5 F H H H H SF 5 F F H H CH 3 SF 5 F F H H C 2 H 5 SF 5 F F H H nC 3 H 7 SF 5 F F H H nC 4 H 9 SF 5 F F H H nc 5 H 11 SF 5 F F H H nc 6 H 13 SF 5 F F H H H CN H H H H CH 3 CN H H H H C 2 H 5 CN H H H H nC 3 H 7 CN H H H H nC 4 H 9 CN H H H H nc 5 H 11 CN H H H H nc 6 H 13 CN H H H H H CN F H H H CH 3 CN F H H H C 2 H 5 CN F H H H nC 3 H 7 CN F H H H nC 4 H 9 CN F H H H nc 5 H 11 CN F H H H nc 6 H 13 CN F H H H H CN F F H H CH 3 CN F F H H C 2 H 5 CN F F H H nC 3 H 7 CN F F H H nC 4 H 9 CN F F H H nc 5 H 11 CN F F H H nc 6 H 13 CN F F H H H F H H F H CH 3 F H H F H C 2 H 5 F H H F H C 3 H 7 F H H F H nC 4 H 9 F H H F H nc 5 H 11 F H H F H nc 6 H 13 F H H F H H F F H F H CH 3 F F H F H C 2 H 5 F F H F H nC 3 H 7 F F H F H nC 4 H 9 F F H F H nc 5 H 11 F F H F H nc 6 H 13 F F H F H H F F F F H CH 3 F F F F H C 2 H 5 F F F F H nC 3 H 7 F F F F H K 98 N 193.0 I, Δε = 37.9; Δn = 0.1649 nC 4 H 9 F F F F H nc 5 H 11 F F F F H nc 6 H 13 F F F F H H Cl H H F H CH 3 Cl H H F H C 2 H 5 Cl H H F H nC 3 H 7 Cl H H F H nC 4 H 9 Cl H H F H nc 5 H 11 Cl H H F H nc 6 H 13 Cl H H F H H Cl F H F H CH 3 Cl F H F H C 2 H 5 Cl F H F H nC 3 H 7 Cl F H F H nC 4 H 9 Cl F H F H nc 5 H 11 Cl F H F H nc 6 H 13 Cl F H F H H Cl F F F H CH 3 Cl F F F H C 2 H 5 Cl F F F H nC 3 H 7 Cl F F F H nC 4 H 9 Cl F F F H nc 5 H 11 Cl F F F H nc 6 H 13 Cl F F F H H OCF 3 H H F H CH 3 OCF 3 H H F H C 2 H 5 OCF 3 H H F H nC 3 H 7 OCF 3 H H F H nC 4 H 9 OCF 3 H H F H nc 5 H 11 OCF 3 H H F H nc 6 H 13 OCF 3 H H F H H OCF 3 F H F H CH 3 OCF 3 F H F H C 2 H 5 OCF 3 F H F H nC 3 H 7 OCF 3 F H F H nC 4 H 9 OCF 3 F H F H nc 5 H 11 OCF 3 F H F H nc 6 H 13 OCF 3 F H F H H OCF 3 F F F H CH 3 OCF 3 F F F H C 2 H 5 OCF 3 F F F H nC 3 H 7 OCF 3 F F F H nC 4 H 9 OCF 3 F F F H nc 5 H 11 OCF 3 F F F H nc 6 H 13 OCF 3 F F F H H OCHF 2 H H F H CH 3 OCHF 2 H H F H C 2 H 5 OCHF 2 H H F H nC 3 H 7 OCHF 2 H H F H nC 4 H 9 OCHF 2 H H F H nc 5 H 11 OCHF 2 H H F H nc 6 H 13 OCHF 2 H H F H H OCHF 2 F H F H CH 3 OCHF 2 F H F H C 2 H 5 OCHF 2 F H F H nC 3 H 7 OCHF 2 F H F H nC 4 H 9 OCHF 2 F H F H nc 5 H 11 OCHF 2 F H F H nc 6 H 13 OCHF 2 F H F H H OCHF 2 F F F H CH 3 OCHF 2 F F F H C 2 H 5 OCHF 2 F F F H nC 3 H 7 OCHF 2 F F F H nC 4 H 9 OCHF 2 F F F H nc 5 H 11 OCHF 2 F F F H nc 6 H 13 OCHF 2 F F F H H OCHFCF 3 H H F H CH 3 OCHFCF 3 H H F H C 2 H 5 OCHFCF 3 H H F H nC 3 H 7 OCHFCF 3 H H F H nC 4 H 9 OCHFCF 3 H H F H nc 5 H 11 OCHFCF 3 H H F H nc 6 H 13 OCHFCF 3 H H F H H OCHFCF 3 F H F H CH 3 OCHFCF 3 F H F H C 2 H 5 OCHFCF 3 F H F H nC 3 H 7 OCHFCF 3 F H F H nC 4 H 9 OCHFCF 3 F H F H nc 5 H 11 OCHFCF 3 F H F H nc 6 H 13 OCHFCF 3 F H F H H OCHFCF 3 F F F H CH 3 OCHFCF 3 F F F H C 2 H 5 OCHFCF 3 F F F H nC 3 H 7 OCHFCF 3 F F F H nC 4 H 9 OCHFCF 3 F F F H nc 5 H 11 OCHFCF 3 F F F H nc 6 H 13 OCHFCF 3 F F F H H OCHFCF 3 H H F H CH 3 OCHFCF 3 H H F H C 2 H 5 OCHFCF 3 H H F H nC 3 H 7 OCHFCF 3 H H F H nC 4 H 9 OCHFCF 3 H H F H nc 5 H 11 OCHFCF 3 H H F H nc 6 H 13 OCHFCF 3 H H F H H OCHFCF 3 F H F H CH 3 OCHFCF 3 F H F H C 2 H 5 OCHFCF 3 F H F H nC 3 H 7 OCHFCF 3 F H F H nC 4 H 9 OCHFCF 3 F H F H nc 5 H 11 OCHFCF 3 F H F H nc 6 H 13 OCHFCF 3 F H F H H OCHFCF 3 F F F H CH 3 OCHFCF 3 F F F H C 2 H 5 OCHFCF 3 F F F H nC 3 H 7 OCHFCF 3 F F F H nC 4 H 9 OCHFCF 3 F F F H nc 5 H 11 OCHFCF 3 F F F H nc 6 H 13 OCHFCF 3 F F F H H OCF 2 CHFCF 3 H H F H CH 3 OCF 2 CHFCF 3 H H F H C 2 H 5 OCF 2 CHFCF 3 H H F H nC 3 H 7 OCF 2 CHFCF 3 H H F H nC 4 H 9 OCF 2 CHFCF 3 H H F H nc 5 H 11 OCF 2 CHFCF 3 H H F H nc 6 H 13 OCF 2 CHFCF 3 H H F H H OCF 2 CHFCF 3 F H F H CH 3 OCF 2 CHFCF 3 F H F H C 2 H 5 OCF 2 CHFCF 3 F H F H nC 3 H 7 OCF 2 CHFCF 3 F H F H nC 4 H 9 OCF 2 CHFCF 3 F H F H nc 5 H 11 OCF 2 CHFCF 3 F H F H nc 6 H 13 OCF 2 CHFCF 3 F H F H H OCF 2 CHFCF 3 F F F H CH 3 OCF 2 CHFCF 3 F F F H C 2 H 5 OCF 2 CHFCF 3 F F F H nC 3 H 7 OCF 2 CHFCF 3 F F F H nC 4 H 9 OCF 2 CHFCF 3 F F F H nc 5 H 11 OCF 2 CHFCF 3 F F F H nc 6 H 13 OCF 2 CHFCF 3 F F F H H NCS H H F H CH 3 NCS H H F H C 2 H 5 NCS H H F H nC 3 H 7 NCS H H F H nC 4 H 9 NCS H H F H nc 5 H 11 NCS H H F H nc 6 H 13 NCS H H F H H NCS F H F H CH 3 NCS F H F H C 2 H 5 NCS F H F H nC 3 H 7 NCS F H F H nC 4 H 9 NCS F H F H nc 5 H 11 NCS F H F H nc 6 H 13 NCS F H F H H NCS F F F H CH 3 NCS F F F H C 2 H 5 NCS F F F H nC 3 H 7 NCS F F F H nC 4 H 9 NCS F F F H nc 5 H 11 NCS F F F H nc 6 H 13 NCS F F F H H C 2 F 5 H H F H CH 3 C 2 F 5 H H F H C 2 H 5 C 2 F 5 H H F H nC 3 H 7 C 2 F 5 H H F H nC 4 H 9 C 2 F 5 H H F H nc 5 H 11 C 2 F 5 H H F H nc 6 H 13 C 2 F 5 H H F H H C 2 F 5 F H F H CH 3 C 2 F 5 F H F H C 2 H 5 C 2 F 5 F H F H nC 3 H 7 C 2 F 5 F H F H nC 4 H 9 C 2 F 5 F H F H nc 5 H 11 C 2 F 5 F H F H nc 6 H 13 C 2 F 5 F H F H H C 2 F 5 F F F H CH 3 C 2 F 5 F F F H C 2 H 5 C 2 F 5 F F F H nC 3 H 7 C 2 F 5 F F F H nC 4 H 9 C 2 F 5 F F F H nc 5 H 11 C 2 F 5 F F F H nC 6 H, 3 C 2 F 5 F F F H H C 3 F 7 H H F H CH 3 C 3 F 7 H H F H C 2 H 5 C 3 F 7 H H F H nC 3 H 7 C 3 F 7 H H F H nC 4 H 9 C 3 F 7 H H F H nc 5 H 11 C 3 F 7 H H F H nc 6 H 13 C 3 F 7 H H F H H C 3 F 7 F H F H CH 3 C 3 F 7 F H F H C 2 H 5 C 3 F 7 F H F H nC 3 H 7 C 3 F 7 F H F H nC 4 H 9 C 3 F 7 F H F H nc 5 H 11 C 3 F 7 F H F H nc 6 H 13 C 3 F 7 F H F H H C 3 F 7 F F F H CH 3 C 3 F 7 F F F H C 2 H 5 C 3 F 7 F F F H nC 3 H 7 C 3 F 7 F F F H nC 4 H 9 C 3 F 7 F F F H nc 5 H 11 C 3 F 7 F F F H nc 6 H 13 C 3 H 7 F F F H H SF 5 H H F H CH 3 SF 5 H H F H C 2 H 5 SF 5 H H F H nC 3 H 7 SF 5 H H F H nC 4 H 9 SF 5 H H F H nc 5 H 11 SF 5 H H F H nc 6 H 13 SF 5 H H F H H SF 5 F H F H CH 3 SF 5 F H F H C 2 H 5 SF 5 F H F H nC 3 H 7 SF 5 F H F H nC 4 H 9 SF 5 F H F H nc 5 H 11 SF 5 F H F H nc 6 H 13 SF 5 F H F H H SF 5 F F F H CH 3 SF 5 F F F H C 2 H 5 SF 5 F F F H nC 3 H 7 SF 5 F F F H nC 4 H 9 SF 5 F F F H nc 5 H 11 SF 5 F F F H nc 6 H 13 SF 5 F F F H H CN H H F H CH 3 CN H H F H C 2 H 5 CN H H F H nC 3 H 7 CN H H F H nC 4 H 9 CN H H F H nc 5 H 11 CN H H F H nc 6 H 13 CN H H F H H CN F H F H CH 3 CN F H F H C 2 H 5 CN F H F H nC 3 H 7 CN F H F H nC 4 H 9 CN F H F H nc 5 H 11 CN F H F H nc 6 H 13 CN F H F H H CN F F F H CH 3 CN F F F H C 2 H 5 CN F F F H nC 3 H 7 CN F F F H nC 4 H 9 CN F F F H nc 5 H 11 CN F F F H nc 6 H 13 CN F F F H H F H H F F CH 3 F H H F F C 2 H 5 F H H F F nC 4 H 9 F H H F F nc 5 H 11 F H H F F nc 6 H 13 F H H F F H F F H F F CH 3 F F H F F C 2 H 5 F F H F F nC 3 H 7 F F H F F nC 4 H 9 F F H F F nc 5 H 11 F F H F F nc 6 H 13 F F H F F H F F F F F CH 3 F F F F F C 2 H 5 F F F F F C 2 H 5 F F F F F nC 3 H 7 F F F F F K 144 N 181.4 I; Δε = 42.1; Δn = 0.1510 nC 4 H 9 F F F F F nc 5 H 11 F F F F F nc 6 H 13 F F F F F H Cl H H F F CH 3 Cl H H F F C 2 H 5 Cl H H F F nC 3 H 7 Cl H H F F nC 4 H 9 Cl H H F F nc 5 H 11 Cl H H F F nc 6 H 13 Cl H H F F H Cl F H F F CH 3 Cl F H F F C 2 H 5 Cl F H F F nC 3 H 7 Cl F H F F nC 4 H 9 Cl F H F F nc 5 H 11 Cl F H F F nc 6 H 13 Cl F H F F H Cl F F F F CH 3 Cl F F F F C 2 H 5 Cl F F F F nC 3 H 7 Cl F F F F nC 4 H 9 Cl F F F F nc 5 H 11 Cl F F F F nc 6 H 13 Cl F F F F H OCF 3 H H F F CH 3 OCF 3 H H F F C 2 H 5 OCF 3 H H F F nC 3 H 7 OCF 3 H H F F nC 4 H 9 OCF 3 H H F -F nc 5 H 11 OCF 3 H H F F nc 6 H 13 OCF 3 H H F F H OCF 3 F H F F CH 3 OCF 3 F H F F C 2 H 5 OCF 3 F H F F nC 3 H 7 OCF 3 F H F F K 121 N 205.2 I; Δε = 37.7; Δn = 0.1634 nC 4 H 9 OCF 3 F H F F nc 5 H 11 OCF 3 F H F F nc 6 H 13 OCF 3 F H F F H OCF 3 F F F F CH 3 OCF 3 F F F F C 2 H 5 OCF 3 F F F F nC 3 H 7 OCF 3 F F F F K 128 N 201.2 I; Δε = 43.8; Δn = 0.1411 nC 4 H 9 OCF 3 F F F F nc 5 H 11 OCF 3 F F F F nc 6 H 13 OCF 3 F F F F H OCHF 2 H H F F CH 3 OCHF 2 H H F F C 2 H 5 OCHF 2 H H F F nC 3 H 7 OCHF 2 H H F F nC 4 H 9 OCHF 2 H H F F nc 5 H 11 OCHF 2 H H F F nc 6 H 13 OCHF 2 H H F F H OCHF 2 F H F F CH 3 OCHF 2 F H F F C 2 H 5 OCHF 2 F H F F nC 3 H 7 OCHF 2 F H F F nC 4 H 9 OCHF 2 F H F F nc 5 H 11 OCHF 2 F H F F nc 6 H 13 OCHF 2 F H F F H OCHF 2 F F F F CH 3 OCHF 2 F F F F C 2 H 5 OCHF 2 F F F F nC 3 H 7 OCHF 2 F F F F nC 4 H 9 OCHF 2 F F F F nc 5 H 11 OCHF 2 F F F F nc 6 H 13 OCHF 2 F F F F H OCHFCF 3 H H F F CH 3 OCHFCF 3 H H F F C 2 H 5 OCHFCF 3 H H F F nC 3 H 7 OCHFCF 3 H H F F nC 4 H 9 OCHFCF 3 H H F F nc 5 H 11 OCHFCF 3 H H F F nc 6 H 13 OCHFCF 3 H H F F H OCHFCF 3 F H F F CH 3 OCHFCF 3 F H F F C 2 H 5 OCHFCF 3 F H F F nC 3 H 7 OCHFCF 3 F H F F nC 4 H 9 OCHFCF 3 F H F F nc 5 H 11 OCHFCF 3 F H F F nc 6 H 13 OCHFCF 3 F H F F H OCHFCF 3 F F F F CH 3 OCHFCF 3 F F F F C 2 H 5 OCHFCF 3 F F F F nC 3 H 7 OCHFCF 3 F F F F nC 4 H 9 OCHFCF 3 F F F F nc 5 H 11 OCHFCF 3 F F F F nc 6 H 13 OCHFCF 3 F F F F H OCHFCF 3 H H F F CH 3 OCHFCF 3 H H F F C 2 H 5 OCHFCF 3 H H F F nC 3 H 7 OCHFCF 3 H H F F nC 4 H 9 OCHFCF 3 H H F F nc 5 H 11 OCHFCF 3 H H F F nc 6 H 13 OCHFCF 3 H H F F H OCHFCF 3 F H F F CH 3 OCHFCF 3 F H F F C 2 H 5 OCHFCF 3 F H F F nC 3 H 7 OCHFCF 3 F H F F nC 4 H 9 OCHFCF 3 F H F F nc 5 H 11 OCHFCF 3 F H F F nc 6 H 13 OCHFCF 3 F H F F H OCHFCF 3 F F F F CH 3 OCHFCF 3 F F F F C 2 H 5 OCHFCF 3 F F F F nC 3 H 7 OCHFCF 3 F F F F nC 4 H 9 OCHFCF 3 F F F F nc 5 H 11 OCHFCF 3 F F F F nc 6 H 13 OCHFCF 3 F F F F H OCF 2 CHFCF 3 H H F F CH 3 OCF 2 CHFCF 3 H H F F C 2 H 5 OCF 2 CHFCF 3 H H F F nC 3 H 7 OCF 2 CHFCF 3 H H F F nC 4 H 9 OCF 2 CHFCF 3 H H F F nc 5 H 11 OCF 2 CHFCF 3 H H F F nc 6 H 13 OCF 2 CHFCF 3 H H F F H OCF 2 CHFCF 3 F H F F CH 3 OCF 2 CHFCF 3 F H F F C 2 H 5 OCF 2 CHFCF 3 F H F F nC 3 H 7 OCF 2 CHFCF 3 F H F F nC 4 H 9 OCF 2 CHFCF 3 F H F F nc 5 H 11 OCF 2 CHFCF 3 F H F F nc 6 H 13 OCF 2 CHFCF 3 F H F F H OCF 2 CHFCF 3 F F F F CH 3 OCF 2 CHFCF 3 F F F F C 2 H 5 OCF 2 CHFCF 3 F F F F nC 3 H 7 OCF 2 CHFCF 3 F F F F nC 4 H 9 OCF 2 CHFCF 3 F F F F nc 5 H 11 OCF 2 CHFCF 3 F F F F nc 6 H 13 OCF 2 CHFCF 3 F F F F H NCS H H F F CH 3 NCS H H F F C 2 H 5 NCS H H F F nC 3 H 7 NCS H H F F nC 4 H 9 NCS H H F F nc 5 H 11 NCS H H F F nc 6 H 13 NCS H H F F H NCS F H F F CH 3 NCS F H F F C 2 H 5 NCS F H F F nC 3 H 7 NCS F H F F nC 4 H 9 NCS F H F F nc 5 H 11 NCS F H F F nc 6 H 13 NCS F H F F H NCS F F F F CH 3 NCS F F F F C 2 H 5 NCS F F F F nC 3 H 7 NCS F F F F nC 4 H 9 NCS F F F F nc 5 H 11 NCS F F F F nc 6 H 13 NCS F F F F H C 2 F 5 H H F F CH 3 C 2 F 5 H H F F C 2 H 5 C 2 F 5 H H F F nC 3 H 7 C 2 F 5 H H F F nC 4 H 9 C 2 F 5 H H F F nc 5 H 11 C 2 F 5 H H F F nc 6 H 13 C 2 F 5 H H F F H C 2 F 5 F H F F CH 3 C 2 F s F H F F C 2 H 5 C 2 F 5 F H F F nC 3 H 7 C 2 F 5 F H F F nC 4 H 9 C 2 F 5 F H F F nc 5 H 11 C 2 F 5 F H F F nc 6 H 13 C 2 F 5 F H F F H C 2 F 5 F F F F CH 3 C 2 F 5 F F F F C 2 H 5 C 2 F 5 F F F F nC 3 H 7 C 2 F 5 F F F F nC 4 H 9 C 2 F 5 F F F F nc 5 H 11 C 2 F 5 F F F F nc 6 H 13 C 2 F 5 F F F F H C 3 F 7 H H F F CH 3 C 3 F 7 H H F F C 2 H 5 C 3 F 7 H H F F nC 3 H 7 C 3 F 7 H H F F nC 4 H 9 C 3 F 7 H H F F nc 5 H 11 C 3 F 7 H H F F nc 5 H 13 C 3 F 7 H H F F H C 3 F 7 F H F F CH 3 C 3 F 7 F H F F C 2 H 5 C 3 F 7 F H F F nC 3 H 7 C 3 F 7 F H F F nC 4 H 9 C 3 F 7 F H F F nc 5 H 11 C 3 F 7 F H F F nc 6 H 13 C 3 F 7 F H F F H C 3 F 7 F F F F CH 3 C 3 F 7 F F F F C 2 H 5 C 3 F 7 F F F F nC 3 H 7 C 3 F 7 F F F F nC 4 H 9 C 3 F 7 F F F F nc 5 H 11 C 3 F 7 F F F F nc 6 H 13 C 3 F 7 F F F F H SF 5 H H F F CH 3 SF 5 H H F F C 2 H 5 SF 5 H H F F nC 3 H 7 SF 5 H H F F nC 4 H 9 SF 5 H H F F nc 5 H 11 SF 5 H H F F nc 6 H 13 SF 5 H H F F H SF 5 F H F F CH 3 SF 5 F H F F C 2 H 5 SF 5 F H F F nC 3 H 7 SF 5 F H F F nC 4 H 9 SF 5 F H F F nc 5 H 11 SF 5 F H F F nc 6 H 13 SF 5 F H F F H SF 5 F F F F CH 3 SF 5 F F F F C 2 H 5 SF 5 F F F F nC 3 H 7 SF 5 F F F F nC 4 H 9 SF 5 F F F F nc 5 H 11 SF 5 F F F F nc 6 H 13 SF 5 F F F F H CN H HF F CH 3 CN H H F F C 2 H 5 CN H H F F nC 3 H 7 CN H H F F nC 4 H 9 CN H H F F nc 5 H 11 CN H H F F nc 6 H 13 CN H H F F H CN F H F F CH 3 CN F H F F C 2 H 5 CN F H F F nC 3 H 7 CN F H F F nC 4 H 9 CN F H F F nc 5 H 11 CN F H F F nc 6 H 13 CN F H F F H CN F F F F CH 3 CN F F F F C 2 H 5 CN F F F F nC 3 H 7 CN F F F F nC 4 H 9 CN F F F F nc 5 H 11 CN F F F F nc 6 H 13 CN F F F F H CF 3 H H F F C 2 H 5 CF 3 H H F F nC 3 H 7 CF 3 H H F F nC 4 H 9 CF 3 H H F F nc 5 H 11 CF 3 H H F F nc 6 H 13 CF 3 H H F F CH 2 = CH CF 3 H H F F H CF 3 F F F F C 2 H 5 CF 3 F F F F nC 3 H 7 CF 3 F F F F nC 4 H 9 CF 3 F F F F nc 5 H 11 CF 3 F F F F nc 6 H 13 CF 3 F F F F CH 2 = CH CF 3 F F F F H F H H F F C 2 H 5 F H H F F nC 3 H 7 F H H F F nC 4 H 9 F H H F F nc 5 H 11 F H H F F nc 6 H 13 F H H F F CH 2 = CH F H H F F

Beispiel 6Example 6

Enantiomerentrennung von

Figure imgb0287
Enantiomer separation of
Figure imgb0287

8,7 g T werden zur Enantiomerentrennung über eine präparative Enantio-HPLC-Säule gegeben. Nach Erhalt der beiden Fraktionen wird jeweils aus Ethanol umkristallisiert und der Drehwert bestimmt.
3,18 g Enantio-HPLC: 99,68 % - Drehwert: +29,0°
3,74 g Enantio-HPLC: 98,25 % - Drehwert: -28,0°
8.7 g of T are added for enantiomer separation via a preparative Enantio HPLC column. After obtaining the two fractions is recrystallized in each case from ethanol and determines the rotation value.
3.18 g Enantio-HPLC: 99.68% - rotation value: + 29.0 °
3.74 g Enantio-HPLC: 98.25% - rotation value: -28.0 °

Analog werden die folgenden Racemate in die Enantiomere getrennt:

Figure imgb0288
Enantio-HPLC: 99,97 % - Drehwert: +32,0° Enantio-HPLC: 99,40 % - Drehwert: -32,1°
Figure imgb0289
Enantio-HPLC: 100,0 % - Drehwert: +4,5°
Enantio-HPLC: 99,9 % - Drehwert: -4,9 °
Figure imgb0290
Enantio-HPLC- 99,98 % - Drehwert: +28,5°
Enantio-HPLC: 100,00 % - Drehwert: -31,4° Analogously, the following racemates are separated into the enantiomers:
Figure imgb0288
Enantio-HPLC: 99.97% - rotation value: + 32.0 °
Enantio-HPLC: 99.40% - rotation: -32.1 °
Figure imgb0289
Enantio-HPLC: 100.0% - rotation value: + 4.5 °
Enantio-HPLC: 99.9% - rotation: -4.9 °
Figure imgb0290
Enantio-HPLC- 99.98% - rotation value: + 28.5 °
Enantio-HPLC: 100.00% - rotation: -31.4 °

MischungsbeispieleExamples mix Beispiel M1Example M1

CCH-5CF3 CCH-5CF 3 3,00 %3.00% Klärpunkt [°C]:Clearing point [° C]: +80,0+80.0 CCP-1F.F.FCCP 1F.F.F 3,00 %3.00% Δn [589 nm, 20°C]:Δn [589 nm, 20 ° C]: +0,0660+0.0660 CCP-2F.F.FCCP 2F.F.F 8,00 %8.00% Δε [kHz, 20°C]:Δε [kHz, 20 ° C]: +10,4+10.4 CCP-3F.F.FCCP 3F.F.F 8,00 %8.00% d · Δn [20 °C, µm]:d · Δn [20 ° C, μm]: 0,500.50 CCP-5F.F.FCCP 5F.F.F 5,00 %5.00% Verdrillung [°]:Twist [°]: 9090 CCP-20CF3.FCCP-20CF 3 .F 8,00 %8.00% V10[V]:V 10 [V]: 1,311.31 CCP-50CF3.FCCP-50CF 3 .F 8,00 %8.00% CCOC-3-3CCOC-3-3 2,00 %2.00% CCOC-4-3CCOC-4-3 2,00 %2.00% CCQU-2-FCCQU-2-F 10,00 %10.00% CCQU-3-FCCQU-3-F 12,00 %12.00% CCQU-5-FCCQU-5-F 8,00 %8.00% ACQU-3-FACQU-3-F 15,00 %15.00% CCH-301CCH 301 3,00 %3.00% CCH-501CCH 501 5,00 %5.00%

Beispiel M2Example M2

CCH-501CCH 501 7,00 %7.00% Klärpunkt [°C]:Clearing point [° C]: +88,5-+ 88,5- CCH-5CF3 CCH-5CF 3 7,00 %7.00% Δn [589 nm, 20°C]:Δn [589 nm, 20 ° C]: +0,0657+0.0657 CCP-2F.F.FCCP 2F.F.F 4,00 %4.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: +9,9+9.9 CCP-3F.F.FCCP 3F.F.F 7,00 %7.00% d · Δn [20 °C, µm]:d · Δn [20 ° C, μm]: 0,500.50 CCP-5F.F.FCCP 5F.F.F 5,00 %5.00% Verdrillung [°]:Twist [°]: 9090 CCP-30CF3.FCCP-30CF 3 .F 8,00 %8.00% V10[V]:V 10 [V]: 1,451.45 CCP-50CF3.FCCP-50CF 3 .F 8,00 %8.00% CCOC-3-3CCOC-3-3 3,00 %3.00% CCOC-3-5CCOC-3-5 2,00 %2.00% CCOC-4-3CCOC-4-3 4,00 %4.00% CCQU-2-FCCQU-2-F 10,00%10.00% CCQU-3-FCCQU-3-F 12,00 %12.00% CCQU-5-FCCQU-5-F 8,00 %8.00% ACQU-3-FACQU-3-F 15,00 %15.00%

Beispiel M3Example M3

CCH-301CCH 301 7,00 %7.00% Klärpunkt [°C]:Clearing point [° C]: +81,0+81.0 CCH-501CCH 501 10,00 %10.00% Δn [589 nm, 20°C]:Δn [589 nm, 20 ° C]: +0,0608+0.0608 CCH-5CF3 CCH-5CF 3 2,00 %2.00% Δε [kHz, 20°C]:Δε [kHz, 20 ° C]: +8,4+8.4 CCP-2F.F.FCCP 2F.F.F 9,00 %9.00% d · Δn [20°C, µm]:d · Δn [20 ° C, μm]: 0,500.50 CCP-3F.F.FCCP 3F.F.F 4,00 %4.00% Verdrillung [°]:Twist [°]: 9090 CCP-5F.F.FCCP 5F.F.F 4,00 %4.00% V10[V]:V 10 [V]: 1,491.49 CCP-30CF3.FCCP-30CF 3 .F 2,00 %2.00% CCP-50CF3.FCCP-50CF 3 .F 4,00 %4.00% CCOC-3-3CCOC-3-3 3,00 %3.00% CCOC-3-5CCOC-3-5 2,00 %2.00% CCOC-4-3CCOC-4-3 4,00 %4.00% ACQU-3-FACQU-3-F 15,00 %15.00% CCQU-2-FCCQU-2-F 10,00 %10.00% CCQU-3-FCCQU-3-F 12,00 %12.00% CCQU-5-FCCQU-5-F 8,00 %8.00% CCH-35CCH-35 4,00 %4.00%

Beispiel M4Example M4

CCP-1 F.F.FCCP-1 F.F.F 4,00 %4.00% Klärpunkt [°C]:Clearing point [° C]: +79,0+79.0 CCP-2F.F.FCCP 2F.F.F 10,00 %10.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: +0,0808+0.0808 CCP-3F.F.FCCP 3F.F.F 9,00 %9.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: +15,5+15.5 CCP-5F.F.FCCP 5F.F.F 5,00 %5.00% d · Δn [20 °C, µm]:d · Δn [20 ° C, μm]: 0,500.50 CCP-30CF3.FCCP-30CF 3 .F 5,00 %5.00% Verdrillung [°]:Twist [°]: 9090 CCP-50CF3.FCCP-50CF 3 .F 7,00 %7.00% γ1 [20 °C, mPa·s]:γ 1 [20 ° C, mPa.s]: 150150 PUQU-2-FPUQU-2-F 5,00 %5.00% V10[V]:V 10 [V]: 0,980.98 PUQU-3-FPUQU-3-F 5,00 %5.00% CCQU-2-FCCQU-2-F 11,00 %.11.00%. CCQU-3-FCCQU-3-F 12,00 %12.00% CCQU-5-FCCQU-5-F 8,00 %8.00% CCGU-3-FCCGU-3-F 4,00 %4.00% ACQU-3-FACQU-3-F 15,00 %15.00%

Beispiel M5Example M5

BCH-3F.FBCH 3F.F 10,80 %10.80% Klärpunkt [°C]:Clearing point [° C]: +89,0+89.0 BCH-5F.FBCH 5F.F 9,00 %9.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: +0,0930+0.0930 ECCP-30CF3 ECCP-30CF 3 4,50 %4.50% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: +6,2+6.2 ECCP-50CF3 ECCP-50CF 3 4,50 %4.50% CBC-33FCBC 33F 1,80 %1.80% CBC-53FCBC-53F 1,80 %1.80% CBC-55FCBC-55F 1,80 %1.80% PCH-6FPCH-6F 7,20 %7.20% PCH-7FPCH-7F 5,40 %5.40% CCP-20CF3 CCP-20CF 3 7,20 %7.20% CCP-30CF3 CCP-30CF 3 10,80 %10.80% CCP-40CF3 CCP-40CF 3 6,30 %6.30% CCP-50CF3 CCP-50CF 3 9,90 %9.90% PCH-5FPCH-5F 9,00 %9.00% ACQU-3-FACQU-3-F 10,00 %10.00%

Beispiel M6Example M6

CCH-35CCH-35 3,00 %3.00% Klärpunkt [°C]:Clearing point [° C]: +81,0+81.0 CC-3-V1CC-3-V1 4,00 %4.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: +0,0912+0.0912 CCP-1 F.F.FCCP-1 F.F.F 10,00 %10.00% d · Δn [20 °C, µm]:d · Δn [20 ° C, μm]: 0,500.50 CCP-2F.F.FCCP 2F.F.F 9,00%9.00% Verdrillung [°]:Twist [°]: 9090 CCP-3F.F.FCCP 3F.F.F 9,00 %9.00% γ1[20 °C, mPa·s]:γ 1 [20 ° C, mPa.s]: 129129 CCP-20CF3.FCCP-20CF 3 .F 6,00 %6.00% V10 [V]:V 10 [V]: 1,301.30 CCG-V-FCCG V F 9,00 %9.00% CCP-20CF3 CCP-20CF 3 8,00 %8.00% CCP-30CF3 CCP-30CF 3 8,00 %8.00% CCP-40CF3 CCP-40CF 3 6,00 %6.00% CCP-50CF3 CCP-50CF 3 7,00 %7.00% PUQU-2-FPUQU-2-F 5,00 %5.00% PUQU-3-FPUQU-3-F 7,00 %7.00% APUQU-2-FAPUQU-2-F 4,50 %4.50% CGUQU-3-FCGUQU-3-F 3,50 %3.50% CBC-33CBC 33 1,00 %1.00%

Beispiel M7Example M7

CCP-2F.F.FCCP 2F.F.F 11,00 %11.00% Klärpunkt [°C]:Clearing point [° C]: +80,0+80.0 CCP-20CF3 CCP-20CF 3 7,00 %7.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: +0,1034+0.1034 CCP-30CF3 CCP-30CF 3 8,00 %8.00% d · Δn [20 °C, µm]:d · Δn [20 ° C, μm]: 0,500.50 CCP-40CF3 CCP-40CF 3 5,00 %5.00% Verdrillung [°]:Twist [°]: 9090 PGU-2-FPGU-2-F 8,00 %8.00% V10 [V]:V 10 [V]: 1,221.22 PGU-3-FPGU-3-F 7,00 %7.00% CC-3-V1CC-3-V1 10,00 %10.00% CCH-35CCH-35 3,00 %3.00% CCP-V-1CCP-V-1 5,00 %5.00% CCP-20CF3.FCCP-20CF 3 .F 8,00 %8.00% CCP-30CF3.FCCP-30CF 3 .F 11,00 %11.00% PUQU-2-FPUQU-2-F 4,00 %4.00% PUQU-3-FPUQU-3-F 6,00 %6.00% ACQU-3-FACQU-3-F 7,00 %7.00%

Beispiel M8Example M8

CCP-1 F.F.FCCP-1 F.F.F 6,00 %6.00% S→N [°C]:S → N [° C]: -40,0-40,0 CCP-2F.F.FCCP 2F.F.F 10,00 %10.00% Klärpunkt [°C]:Clearing point [° C]: +80,0+80.0 CCP-20CF3 CCP-20CF 3 8,00 %8.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: +0,1029+0.1029 CCP-30CF3 CCP-30CF 3 8,00 %8.00% d · Δn [20 °C, µm]:d · Δn [20 ° C, μm]: 0,500.50 CCP-40CF3 CCP-40CF 3 6,00 %6.00% Verdrillung [°]:Twist [°]: 9090 CCP-50CF3 CCP-50CF 3 8,00 %8.00% V10 [V]:V 10 [V]: 1,241.24 PGU-2-FPGU-2-F 8,00%8.00% PGU-3-FPGU-3-F 7,00 %7.00% CC-3-V1CC-3-V1 8,00 %8.00% CCH-35CCH-35 5,00 %5.00% CCP-V-1CCP-V-1 5,00 %5.00% CCP-30CF3.FCCP-30CF 3 .F 3,00 %3.00% PUQU-2-FPUQU-2-F 4,00 %4.00% PUQU-3-FPUQU-3-F 6,00 %6.00% ACQU-3-FACQU-3-F 8,00%8.00%

Beispiel M9Example M9

CC-3-V1CC-3-V1 5,00 %5.00% S → N [°C]:S → N [° C]: -30,0-30.0 CCP-1 F.F.FCCP-1 F.F.F 5,00 %5.00% Klärpunkt [°C]:Clearing point [° C]: +85,5+85.5 CCP-2F.F.FCCP 2F.F.F 8,00 %8.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: +0,0931+0.0931 CCP-20CF3.FCCP-20CF 3 .F 8,00 %8.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 12,112.1 CCP-20CF3 CCP-20CF 3 5,00 %5.00% γ1 [20 °C, mPa.s]:γ 1 [20 ° C, mPa.s]: 135135 CCP-30CF3 CCP-30CF 3 8,00 %8.00% d · Δn [20 °C, µm]:d · Δn [20 ° C, μm]: 0,500.50 CCP-40CF3 CCP-40CF 3 6,00 %6.00% Verdrillung [°]:Twist [°]: 9090 CCP-50CF3 CCP-50CF 3 8,00 %8.00% V10 [V]:V 10 [V]: 1,231.23 PUQU-2-FPUQU-2-F 5,00 %5.00% PUQU-3-FPUQU-3-F 7,00 %7.00% PGU-2-FPGU-2-F 5,00 %5.00% CCP-V-1CCP-V-1 10,00 %10.00% ACQU-3-FACQU-3-F 12,00 %12.00% ACQU-4-FACQU-4-F 8,00 %8.00%

Beispiel M10Example M10

CC-3-V1CC-3-V1 6,00 %6.00% S→ N [°C]:S → N [° C]: -40,0-40,0 CCP-1 F.F.FCCP-1 F.F.F 6,00 %6.00% Klärpunkt [°C]:Clearing point [° C]: +83,5+83.5 CCP-2F.F.FCCP 2F.F.F 7,00 %7.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: +0,0917+0.0917 CCP-20CF3.FCCP-20CF 3 .F 10,00 %10.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 11,711.7 CCP-20CF3 CCP-20CF 3 8,00 %8.00% γ1 [20°C, mPa·s]:γ 1 [20 ° C, mPa.s]: 125125 CCP-30CF3 CCP-30CF 3 8,00 %8.00% d · Δn [20 °C, µm]:d · Δn [20 ° C, μm]: 0,500.50 CCP-40CF3 CCP-40CF 3 6,00 %6.00% Verdrillung [°]:Twist [°]: 9090 CCP-50CF3 CCP-50CF 3 4,00 %4.00% V10 [V]:V 10 [V]: 1,251.25 PUQU-2-FPUQU-2-F 5,00 %5.00% PUQU-3-FPUQU-3-F 8,00 %8.00% PGU-2-FPGU-2-F 4,00 %4.00% CCP-V-1CCP-V-1 10,00 %10.00% ACQU-3-FACQU-3-F 10,00 %10.00% ACQU-4-FACQU-4-F 8,00 %8.00%

Beispiel M11 (IPS)Example M11 (IPS)

CDU-2-FCDU-2-F 5,00 %5.00% Klärpunkt [°C]:Clearing point [° C]: +81+81 PGU-2-FPGU-2-F 2,50 %2.50% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: +0,0850+0.0850 CCZU-2-FCCZU-2-F 4,00 %4.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 10,110.1 CCZU-3-FCCZU-3-F 11,00 %11.00% γ1 [20 °C, mPa·s]:γ 1 [20 ° C, mPa.s]: 9898 CCP-V-1CCP-V-1 15,00 %15.00% CCQU-3-FCCQU-3-F 10,00 %10.00% PUQU-2-FPUQU-2-F 4,00 %4.00% PUQU-3-FPUQU-3-F 5,00 %5.00% CC-3-V1CC-3-V1 11,00 %11.00% PCH-302PCH-302 3,50 %3.50% CC-5-VCC-5-V 11,00 %11.00% ACQU-3-FACQU-3-F 9,00 %9.00% ACQU-4-FACQU-4-F 9,00 %9.00%

Beispiel M12 (IPS)Example M12 (IPS)

PGU-2-FPGU-2-F 9,00 %9.00% Klärpunkt [°C]:Clearing point [° C]: 81,081.0 PGU-3-FPGU-3-F 2,00 %2.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: 0,1090.1090 CGZP-2-OTCGZP-2-OT 8,00 %8.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 11,011.0 CGZP-3-OTCGZP-3-OT 10,00 %10.00% γ1 [20°C, mPa·s]:γ 1 [20 ° C, mPa.s]: 100100 CCP-20CF3 CCP-20CF 3 6,00 %6.00% CCP-30CF3 CCP-30CF 3 6,50 %6.50% PUQU-2-FPUQU-2-F 4,00 %4.00% PUQU-3-FPUQU-3-F 3,50 %3.50% CCP-V-1CCP-V-1 9,00 %9.00% CC-3-V1CC-3-V1 11,00 %11.00% PCH-302PCH-302 15,00 %15.00% ACQU-3-FACQU-3-F 8,00 %8.00% ACQU-4-FACQU-4-F 8,00 %8.00%

Beispiel M13Example M13

CC-4-VCC-4-V 17,00 %17.00% Klärpunkt [°C]:Clearing point [° C]: 74,574.5 CC-3-V1CC-3-V1 3,00 %3.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: +0,0890+0.0890 CCQU-2-FCCQU-2-F 12,00 %12.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 12,712.7 CCQU-3-FCCQU-3-F 12,00 %12.00% γ1 [20 °C, mPa·s]:γ 1 [20 ° C, mPa.s]: 119119 CCQU-5-FCCQU-5-F 10,00 %10.00% V10 [V]:V 10 [V]: 1,091.09 CCP-20CF3 CCP-20CF 3 5,00 %5.00% PGU-2-FPGU-2-F 3,00 %3.00% PGU-3-FPGU-3-F 6,00 %6.00% AUUQGU-3-FAUUQGU-3-F 8,00 %8.00% CCP-1 F.F.FCCP-1 F.F.F 8,00 %8.00% CCP-3F.F.FCCP 3F.F.F 9,00 %9.00% BCH-3F.F.FBCH 3F.F.F 7,00 %7.00%

Beispiel M14Example M14

CC-3-V1CC-3-V1 6,00 %6.00% S →N [°C]:S → N [° C]: < -40,0<-40,0 CCP-1 F.F.FCCP-1 F.F.F 9,00 %9.00% Klärpunkt [°C]:Clearing point [° C]: 83,583.5 CCP-2F.F.FCCP 2F.F.F 9,00 %9.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: 0,09410.0941 CCP-3F.F.FCCP 3F.F.F 10,00 %10.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 11,411.4 CCQU-3-FCCQU-3-F 11,00 %11.00% γ1[20 °C, mPa·s]:γ 1 [20 ° C, mPa.s]: 137137 CCQU-5-FCCQU-5-F 9,00 %9.00% V10 [V]:V 10 [V]: 1,231.23 CCP-20CF3 CCP-20CF 3 6,00 %6.00% CCP-30CF3 CCP-30CF 3 8,00 %8.00% CCP-50CF3 CCP-50CF 3 2,00 %2.00% CGU-2-FCGU-2-F 4,00 %4.00% PGU-2-FPGU-2-F 6,00 %6.00% PGU-3-FPGU-3-F 6,00 %6.00% CCP-V-1CCP-V-1 7,00 %7.00% ACQU-3-FACQU-3-F 7,00 %7.00%

Beispiel M15Example M15

CC-3-V1CC-3-V1 5,00 %5.00% S → N [°C]:S → N [° C]: < -40,0<-40,0 CCP-1 F.F.FCCP-1 F.F.F 7,00 %7.00% Klärpunkt [°C]:Clearing point [° C]: 84,084.0 CCP-2F.F.FCCP 2F.F.F 10,00 %10.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: 0,0919.0919 ACQU-1-FACQU-1-F 8,00 %8.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 11,911.9 ACQU-3-FACQU-3-F 8,00 %8.00% γ1 [20 °C, mPa·s]:γ 1 [20 ° C, mPa.s]: 135135 CCG-V-FCCG V F 11,00 %11.00% V10[V]:V 10 [V]: 1,191.19 BCH-3F.FBCH 3F.F 2,50 %2.50% CCP-20CF3 CCP-20CF 3 8,00 %8.00% CCP-30CF3 CCP-30CF 3 8,00 %8.00% CCP-40CF3 CCP-40CF 3 5,00 %5.00% CCP-V-1CCP-V-1 8,00 %8.00% PUQU-2-FPUQU-2-F 5,50 %5.50% PUQU-3-FPUQU-3-F 8,00 %8.00% CCGU-3-FCCGU-3-F 6,00 %6.00%

Beispiel M16Example M16

CC-3-V1CC-3-V1 5,00 %5.00% CCP-1 F.F.FCCP-1 F.F.F 7,00 %7.00% CCP-2F.F.FCCP 2F.F.F 6,00 %6.00% CCQU-3-FCCQU-3-F 10,00%10.00% CCG-V-FCCG V F 6,00 %6.00% CCP-20CF3 CCP-20CF 3 8,00 %8.00% CCP-30CF3 CCP-30CF 3 8,00 %8.00% CCP-40CF3 CCP-40CF 3 6,00 %6.00% CCP-50CF3 CCP-50CF 3 8,00 %8.00% ACQU-2-FACQU-2-F 6,00 %6.00% ACQU-3-FACQU-3-F 6,00 %6.00% PUQU-2-FPUQU-2-F 5,00 %5.00% PUQU-3-FPUQU-3-F 7,00 %7.00% PGU-3-FPGU-3-F 6,00 %6.00% CCP-V-1CCP-V-1 6,00 %6.00%

Beispiel M17Example M17

CCP-20CF3 CCP-20CF 3 8,00 %8.00% S → N [°C]:S → N [° C]: < -30,0<-30,0 CCP-30CF3 CCP-30CF 3 8,00 %8.00% Klärpunkt [°C]:Clearing point [° C]: 75,075.0 CCP-40CF3 CCP-40CF 3 5,00 %5.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: 0,0858.0858 PGU-2-FPGU-2-F 5,00 %5.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 13,313.3 PGU-3-FPGU-3-F 5,00 %5.00% γ1 [20 °C, mPa-s]:γ 1 [20 ° C, mPa-s]: 152152 CCP-1 F.F.FCCP-1 F.F.F 10,00 %10.00% V10 [V]:V 10 [V]: 1,071.07 CCP-2F.F.FCCP 2F.F.F 11,00 %11.00% CCP-3F.F.FCCP 3F.F.F 12,00 %12.00% CCZU-2-FCCZU-2-F 3,00 %3.00% CCZU-3-FCCZU-3-F 13,00 %13.00% ACQU-2-FACQU-2-F 8,00 %8.00% ACQU-3-FACQU-3-F 8,00 %8.00% ACQU-5-FACQU-5-F 4,00 %4.00%

Beispiel M18Example M18

CC-4-VCC-4-V 11,00 %11.00% S→ N [°C]:S → N [° C]: < -40,0<-40,0 CDU-2-FCDU-2-F 7,00 %7.00% Klärpunkt [°C]:Clearing point [° C]: 76,576.5 CDU-3-FCDU-3-F 8,00 %8.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: 0,0870.0870 CDU-5-FCDU-5-F 9,00 %9.00% Δε [kHz, 20°C]:Δε [kHz, 20 ° C]: 13,613.6 CCP-1F.F.FCCP 1F.F.F 8,50 %8.50% γ1 [20 °C, mPa·s]:γ 1 [20 ° C, mPa.s]: 146146 CCP-20CF3 CCP-20CF 3 8,00 %8.00% V10 [V]:V 10 [V]: 1,091.09 CCP-30CF3 CCP-30CF 3 6,50 %6.50% PGU-2-FPGU-2-F 3,00 %3.00% PGU-3-FPGU-3-F 6,00 %6.00% CCGU-3-FCCGU-3-F 6,00 %6.00% CBC-33CBC 33 3,00%3.00% ACQU-2-FACQU-2-F 8,00%8.00% ACQU-3-FACQU-3-F 8,00%8.00% ACQU-5-FACQU-5-F 8,00%8.00%

Beispiel M19Example M19

CC-4-VCC-4-V 10,00 %10.00% S → N [°C]:S → N [° C]: < -40,0<-40,0 CCP-1 F.F.FCCP-1 F.F.F 9,00 %9.00% Klärpunkt [°C]:Clearing point [° C]: 75,075.0 CCP-2F.F.FCCP 2F.F.F 9,00 %9.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: 0,0869.0869 CCP-30CF3.FCCP-30CF 3 .F 8,00 %8.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 13,113.1 CCP-20CF3 CCP-20CF 3 8,00 %8.00% γ1 [20 °C, mPa·s]:γ 1 [20 ° C, mPa.s]: 128128 CCP-30CF3 CCP-30CF 3 8,00 %8.00% V10[V]:V 10 [V]: 1,061.06 ACQU-2-FACQU-2-F 8,00 %8.00% ACQU-3-FACQU-3-F 8,00 %8.00% ACQU-4-FACQU-4-F 8,00 %8.00% PGU-2-FPGU-2-F 2,00 %2.00% PUQU-2-FPUQU-2-F 5,00%5.00% PUQU-3-FPUQU-3-F 8,00%8.00% CCGU-3-FCCGU-3-F 6,00 %6.00% CBC-33CBC 33 3,00 %3.00%

Beispiel M20Example M20

CC-4-VCC-4-V 18,00 %18.00% S→ N [°C]:S → N [° C]: < -40,0<-40,0 CC-3-V1CC-3-V1 3,00 %3.00% Klärpunkt [°C]:Clearing point [° C]: 75,075.0 CCQU-2-FCCQU-2-F 11,00 %11.00% Δn [589 nm, 20°C]:Δn [589 nm, 20 ° C]: 0,08910.0891 CCQU-3-FCCQU-3-F 12,00%12.00% Δε [kHz, 20°C]:Δε [kHz, 20 ° C]: 13,013.0 CCQU-5-FCCQU-5-F 8,00 %8.00% γ1 [20°C, mPa·s]:γ 1 [20 ° C, mPa.s]: 113113 CCP-20CF3 CCP-20CF 3 8,00 %8.00% V10 [V]:V 10 [V]: 1,081.08 PGU-2-FPGU-2-F 2,00 %2.00% PGU-3-FPGU-3-F 6,00 %6.00% APUQU-2-FAPUQU-2-F 8,00%8.00% APUQU-3-FAPUQU-3-F 9,00 %9.00% CCP-1F.F.FCCP 1F.F.F 7,00 %7.00% CCP-2F.F.FCCP 2F.F.F 7,00 %7.00% CCGU-3-FCCGU-3-F 1,00 %1.00%

Beispiel M21Example M21

CC-4-VCC-4-V 17,00 %17.00% S → N [°C]:S → N [° C]: < -40,0<-40,0 PUQU-2-FPUQU-2-F 5,00 %5.00% Klärpunkt [°C]:Clearing point [° C]: 75,575.5 PUQU-3-FPUQU-3-F 7,00 %7.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: 0,08940.0894 CCP-20CF3 CCP-20CF 3 6,00 %6.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 14,014.0 CCP-30CF3 CCP-30CF 3 5,00 %5.00% γ1 [20 °C, mPa·s]:γ 1 [20 ° C, mPa.s]: 120120 CCP-2F.F.FCCP 2F.F.F 5,00 %5.00% V10[V]:V 10 [V]: 1,061.06 CCZU-2-FCCZU-2-F 3,00 %3.00% CCZU-3-FCCZU-3-F 13,00 %13.00% PGU-3-FPGU-3-F 6,00 %6.00% ACQU-1-FACQU-1-F 8,00 %8.00% ACQU-3-FACQU-3-F 8,00 %8.00% ACQU-4-FACQU-4-F 8,00 %8.00% CCGU-3-FCCGU-3-F 6,00 %6.00% CBC-33CBC 33 3,00 %3.00%

Beispiel M22Example M22

CC-4-VCC-4-V 16,00 %16.00% S→ N[°C]:S → N [° C]: < -40,0<-40,0 CC-3-V1CC-3-V1 8,00 %8.00% Klärpunkt [°C]:Clearing point [° C]: 75,575.5 CCP-1 F.F.FCCP-1 F.F.F 5,00 %5.00% Δn [589 nm, 20°C]:Δn [589 nm, 20 ° C]: 0,09160.0916 CCP-2F.F.FCCP 2F.F.F 6,00 %6.00% Δε [kHz, 20°C]:Δε [kHz, 20 ° C]: 13,613.6 CCQU-2-FCCQU-2-F 10,00 %10.00% γ1 [20°C, mPa·s]:γ 1 [20 ° C, mPa.s]: 107107 CCQU-3-FCCQU-3-F 12,00 %12.00% V10 [V]:V 10 [V]: 1,081.08 CCP-20CF3 CCP-20CF 3 4,00 %4.00% CCZU-3-FCCZU-3-F 13,00 %13.00% PGU-2-FPGU-2-F 5,00 %5.00% PGU-3-FPGU-3-F 5,00 %5.00% APUQU-2-FAPUQU-2-F 8,00 %8.00% APUQU-3-FAPUQU-3-F 8,00 %8.00%

Beispiel M23Example M23

CCP-1 F.F.FCCP-1 F.F.F 6,00 %6.00% Klärpunkt [°C]:Clearing point [° C]: 78,278.2 CCP-2F.F.FCCP 2F.F.F 9,00 %9.00% Δn [589 nm, 20°C]:Δn [589 nm, 20 ° C]: 0,07910.0791 CCP-3F.F.FCCP 3F.F.F 6,00 %6.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 14,314.3 CCP-5F.F.FCCP 5F.F.F 4.00 %4.00% CCP-20CF3.FCCP-20CF 3 .F 5,00 %5.00% CCP-30CF3.FCCP-30CF 3 .F 5,00 %5.00% CCP-50CF3.FCCP-50CF 3 .F 7,00 %7.00% CDU-2-FCDU-2-F 7,00 %7.00% CDU-3-FCDU-3-F 10,00 %10.00% CDU-5-FCDU-5-F 10,00 %10.00% CGU-3-FCGU-3-F 4,00 %4.00% CCGU-3-FCCGU-3-F 9,00 %9.00% ACQU-3-FACQU-3-F 18,00 %18.00%

Beispiel M24Example M24

CCQU-2-FCCQU-2-F 13,00 %13.00% Klärpunkt [°C]:Clearing point [° C]: 84,584.5 CCQU-3-FCCQU-3-F 14,00 %14.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: 0,07790.0779 CCQU-5-FCCQU-5-F 13,00 %13.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 18,718.7 ACQU-5-FACQU-5-F 33,00 %33.00% γ1 [20 °C, mPa·s]:γ 1 [20 ° C, mPa.s]: 182182 APUQU-2-FAPUQU-2-F 7,00 %7.00% V10[M]:V 10 [M]: 0,950.95 APUQU-3-FAPUQU-3-F 9,00 %9.00% CC-4-VCC-4-V 11,00 %11.00%

Beispiel M25Example M25

CC-4-VCC-4-V 18,00 %18.00% Klärpunkt [°C]:Clearing point [° C]: 74,574.5 CC-3-V1CC-3-V1 5,00 %5.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: 0,0882.0882 CCP-2F.F.FCCP- 2 FFF 8,00 %8.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 12,912.9 CCQU-2-FCCQU-2-F 9,00 %9.00% γ1 [20 °C, mPa.s]:γ 1 [20 ° C, mPa.s]: 103103 CCQU-3-FCCQU-3-F 11,00 %11.00% V10 [V]:V 10 [V]: 1,091.09 CCQU-5-FCCQU-5-F 11,00 %11.00% CCQG-3-FCCQG-3-F 6,00 %6.00% BCH-3F.F.FBCH 3F.F.F 8,00 %8.00% APUQU-2-FAPUQU-2-F 6,00 %6.00% APUQU-3-FAPUQU-3-F 6,00 %6.00% PUQU-2-FPUQU-2-F 3,00 %3.00% PUQU-3-FPUQU-3-F 6,00 %6.00% CCGU-3-FCCGU-3-F 1,50 %1.50% PGP-2-3PGP-2-3 1,50 %1.50%

Beispiel M26 (IPS) Example M26 (IPS)

CCP-20CF3 CCP-20CF 3 7,00 %7.00% Klärpunkt [°C]:Clearing point [° C]: 80,080.0 CCP-30CF3 CCP-30CF 3 7,00 %7.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: 0,1102.1102 CCP-40CF3 CCP-40CF 3 7,00 %7.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 11,111.1 CCP-50CF3 CCP-50CF 3 3,50 %3.50% γ1 [20 °C, mPa·s]:γ 1 [20 ° C, mPa.s]: 8282 CCZU-3-FCCZU-3-F 5,00 %5.00% V10[V]: 1,13V 10 [V]: 1.13 PGU-2-FPGU-2-F 9,00 %9.00% PGU-3-FPGU-3-F 8,00 %8.00% PUQU-2-FPUQU-2-F 6,00 %6.00% PUQU-3-FPUQU-3-F 6,00 %6.00% CC-3-V1CC-3-V1 13,00 %13.00% CC-4-VCC-4-V 14,00 %14.00% CCP-V-1CCP-V-1 8,00 %8.00% APUQU-2-FAPUQU-2-F 6,50 %6.50%

Beispiel M27 (IPS) Example M27 (IPS)

CCP-20CF3 CCP-20CF 3 8,00 %8.00% Klärpunkt [°C]:Clearing point [° C]: 79,579.5 CCP-30CF3 CCP-30CF 3 8,00 %8.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: 0,1095.1095 CCP-40CF3 CCP-40CF 3 8,00 %8.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 11,411.4 CCZU-3-FCCZU-3-F 5,00 %5.00% γ1 [20 °C, mPa.s]:γ 1 [20 ° C, mPa.s]: 8787 PGU-2-FPGU-2-F 9,00 %9.00% V10[V]: 1,11V 10 [V]: 1.11 PGU-3-FPGU-3-F 8,50 %8.50% PUQU-2-FPUQU-2-F 6,00 %6.00% PUQU-3-FPUQU-3-F 5,00 %5.00% CC-3-V1CC-3-V1 12,50 %12.50% CC-4-VCC-4-V 14,00 %14.00% CCP-V-1CCP-V-1 9,00 %9.00% AGUQU-2-FAGUQU-2-F 3,50 %3.50% AGUQU-3-FAGUQU-3-F 3,50 %3.50%

Beispiel M28 (IPS) Example M28 (IPS)

CCP-2F.F.FCCP 2F.F.F 6,50 %6.50% Klärpunkt [°C]:Clearing point [° C]: 78,078.0 CCP-30CF3 CCP-30CF 3 6,00 %6.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: 0,0805.0805 CCZU-2-FCCZU-2-F 4,00 %4.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 14,814.8 CCZU-3-FCCZU-3-F 15,00 %15.00% γ1 [20°C, mPa·s]:γ 1 [20 ° C, mPa.s]: 121121 CDU-2-FCDU-2-F 9,00 %9.00% CDU-3-FCDU-3-F 4,00 %4.00% CCQU-3-FCCQU-3-F 13,00 %13.00% CCQU-5-FCCQU-5-F 10,00 %10.00% PUQU-2-FPUQU-2-F 5,00 %5.00% PUQU-3-FPUQU-3-F 5,00 %5.00% APUQU-2-FAPUQU-2-F 6,00 %6.00% CC-3-V1CC-3-V1 12,00 %12.00% CC-4-VCC-4-V 4;50 %4, 50%

Beispiel 28 (lPS) Example 28 (IPS)

CDU-2-FCDU-2-F 9,00 %9.00% Klärpunkt [°C]:Clearing point [° C]: 76,576.5 CDU-3-FCDU-3-F 8,00 %8.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: 0,09600.0960 PGU-2-FPGU-2-F 9,00 %9.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 12,712.7 CCZU-2-FCCZU-2-F 4,00 %4.00% γ1 [20°C, mPa·s]:γ 1 [20 ° C, mPa.s]: 9292 CCZU-3-FCCZU-3-F 11,00 %11.00% V10 [V]:V 10 [V]: 1,021.02 PUQU-2-FPUQU-2-F 4,00 %4.00% PUQU-3-FPUQU-3-F 6,00 %6.00% APUQU-2-FAPUQU-2-F 7,00 %7.00% CCP-V-1CCP-V-1 14,50 %14.50% CC-3-V1CC-3-V1 12,50 %12.50% CC-4-VCC-4-V 10,00 %10.00% CCH-35CCH-35 5,00 %5.00%

Beispiel M30 (IPS) Example M30 (IPS)

CCP-30CF3 CCP-30CF 3 3,50 %3.50% Klärpunkt [°C]:Clearing point [° C]: 75,575.5 CDU-2-FCDU-2-F 5,00 %5.00% Δn [589 nm, 20°C]: .Δn [589 nm, 20 ° C]:. 0,09750.0975 PGU-2-FPGU-2-F 6,50 %6.50% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 8,48.4 PUQU-2-FPUQU-2-F 8,00 %8.00% γ1 [20 °C, mPa·s]:γ 1 [20 ° C, mPa.s]: 6767 PUQU-3-FPUQU-3-F 8,00 %8.00% V10 [V]:V 10 [V]: 1,281.28 CCP-V-1CCP-V-1 13,00 %13.00% CCP-V2-1CCP-V2-1 9,50 %9.50% CC-3-V1CC-3-V1 13,00 %13.00% CC-5-VCC-5-V 9,00 %9.00% CC-4-VCC-4-V 14,00 %14.00% PCH-302PCH-302 3,50 %3.50% APUQU-2-FAPUQU-2-F 7,00 %7.00%

Beispiel M31 (IPS) Example M31 (IPS)

PGU-2-FPGU-2-F 6,50 %6.50% Klärpunkt [°C]:Clearing point [° C]: 74,074.0 CDU-2-FCDU-2-F 9,00 %9.00% Δn [589 nm, 20°C]:Δn [589 nm, 20 ° C]: 0,1005.1005 PUQU-2-FPUQU-2-F 11,00 %11.00% Δε [kHz, 20°C]:Δε [kHz, 20 ° C]: 14,114.1 PUQU-3-FPUQU-3-F 10,00 %10.00% γ1 [20°C, mPa.s]:γ 1 [20 ° C, mPa.s]: 9292 CCP-30CF3 CCP-30CF 3 8,00 %8.00% CCZU-3-FCCZU-3-F 11,50 %11.50% CC-4-VCC-4-V 10,00 %10.00% CC-5-VCC-5-V 3,00 %3.00% CC-3-V1CC-3-V1 11,00 %11.00% CCP-V2-1CCP-V2-1 13,00 %13.00% APUQU-2-FAPUQU-2-F 7,00 %7.00%

Beispiel M32Example M32

CCQU-2-FCCQU-2-F 10,00 %10.00% Klärpunkt [°C]:Clearing point [° C]: 82,082.0 CCQU-3-FCCQU-3-F 12,00 %12.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: 0,07920.0792 CCQU-5-FCCQU-5-F 8,00 %8.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 11,211.2 CCP-1 F.F,FCCP-1 F.F, F 6,00 %6.00% V10 [V]:V 10 [V]: 1,201.20 CCP-2F.F.FCCP 2F.F.F 5,00 %5.00% CCP-3F.F.FCCP 3F.F.F 5,00 %5.00% CC-3-V1CC-3-V1 10,00 %10.00% CC-4-VCC-4-V 14,00 %14.00% CGU-2-FCGU-2-F 5,00 %5.00% CCGU-3-FCCGU-3-F 5,00 %5.00% ACQG-3-FACQG-3-F 5,00 %5.00% ACQG-4-FACQG-4-F 5,00 %5.00% APUQU-2-FAPUQU-2-F 5,00 %5.00% APUQU-3-FAPUQU-3-F 5,00 %5.00%

Beispiel M33Example M33

CCQU-2-FCCQU-2-F 11,00 %11.00% Klärpunkt [°C]:Clearing point [° C]: 81,581.5 CCQU-3-FCCQU-3-F 13,00 %13.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: 0,0804.0804 CCQU-5-FCCQU-5-F 11,00 %11.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 13,613.6 CCP-1 F.F.FCCP-1 F.F.F 8,00 %8.00% γ1 [20 °C, mPa.s]:γ 1 [20 ° C, mPa.s]: 153153 CCP-2F.F.FCCP 2F.F.F 10,00 %10.00% V10[V]:V 10 [V]: 1,061.06 CCP-3F.F.FCCP 3F.F.F 10,00 %10.00% CCP-5F.F.FCCP 5F.F.F 6,00 %6.00% CC-3-V1CC-3-V1 9,00 %9.00% CGU-3-FCGU-3-F 4,00 %4.00% ACQG-3-FACQG-3-F 3,00 %3.00% ACQG-4-FACQG-4-F 5,00 %5.00% APUQU-2-FAPUQU-2-F 5,00 %5.00% APUQU-3-FAPUQU-3-F 5,00 %5.00%

Beispiel M34Example M34

CCH-5CF3 CCH-5CF 3 5,00 %5.00% Klärpunkt [°C]:Clearing point [° C]: 80,580.5 CCP-1 F.F.FCCP-1 F.F.F 5,00 %5.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: 0,06600.0660 CCP-2F.F.FCCP 2F.F.F 9,00 %9.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 9,79.7 CCP-3F.F.FCCP 3F.F.F 8,00 %8.00% V10 [V]:V 10 [V]: 1,271.27 CCP-5F.F.FCCP 5F.F.F 5,00 %5.00% CCP-20CF3.FCCP-20CF 3 .F 6,00 %6.00% CCP-50CF3.FCCP-50CF 3 .F 6,00 %6.00% CCOC-3-3CCOC-3-3 2,00 %2.00% CCOC-4-3CCOC-4-3 2,00%2.00% CCQU-2-FCCQU-2-F 10,00 %10.00% CCQU-3-FCCQU-3-F 12,00 %12.00% CCQU-5-FCCQU-5-F 8,00 %8.00% CCH-501CCH 501 6,00 %6.00% ACQG-3-FACQG-3-F 8,00 %8.00% ACQG-4-FACQG-4-F 8,00 %8.00%

Beispiel M35Example M35

CCP-1 F.F.FCCP-1 F.F.F 7,00 %7.00% Klärpunkt [°C]:Clearing point [° C]: 81,581.5 CCP-2F.F.FCCP 2F.F.F 8,00 %8.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: 0,06580.0658 CCP-3F.F.FCCP 3F.F.F 7,00 %7.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 13,513.5 CCP-5F.F.FCCP 5F.F.F 4,00 %4.00% V10[V]:V 10 [V]: 1,061.06 CCQU-2-FCCQU-2-F 11,00 %11.00% CCQU-3-FCCQU-3-F 12,00 %12.00% CCQU-5-FCCQU-5-F 8,00 %8.00% ACQU-2-FACQU-2-F 8,00 %8.00% ACQU-3-FACQU-3-F 9,00 %9.00% ACQU-5-FACQU-5-F 8,00 %8.00% ACQG-3-FACQG-3-F 7,00 %7.00% ACQG-4-FACQG-4-F 5,00 %5.00% CCOC-3-3CCOC-3-3 3,00 %3.00% CCOC-4-3CCOC-4-3 3,00 %3.00%

Beispiel M36Example M36

AUUQU-3-FAUUQU-3-F 6,00 %6.00% Klärpunkt [°C]:Clearing point [° C]: 98,098.0 AGUQU-3-FAGUQU-3-F 6,00 %6.00% Δn [589 nm, 20°C]:Δn [589 nm, 20 ° C]: 0,0927.0927 APUQU-2-FAPUQU-2-F 6,00%6.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 18,918.9 CGU-2-FCGU-2-F 5,00 %5.00% CGU-3-FCGU-3-F 5,00 %5.00% CGU-5-FCGU-5-F 5,00 %5.00% CCZU-2-FCCZU-2-F 5,50 %5.50% CCZU-3-FCCZU-3-F 10,50 %10.50% CCZU-5-FCCZU-5-F 5,50 %5.50% CCQU-2-FCCQU-2-F 10,00 %10.00% CCQU-3-FCCQU-3-F 10,00 %10.00% CCQU-5-FCCQU-5-F 10,00 %10.00% CC-5-VCC-5-V 9,50 %9.50% CCPC-33CCPC-33 2,00 %2.00% CCPC-34CCPC-34 2,00 %2.00% CCPC-35CCPC-35 2,00 %2.00%

Beispiel M37Example M37

CCQU-2-FCCQU-2-F 7,00 %7.00% Klärpunkt [°C]:Clearing point [° C]: 85,585.5 CCQU-3-FCCQU-3-F 8,00 %8.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: 0,0783.0783 CCQU-5-FCCQU-5-F 8,00 %8.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 11,6611.66 CCQG-3-FCCQG-3-F 6,00 %6.00% γ1 [20 °C, mPa·s]:γ 1 [20 ° C, mPa.s]: 213213 ACQU-2-FACQU-2-F 17,00 %17.00% V10 [V]:V 10 [V]: 0,900.90 ACQU-5-FACQU-5-F 16,00 %16.00% PUQU-2-FPUQU-2-F 5,00 %5.00% PUQU-3-FPUQU-3-F 5,00 %5.00% CCGU-3-FCCGU-3-F 5,00 %5.00% CCOC-4-3CCOC-4-3 3,00 %3.00% CCZU-2-FCCZU-2-F 3,00 %3.00% CCZU-3-FCCZU-3-F 14,00 %14.00% CCZU-5-FCCZU-5-F 3,00 %3.00%

Beispiel M38Example M38

BCH-3F.FBCH 3F.F 10,80 %10.80% Klärpunkt [°C]:Clearing point [° C]: 56,956.9 BCH-5F.FBCH 5F.F 9,00 %9.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: 0,0834.0834 ECCP-30CF3 ECCP-30CF 3 4,50 %4.50% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 4,14.1 ECCP-50CF3 ECCP-50CF 3 4,50 %4.50% γ1[20 °C, mPa·s]:γ 1 [20 ° C, mPa.s]: 6565 CBC-33FCBC 33F 1,80 %1.80% CBC-53FCBC-53F 1,80 %1.80% CBC-55FCBC-55F 1,80 %1.80% PCH-6FPCH-6F 7,20 %7.20% PCH-7FPCH-7F 5,40 %5.40% CCP-20CF3 CCP-20CF 3 7,20 %7.20% CCP-30CF3 CCP-30CF 3 10,80 %10.80% CCP-40CF3 CCP-40CF 3 6,30 %6.30% CCP-50CF3 CCP-50CF 3 9,90 %9.90% PCH-5FPCH-5F 9,00%9.00% AUUQPU-3-FAUUQPU-3-F 10,00 %10.00%

Beispiel M39Example M39

CCP-1 F.F.FCCP-1 F.F.F 3,00 %3.00% Klärpunkt [°C]:Clearing point [° C]: 79,579.5 CCP-2F.F.FCCP 2F.F.F 6,00 %6.00% Δn [589 nm, 20°C]:Δn [589 nm, 20 ° C]: 0,07960.0796 CCP-3F.F.FCCP 3F.F.F 7,00 %7.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 10,1210.12 CCP-5F.F.FCCP 5F.F.F 5,00 %5.00% γ1 [20°C, mPa·s]:γ 1 [20 ° C, mPa.s]: 202202 CCQU-2-FCCQU-2-F 11,00 %11.00% V10 [V]:V 10 [V]: 0,930.93 CCQU-3-FCCQU-3-F 12,00 %12.00% CCQU-5-FCCQU-5-F 8,00 %8.00% CGU-2-FCGU-2-F 4,00 %4.00% CGU-3-FCGU-3-F 7,00 %7.00% CCGU-3-FCCGU-3-F 9,00 %9.00% ACQU-2-FACQU-2-F 8,00 %8.00% ACQU-3-FACQU-3-F 10,00 %10.00% ACQU-4-FACQU-4-F 10,00 %10.00%

Beispiel M40Example M40

CCH-5CF3 CCH-5CF 3 2,00 %2.00% Klärpunkt [°C]:Clearing point [° C]: 79,579.5 CCP-2F.F.FCCP 2F.F.F 9,00 %9.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: 0,0659.0659 CCP-3F.F.FCCP 3F.F.F 7,00 %7.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 8,228.22 CCP-5F.F.FCCP 5F.F.F 4,00 %4.00% γ1 [20 °C, mPa.s]:γ 1 [20 ° C, mPa.s]: 169169 CCP-20CF3.FCCP-20CF 3 .F 7,00 %7.00% V10[V]:V 10 [V]: 1,141.14 CCP-50CF3.FCCP-50CF 3 .F 6,00 %6.00% CCOC-3-3CCOC-3-3 2,00 %2.00% CCOC-4-3CCOC-4-3 2,00 %2.00% CCQU-2-FCCQU-2-F 10,00 %10.00% CCQU-3-FCCQU-3-F 12,00 %12.00% CCQU-5-FCCQU-5-F 8,00 %8.00% ACQU-2-FACQU-2-F 8,00 %8.00% ACQU-3-FACQU-3-F 10,00 %10.00% ACQU-4-FACQU-4-F 8,00%8.00% CCH-501CCH 501 5,00 %5.00%

Beispiel M41Example M41

CCP-1 F.F.FCCP-1 F.F.F 6,00 %6.00% Klärpunkt [°C]:Clearing point [° C]: 80,080.0 CCP-2F.F.FCCP 2F.F.F 9,00 %9.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: 0,06940.0694 CCP-3F.F.FCCP 3F.F.F 10,00 %10.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 8,968.96 CCP-5F.F.FCCP 5F.F.F 6,00 %6.00% γ1 [20 °C, mPa·s]:γ 1 [20 ° C, mPa.s]: 175175 CCP-20CF3.FCCP-20CF 3 .F 4,00 %4.00% V10[V]:V 10 [V]: 1,111.11 CCP-50CF3.FCCP-50CF 3 .F 8,00 %8.00% CCQU-2-FCCQU-2-F 11,00 %11.00% CCQU-3-FCCQU-3-F 12,00 %12.00% CCQU-5-FCCQU-5-F 8,00 %8.00% ACQU-3-FACQU-3-F 26,00 %26.00%

Beispiel M42Example M42

CCP-1F.F.FCCP 1F.F.F 8,00 %8.00% Klärpunkt [°C]:Clearing point [° C]: 88,088.0 CCP-2F.F.FCCP 2F.F.F 7,00 %7.00% Δn [589 nm, 20°C]:Δn [589 nm, 20 ° C]: 0,07880.0788 CCP-3F.F.FCCP 3F.F.F 9,00 %9.00% Δε [kHz, 20°C]:Δε [kHz, 20 ° C]: 8,518.51 CCP-5F.F.FCCP 5F.F.F 6,00 %6.00% γ1 [20 °C, mPa-s]:γ 1 [20 ° C, mPa-s]: 192192 CCP-30CF3.FCCP-30CF 3 .F 9,00 %9.00% V10[V]:V 10 [V]: 1,131.13 CCP-50CF3.FCCP-50CF 3 .F 9,00 %9.00% CGU-2-FCGU-2-F 5,00 %5.00% CCGU-3-FCCGU-3-F 5,00 %5.00% CCQU-2-FCCQU-2-F 11,00 %11.00% CCQU-3-FCCQU-3-F 12,00 %12.00% CCQU-5-FCCQU-5-F 8,00 %8.00% ACQU-3-FACQU-3-F 6,00 %6.00% ACQU-4-FACQU-4-F 5,00 %5.00%

Beispiel M43Example M43

CCP-1F.F.FCCP 1F.F.F 2,00 %2.00% Klärpunkt [°C]:Clearing point [° C]: 81,081.0 CCP-20CF3 CCP-20CF 3 8,00 %8.00% Δn [589 nm, 20 °C]:Δn [589 nm, 20 ° C]: 0,07850.0785 CCP-30CF3 CCP-30CF 3 8,00 %8.00% Δε [kHZ, 20°C]:Δε [kHZ, 20 ° C]: 7,277.27 CCP-40CF3 CCP-40CF 3 6,00 %6.00% γ1 [20°C, mPa·s]:γ 1 [20 ° C, mPa.s]: 108108 CCP-50CF3 CCP-50CF 3 8,00 %8.00% V10 [V]:V 10 [V]: 1,341.34 CCP-20CF3.FCCP-20CF 3 .F 12,00 %12.00% ACQU-2-FACQU-2-F 8,00 %8.00% ACQU-3-FACQU-3-F 8,00 %8.00% ACQU-4-FACQU-4-F 8,00 %8.00% PUQU-2-FPUQU-2-F 5,00 %5.00% PUQU-3-FPUQU-3-F 7,00%7.00% CC-3-V1CC-3-V1 8,00%8.00% CC-4-VCC-4-V 9,00 %9.00% CCOC-4-3CCOC-4-3 3,00 %3.00%

Beispiel M44Example M44

CC-3-V1CC-3-V1 5,00 %5.00% S → N [°C]:S → N [° C]: < 20,0<20.0 CCP-1 F.F.FCCP-1 F.F.F 8,00 %8.00% Klärpunkt [°C]:Clearing point [° C]: 82,582.5 CCP-2F.F.FCCP 2F.F.F 10,00 %10.00% An [589 nm, 20°C]:At [589 nm, 20 ° C]: 0,0939.0939 CCQU-2-FCCQU-2-F 10,00 %10.00% Δε [kHz, 20 °C]:Δε [kHz, 20 ° C]: 10,610.6 CCQU-3-FCCQU-3-F 5,00 %5.00% γ1 [20 °C, mPa·s]:γ 1 [20 ° C, mPa.s]: 128128 CCP-20CF3 CCP-20CF 3 8,00 %8.00% V10[V]:V 10 [V]: 1,191.19 CCP-30CF3 CCP-30CF 3 8,00 %8.00% CGU-2-FCGU-2-F 9,00 %9.00% PGU-3-FPGU-3-F 5,00 %5.00% CCP-V-1CCP-V-1 6,00 %6.00% CCG-V-FCCG V F 18,00 %18.00% APUQU-3-FAPUQU-3-F 8,00 %8.00%

Beispiel M45Example M45

CCP-2F.F.FCCP 2F.F.F 7,00 %7.00% Klärpunkt [°C]:Clearing point [° C]: 88,088.0 CCP-3F.F.FCCP 3F.F.F 6,00 %6.00% Δn [589 nm, 20°C]:Δn [589 nm, 20 ° C]: 0,07200.0720 CCP-5F.F.FCCP 5F.F.F 6,00 %6.00% Δε [kHz, 20°C]:Δε [kHz, 20 ° C]: 16,116.1 ACQU-2-FACQU-2-F 10,00 %10.00% γ1 [20 °C, mPa·s]:γ 1 [20 ° C, mPa.s]: 210210 ACQU-3-FACQU-3-F 10,00 %10.00% V10[V]:V 10 [V]: 0,970.97 ACQU-5-FACQU-5-F 11,00 %11.00% CCQU-2-FCCQU-2-F 10,00 %10.00% CCQU-3-FCCQU-3-F 12,00 %12.00% CCQU-5-FCCQU-5-F 10,00 %10.00% CCGU-3-FCCGU-3-F 5,00 %5.00% CCZU-2-FCCZU-2-F 4,00 %4.00% CCZU-3-FCCZU-3-F 9,00.%9.00.%

Claims (10)

  1. Liquid-crystalline compounds of the formula I
    Figure imgb0336
    in which
    R1 and R2 each, independently of one another, denote H, halogen, a halogenated or unsubstituted alkyl or alkoxy radical having 1 to 15 C atoms, where, in addition, one or more CH2 groups in these radicals may each, independently of one another, be replaced by -C≡C-, -CH=CH-, -O-, -CO-O- or -O-CO- in such a way that O atoms are not linked directly to one another, where one of the radicals R1 and R2 may alternatively denote CN, OCN, SCN, NCS or SF5,
    A1, A2, A3 and A4 each, independently of one another, denote
    Figure imgb0337
    Figure imgb0338
    Figure imgb0339
    or
    Figure imgb0340
    Z1, Z2 and Z3 each, independently of one another, denote -CO-O-, -O-CO-, -CF2O-, -OCF2-, -CH2O-, -OCH2-, -CH2CH2-, -(CH2)4-, -C2F4-, -CH2CF2-, -CF2CH2-, -CF=CF-, -CH=CH-, -C≡C- or a single bond, and
    a, b and c each, independently of one another, denote 0, 1, 2 or 3, where a + b + c ≤ 3.
  2. Liquid-crystalline compounds of the formula IA
    Figure imgb0341
    in which
    R1, R2, a and b have the meanings indicated in Claim 1, where a + b = 1 or 2, and
    L1 and L2 each, independently of one another, denote H or F.
  3. Liquid-crystalline compounds according to Claim 1 or 2, characterised in that a = 1 and b = 0 or a=0 and b=1.
  4. Liquid-crystalline compounds according to Claim 2, characterised in that L1 denotes fluorine and L2 denotes fluorine or hydrogen.
  5. Liquid-crystalline compounds according to Claim 2, characterised in that L1 and L2 denote fluorine.
  6. Liquid-crystalline compounds of the formulae 11 to 131
    Figure imgb0342
    Figure imgb0343
    Figure imgb0344
    Figure imgb0345
    Figure imgb0346
    Figure imgb0347
    Figure imgb0348
    Figure imgb0349
    Figure imgb0350
    Figure imgb0351
    Figure imgb0352
    Figure imgb0353
    Figure imgb0354
    Figure imgb0355
    Figure imgb0356
    Figure imgb0357
    Figure imgb0358
    Figure imgb0359
    Figure imgb0360
    Figure imgb0361
    Figure imgb0362
    Figure imgb0363
    Figure imgb0364
    Figure imgb0365
    Figure imgb0366
    Figure imgb0367
    Figure imgb0368
    Figure imgb0369
    Figure imgb0370
    Figure imgb0371
    Figure imgb0372
    in which R1 has the meanings indicated in Claim 1 and X has the meaning of R2.
  7. Liquid-crystalline medium comprising at least two mesogenic compounds, characterised in that it comprises at least one compound of the formula I according to Claim 1.
  8. Liquid-crystalline medium according to Claim 7, characterised in that it comprises one or more compounds selected from the group consisting of the general formulae II to IX
    Figure imgb0373
    Figure imgb0374
    Figure imgb0375
    Figure imgb0376
    Figure imgb0377
    Figure imgb0378
    Figure imgb0379
    Figure imgb0380
    in which
    R0 denotes n-alkyl, oxaalkyl, fluoroalkyl, alkenyloxy or alkenyl, each having up to 9 C atoms,
    X0 denotes F, Cl, halogenated alkyl, halogenated alkenyl, halogenated alkenyloxy or halogenated alkoxy having up to 7 C atoms,
    Z0 denotes -CH=CH-, -C2H4-, -(CH2)4-, -C2F4-, -CH2O-, -OCH2-, -CF=CF-, -CF2O-, -OCF2- or -COO-,
    Y1,Y2, Y3 and Y4 each, independently of one another, denote H or F, and
    r denotes 0 or 1.
  9. Use of the liquid-crystalline medium according to Claim 7 or 8 for electro-optical purposes.
  10. Electro-optical liquid-crystal display containing a liquid-crystalline medium according to Claim 7 or 8.
EP03811758A 2002-11-27 2003-11-17 Liquid crystalline compounds Expired - Lifetime EP1565540B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10255311 2002-11-27
DE10255311 2002-11-27
PCT/EP2003/012813 WO2004048501A1 (en) 2002-11-27 2003-11-17 Liquid crystalline compounds

Publications (2)

Publication Number Publication Date
EP1565540A1 EP1565540A1 (en) 2005-08-24
EP1565540B1 true EP1565540B1 (en) 2007-09-26

Family

ID=32308747

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03811758A Expired - Lifetime EP1565540B1 (en) 2002-11-27 2003-11-17 Liquid crystalline compounds

Country Status (10)

Country Link
US (1) US7291367B2 (en)
EP (1) EP1565540B1 (en)
JP (2) JP4711392B2 (en)
KR (1) KR101070102B1 (en)
CN (2) CN101294079B (en)
AT (1) ATE374232T1 (en)
AU (1) AU2003302394A1 (en)
DE (2) DE10353658A1 (en)
TW (1) TWI320054B (en)
WO (1) WO2004048501A1 (en)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10243776B4 (en) * 2001-09-29 2017-11-16 Merck Patent Gmbh Liquid crystalline compounds
US7291367B2 (en) * 2002-11-27 2007-11-06 Merck Patent Gmbh Liquid-crystalline compounds
ATE366247T1 (en) * 2002-11-27 2007-07-15 Merck Patent Gmbh TETRAHYDROPYRAN DERIVATIVES
DE102004004884B4 (en) 2003-02-25 2018-08-23 Merck Patent Gmbh Liquid crystal medium and its use in an electro-optical liquid crystal display
DE102004025809A1 (en) 2003-05-27 2004-12-16 Merck Patent Gmbh 4-(tetrahydropyran-2-yl)-1-substituted-terphenyl liquid crystal compounds used in liquid crystal medium for electrooptical purposes, especially in matrix, in-plane switching and twisted and supertwisted nematic displays are new
DE502004010915D1 (en) * 2003-07-11 2010-04-29 Merck Patent Gmbh LIQUID CRYSTALLINE MEDIUM WITH MONOFLUOR TERPHENYL COMPOUNDS
US7419706B2 (en) 2003-08-25 2008-09-02 Merck Patent Gesellschaft Mit Beschrankter Haftung Liquid crystalline medium
US7317124B2 (en) 2003-11-13 2008-01-08 Sanofi-Aventis Deutschland Gmbh Ortho-substituted pentafluorosulfanylbenzenes, process for their preparation and their use as valuable synthetic intermediates
FR2873922B1 (en) 2004-08-06 2008-10-17 Mane Fils Sa V BETA-SUBSTITUTED TETRAHYDROPYRAN (ON), PROCESS FOR THEIR SYNTHESIS AND THEIR USE IN PERFUMERY
CN101031631B (en) * 2004-10-04 2013-02-13 Jnc株式会社 Liquid crystal composition and liquid crystal display element
EP1831190A2 (en) * 2004-10-07 2007-09-12 Merck Patent GmbH Chroman derivatives and use thereof in liquid crystal media
JP2006199941A (en) * 2004-12-20 2006-08-03 Chisso Corp Liquid crystalline composition containing chroman ring compound
WO2006125511A1 (en) * 2005-05-25 2006-11-30 Merck Patent Gmbh Pyran/dioxan derivatives and use thereof in liquid crystal media
JP5260279B2 (en) * 2005-05-25 2013-08-14 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Process for the preparation of 2,5-2 substituted tetrahydropyran derivatives by reductive elimination of the corresponding 4-halogen derivatives
JP5259391B2 (en) * 2005-05-25 2013-08-07 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Process for the preparation of tetrahydropyran derivatives
ATE417910T1 (en) * 2005-05-25 2009-01-15 Merck Patent Gmbh LIQUID CRYSTAL MEDIUM AND LIQUID CRYSTAL DISPLAY
WO2007079949A1 (en) * 2006-01-10 2007-07-19 Merck Patent Gmbh Liquid crystal medium
EP1808473B1 (en) 2006-01-13 2010-02-10 Merck Patent GmbH Liquid crystal medium
DE602006012167D1 (en) * 2006-01-13 2010-03-25 Merck Patent Gmbh Liquid crystalline medium
US7553523B2 (en) * 2006-01-13 2009-06-30 Merck Patent Gmbh Liquid crystal medium
DE602006009892D1 (en) * 2006-01-27 2009-12-03 Merck Patent Gmbh Liquid-crystalline medium and liquid-crystal display
EP1845147B1 (en) * 2006-04-13 2011-09-28 Merck Patent GmbH Liquid-crystalline compounds
JP5098247B2 (en) * 2006-08-02 2012-12-12 Jnc株式会社 Liquid crystal composition and liquid crystal display element
JP5098249B2 (en) * 2006-08-07 2012-12-12 Jnc株式会社 Liquid crystal composition and liquid crystal display element
EP1887069B1 (en) * 2006-08-11 2010-11-10 Merck Patent GmbH Bicyclooctyl reactive mesogens
US8465672B2 (en) * 2006-08-18 2013-06-18 Merck Patent Gmbh Tetrahydropyran compounds
KR20080028572A (en) * 2006-09-27 2008-04-01 삼성전자주식회사 Liquid crystal composition and liquid crystal display comprising the same
EP2248872B1 (en) 2006-10-04 2013-01-09 Merck Patent GmbH Liquid crystalline medium
DE102007007143A1 (en) * 2006-10-04 2008-04-10 Merck Patent Gmbh Liquid crystalline medium
ATE458796T1 (en) * 2006-11-27 2010-03-15 Merck Patent Gmbh LIQUID CRYSTAL MEDIUM AND LIQUID CRYSTAL DISPLAY
EP1925653B1 (en) 2006-11-27 2010-02-24 MERCK PATENT GmbH Liquid crystalline medium and liquid crystal display
US7951433B2 (en) 2007-02-28 2011-05-31 Chisso Corporation Five-ring liquid crystal compound having CF2O bonding group, liquid crystal composition, and liquid crystal display device
JP5470757B2 (en) * 2007-08-29 2014-04-16 Jnc株式会社 Optically isotropic liquid crystal medium and optical element
US10133719B2 (en) * 2007-09-28 2018-11-20 Microsoft Technology Licensing, Llc Spreadsheet workbook part libraries
DE102008024866A1 (en) 2007-12-21 2009-06-25 Merck Patent Gmbh Liquid crystalline medium
KR20090068709A (en) * 2007-12-24 2009-06-29 삼성전자주식회사 Liquid crystal composition and liquid crystlal display device having the same
JP5524092B2 (en) * 2008-03-10 2014-06-18 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Liquid crystal media
JP5561162B2 (en) * 2008-06-09 2014-07-30 Jnc株式会社 Pentacyclic liquid crystal compound having cyclohexane ring, liquid crystal composition, and liquid crystal display element
JP5359053B2 (en) * 2008-06-24 2013-12-04 Jnc株式会社 Liquid crystal composition and liquid crystal display element
JP5359055B2 (en) * 2008-06-25 2013-12-04 Jnc株式会社 Liquid crystal composition and liquid crystal display element
US8030512B2 (en) * 2008-10-20 2011-10-04 Ube Industries, Ltd. Polycyclic pentafluorosulfanylbenzene compound and process for producing the compound
WO2010047260A1 (en) 2008-10-21 2010-04-29 チッソ株式会社 Pentacyclic liquid crystal compound having nitrogen-containing heterocyclic ring, liquid crystal composition, and liquid crystal display element
JP5359545B2 (en) * 2009-05-20 2013-12-04 Jnc株式会社 Liquid crystal composition and liquid crystal display element
EP2368966B1 (en) * 2010-03-23 2013-05-15 Merck Patent GmbH Liquid crystalline compounds and liquid crystalline media
DE102011015813A1 (en) 2010-04-17 2011-10-20 Merck Patent Gmbh Liquid crystalline compounds and liquid crystalline media
JP5720114B2 (en) * 2010-04-27 2015-05-20 Jnc株式会社 Liquid crystal compound, liquid crystal composition, and liquid crystal display device
EP2457975B1 (en) * 2010-11-29 2014-06-25 Merck Patent GmbH Liquid-crystalline mixtures
US10047292B2 (en) 2010-12-17 2018-08-14 Merck Patent Gmbh Liquid-crystalline medium
DE102011122559A1 (en) 2011-01-25 2012-07-26 Merck Patent Gmbh Liquid crystalline compounds and liquid crystalline media
CN103781877B (en) * 2011-09-06 2017-12-12 默克专利股份有限公司 Liquid crystal media and liquid crystal display
GB201301786D0 (en) 2012-02-15 2013-03-20 Merck Patent Gmbh Liquid-crystalline medium
CN102618296B (en) * 2012-02-17 2013-09-11 北京八亿时空液晶科技股份有限公司 Liquid crystal compound and preparation method thereof
WO2013182271A1 (en) * 2012-06-05 2013-12-12 Merck Patent Gmbh Liquid crystal medium and liquid crystal display
CN103333146A (en) * 2012-06-20 2013-10-02 石家庄诚志永华显示材料有限公司 Liquid crystal compounds containing 2-alkyltetrahydropyrane structure, and preparation method and application thereof
CN103319444B (en) * 2012-06-20 2016-01-27 石家庄诚志永华显示材料有限公司 Liquid crystalline cpd containing 4-tetrahydropyrans structure and preparation method thereof and application
DE102012014896A1 (en) * 2012-07-26 2014-02-13 Merck Patent Gmbh Preparing tetrahydropyran derivatives comprises cyclizing 4-pentenyl alcohol compound
WO2014030482A1 (en) 2012-08-22 2014-02-27 Dic株式会社 Nematic liquid crystal composition
KR101555596B1 (en) 2012-08-22 2015-09-24 디아이씨 가부시끼가이샤 Nematic liquid crystal composition
US20150322343A1 (en) * 2012-10-17 2015-11-12 Dic Corporation Nematic liquid crystal composition
KR101555599B1 (en) * 2012-10-17 2015-09-24 디아이씨 가부시끼가이샤 Nematic liquid crystal composition
JP6299020B2 (en) * 2012-10-23 2018-03-28 Jnc株式会社 Liquid crystal compound, liquid crystal medium, and optical element
DE102012020940B4 (en) * 2012-10-25 2014-12-11 Merck Patent Gmbh Liquid-crystalline medium and its use in an electro-optical liquid crystal display
TW201432032A (en) * 2012-11-09 2014-08-16 Dainippon Ink & Chemicals Liquid crystal composition, and liquid crystal display element using same
JP5850023B2 (en) 2012-11-27 2016-02-03 Jnc株式会社 Liquid crystal compound, liquid crystal composition and liquid crystal display element having CF2OCF3 at terminal
US20150252263A1 (en) * 2012-12-27 2015-09-10 Dic Corporation Fluorobiphenyl-containing composition
US9441160B2 (en) 2012-12-27 2016-09-13 Dic Corporation Fluorobiphenyl-containing composition
JP5459456B1 (en) * 2013-02-20 2014-04-02 Dic株式会社 Liquid crystal composition, liquid crystal display element and liquid crystal display
JP5828367B2 (en) * 2013-03-12 2015-12-02 Dic株式会社 Liquid crystal composition, liquid crystal display element and liquid crystal display
WO2014155491A1 (en) * 2013-03-25 2014-10-02 Dic株式会社 Liquid crystal composition and liquid crystal display element employing same
TWI629344B (en) * 2013-03-26 2018-07-11 迪愛生股份有限公司 Liquid crystal composition, and liquid crystal display element using the same
JP5477502B1 (en) * 2013-08-09 2014-04-23 Dic株式会社 Fluorobibiphenyl-containing composition
WO2015029876A1 (en) 2013-08-30 2015-03-05 Dic株式会社 Nematic liquid crystal composition
WO2015037517A1 (en) * 2013-09-12 2015-03-19 Dic株式会社 Composition and liquid crystal display element using same
KR20160058093A (en) * 2013-09-12 2016-05-24 디아이씨 가부시끼가이샤 Composition and liquid crystal display element using same
CN103787845A (en) 2014-01-21 2014-05-14 石家庄诚志永华显示材料有限公司 Deuterium-substituted difluoro-oxymethane derivative
CN103773389B (en) * 2014-01-22 2015-09-09 石家庄诚志永华显示材料有限公司 Containing the liquid-crystal composition of pyranylation compound
CN103820128B (en) * 2014-01-25 2016-04-06 石家庄诚志永华显示材料有限公司 A kind of positive dielectric anisotropy liquid crystal composition
CN103788039B (en) * 2014-03-12 2016-09-07 石家庄诚志永华显示材料有限公司 Liquid-crystal compounds containing oxinane difluoromethylenedioconnecting linking group and preparation method and application
CN104031654B (en) * 2014-05-28 2016-06-15 石家庄诚志永华显示材料有限公司 Containing the liquid-crystal composition of difluoro methylene based compound
CN104031653A (en) * 2014-05-28 2014-09-10 石家庄诚志永华显示材料有限公司 Liquid crystal composition containing difluoromethylene ether compound
WO2016017615A1 (en) 2014-07-31 2016-02-04 Dic株式会社 Nematic liquid crystal composition
JP5910800B1 (en) * 2014-07-31 2016-04-27 Dic株式会社 Nematic liquid crystal composition
CN105481662B (en) * 2014-09-18 2017-10-24 江苏和成新材料有限公司 The method for preparing the intermediate for producing the liquid-crystal compounds containing difluoro-methoxy
CN104449761A (en) 2014-11-20 2015-03-25 蒋战英 Liquid crystal compound containing difluoromethoxy bridged bonds and application thereof
CN104498053B (en) 2014-11-27 2016-05-11 北京八亿时空液晶科技股份有限公司 A kind of liquid-crystal compounds that contains difluoro-methoxy bridged bond, composition and application thereof
CN104479688B (en) 2014-11-27 2016-06-29 北京八亿时空液晶科技股份有限公司 A kind of containing the liquid-crystal compounds of difluoro-methoxy bridged bond, compositions and application thereof
DE102016009363A1 (en) * 2015-08-07 2017-02-09 Merck Patent Gmbh Liquid crystalline medium
US20190040319A1 (en) 2016-03-25 2019-02-07 Jnc Corporation Liquid crystal composition and liquid crystal display device
EP3375842A1 (en) 2017-03-16 2018-09-19 Merck Patent GmbH Liquid-crystalline medium

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3306960A1 (en) * 1983-02-28 1984-08-30 Merck Patent Gmbh, 6100 Darmstadt TETRAHYDROPYRANE
GB2229438B (en) * 1989-03-18 1993-06-16 Merck Patent Gmbh Difluoromethylene compounds and liquid crystalline-media containing such compounds
JP3823354B2 (en) * 1995-12-05 2006-09-20 チッソ株式会社 Alkenyl compound having an oxygen atom-containing linking group, liquid crystal composition, and liquid crystal display device
EP1043299B1 (en) * 1996-04-02 2008-10-15 Chisso Corporation Liquid crystalline compound, liquid crystal composition comprising the liquid crystalline compound, and liquid crystal display device using the liquid crystal composition
DE10008712B4 (en) * 1999-02-27 2012-10-11 Merck Patent Gmbh Liquid-crystalline medium and its use
JP4547742B2 (en) * 1999-10-13 2010-09-22 チッソ株式会社 Liquid crystal composition and liquid crystal display element
DE10124480B4 (en) * 2000-06-28 2009-12-03 Merck Patent Gmbh Pentafluorosulfuranylbenzene derivatives and their use
JP4734579B2 (en) 2000-08-10 2011-07-27 Jnc株式会社 Difluoromethyl ether derivative and process for producing the same
DE10229476B4 (en) * 2001-07-25 2011-05-05 Merck Patent Gmbh Liquid crystalline compounds, liquid crystalline media containing them and their use for electro-optical purposes
DE10243776B4 (en) * 2001-09-29 2017-11-16 Merck Patent Gmbh Liquid crystalline compounds
DE10150198A1 (en) * 2001-10-12 2003-04-24 Merck Patent Gmbh Liquid crystalline medium
DE10204790A1 (en) * 2002-02-06 2003-08-14 Merck Patent Gmbh Liquid crystalline medium
DE10303638B4 (en) * 2002-02-28 2018-10-04 Merck Patent Gmbh Axial substituted cyclohexylene derivative and liquid crystalline medium
ATE362501T1 (en) * 2002-09-30 2007-06-15 Merck Patent Gmbh LIQUID CRYSTALLINE MEDIUM
US7291367B2 (en) * 2002-11-27 2007-11-06 Merck Patent Gmbh Liquid-crystalline compounds
DE10359469A1 (en) * 2002-12-21 2004-07-08 Merck Patent Gmbh New fluorinated pyran liquid crystalline compounds are useful for liquid crystal media for optoelectronic applications including twisted nematic, super twisted nematic and in-plane switching

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
JP5314709B2 (en) 2013-10-16
US7291367B2 (en) 2007-11-06
DE50308290D1 (en) 2007-11-08
JP2006508150A (en) 2006-03-09
TWI320054B (en) 2010-02-01
US20060061699A1 (en) 2006-03-23
CN101294079A (en) 2008-10-29
WO2004048501A1 (en) 2004-06-10
ATE374232T1 (en) 2007-10-15
CN101294079B (en) 2013-06-19
JP4711392B2 (en) 2011-06-29
EP1565540A1 (en) 2005-08-24
DE10353658A1 (en) 2004-06-09
KR20050086861A (en) 2005-08-30
AU2003302394A1 (en) 2004-06-18
JP2011136998A (en) 2011-07-14
KR101070102B1 (en) 2011-10-05
TW200418961A (en) 2004-10-01
CN1717468A (en) 2006-01-04

Similar Documents

Publication Publication Date Title
EP1565540B1 (en) Liquid crystalline compounds
EP1302523B1 (en) Liquid crystalline medium
DE10243776B4 (en) Liquid crystalline compounds
EP1436358B1 (en) Liquid crystal compounds
EP1248826B1 (en) Liquid crystalline medium
DE102004058002B4 (en) Liquid-crystalline medium and its use
DE102007009944B4 (en) Liquid-crystalline medium and its use
DE10229476B4 (en) Liquid crystalline compounds, liquid crystalline media containing them and their use for electro-optical purposes
EP1341746B1 (en) Liquid crystalline compounds
DE10225048B4 (en) Fluorinated (dihydro) phenanthrene derivatives and their use in liquid-crystalline media
DE102004056901B4 (en) Liquid-crystalline medium and its use
EP1746079B1 (en) Fluorinated biphenyl compounds for use in liquid crystal compositions
EP2542648B1 (en) Liquid-crystalline medium
DE10128017B4 (en) Liquid-crystalline medium and its use
DE112007000676B4 (en) Liquid-crystalline medium and its use
DE10318420A1 (en) Liquid crystalline compounds for use in media for electro-optical displays, e.g. in cars or aircraft, comprise compounds with tetrahydropyran-3,6- diyl and oxydifluoromethylene linking groups
DE102004024456B4 (en) Liquid-crystalline medium and its use
DE10158803A1 (en) Production of difluoromethoxy-bridged compounds, involves addition of acid to ketene dithioketal, reaction of the carbenium salt with hydroxy compound and fluorodesulfurisation of the dithio-ortho-ester
EP1255799B1 (en) Liquid crystalline phenol esters
DE10338111B4 (en) Liquid crystalline medium
DE10136751B4 (en) 4-core and 5-core compounds and their use in liquid-crystalline media
DE10002462B4 (en) Liquid-crystalline medium and its use
DE10058661A1 (en) Liquid crystalline medium, useful for electro-optical displays, comprises mixture of polar compounds with positive dielectric anisotropy and fluorinated compound with aromatic ester group
DE102006052123B4 (en) Liquid-crystalline medium and its use for electro-optical purposes
EP1416030A1 (en) Liquid crystalline medium

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050407

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20051125

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIN1 Information on inventor provided before grant (corrected)

Inventor name: KIRSCH, PEER

Inventor name: HECKMEIER, MICHAEL

Inventor name: HOCK, CHRISTIAN

Inventor name: HAHN, ALEXANDER

Inventor name: LUESSEM, GEORG

Inventor name: POETSCH, EIKE

Inventor name: KLASEN-MEMMER, MELANIE

Inventor name: MEYER, VOLKER

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REF Corresponds to:

Ref document number: 50308290

Country of ref document: DE

Date of ref document: 20071108

Kind code of ref document: P

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: GERMAN

RIN2 Information on inventor provided after grant (corrected)

Inventor name: POETSCH, EIKE

Inventor name: HOCK, CHRISTIAN

Inventor name: BRIGITTE SCHULER

Inventor name: HAHN, ALEXANDER

Inventor name: KLASEN-MEMMER, MELANIE

Inventor name: HECKMEIER, MICHAEL

Inventor name: KIRSCH, PEER

Inventor name: LUESSEM, GEORG

Inventor name: MEYER, VOLKER

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070926

GBT Gb: translation of ep patent filed (gb section 77(6)(a)/1977)

Effective date: 20080110

NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080106

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070926

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20071227

REG Reference to a national code

Ref country code: IE

Ref legal event code: FD4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070926

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080226

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070926

BERE Be: lapsed

Owner name: MERCK PATENT G.M.B.H.

Effective date: 20071130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20071226

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20071130

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070926

EN Fr: translation not filed
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20071130

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070926

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20071130

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20080627

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20071130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080704

Ref country code: IE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070926

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070926

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20071117

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070926

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070926

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20071226

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20071117

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070926

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080327

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20071130

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20201104

Year of fee payment: 18

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20211117

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20211117

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20220921

Year of fee payment: 20

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230518

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 50308290

Country of ref document: DE